id	sid	tid	token	lemma	pos
iajs-3750	1	1	256	256	NUM
iajs-3750	1	2	©	©	ADP
iajs-3750	1	3	2025	2025	NUM
iajs-3750	1	4	the	the	DET
iajs-3750	1	5	author(s	author(s	NOUN
iajs-3750	1	6	)	)	PUNCT
iajs-3750	1	7	.	.	PUNCT
iajs-3750	2	1	published	publish	VERB
iajs-3750	2	2	by	by	ADP
iajs-3750	2	3	college	college	NOUN
iajs-3750	2	4	of	of	ADP
iajs-3750	2	5	education	education	NOUN
iajs-3750	2	6	for	for	ADP
iajs-3750	2	7	pure	pure	ADJ
iajs-3750	2	8	science	science	NOUN
iajs-3750	2	9	(	(	PUNCT
iajs-3750	2	10	ibn	ibn	PROPN
iajs-3750	2	11	al	al	PROPN
iajs-3750	2	12	-	-	PUNCT
iajs-3750	2	13	haitham	haitham	PROPN
iajs-3750	2	14	)	)	PUNCT
iajs-3750	2	15	,	,	PUNCT
iajs-3750	2	16	university	university	NOUN
iajs-3750	2	17	of	of	ADP
iajs-3750	2	18	baghdad	baghdad	PROPN
iajs-3750	2	19	.	.	PUNCT
iajs-3750	3	1	this	this	PRON
iajs-3750	3	2	is	be	AUX
iajs-3750	3	3	an	an	DET
iajs-3750	3	4	open	open	ADJ
iajs-3750	3	5	-	-	PUNCT
iajs-3750	3	6	access	access	NOUN
iajs-3750	3	7	article	article	NOUN
iajs-3750	3	8	distributed	distribute	VERB
iajs-3750	3	9	under	under	ADP
iajs-3750	3	10	the	the	DET
iajs-3750	3	11	terms	term	NOUN
iajs-3750	3	12	of	of	ADP
iajs-3750	3	13	the	the	DET
iajs-3750	3	14	creative	creative	ADJ
iajs-3750	3	15	commons	common	NOUN
iajs-3750	3	16	attribution	attribution	NOUN
iajs-3750	3	17	4.0	4.0	NUM
iajs-3750	3	18	international	international	ADJ
iajs-3750	3	19	license	license	NOUN
iajs-3750	3	20	measurement	measurement	NOUN
iajs-3750	3	21	of	of	ADP
iajs-3750	3	22	some	some	DET
iajs-3750	3	23	biochemical	biochemical	ADJ
iajs-3750	3	24	parameters	parameter	NOUN
iajs-3750	3	25	in	in	ADP
iajs-3750	3	26	metabolic	metabolic	NOUN
iajs-3750	3	27	syndrome	syndrome	PROPN
iajs-3750	3	28	suhair	suhair	NOUN
iajs-3750	3	29	abdul	abdul	PROPN
iajs-3750	3	30	-	-	PUNCT
iajs-3750	3	31	raheem	raheem	PROPN
iajs-3750	3	32	ahmed	ahme	VERB
iajs-3750	3	33	1	1	NUM
iajs-3750	3	34	and	and	CCONJ
iajs-3750	3	35	israa	israa	ADJ
iajs-3750	3	36	fadhil	fadhil	NOUN
iajs-3750	3	37	ascar	ascar	VERB
iajs-3750	3	38	2	2	NUM
iajs-3750	3	39	*	*	SYM
iajs-3750	3	40	1,2	1,2	NUM
iajs-3750	3	41	department	department	NOUN
iajs-3750	3	42	of	of	ADP
iajs-3750	3	43	chemistry	chemistry	NOUN
iajs-3750	3	44	,	,	PUNCT
iajs-3750	3	45	college	college	NOUN
iajs-3750	3	46	of	of	ADP
iajs-3750	3	47	science	science	NOUN
iajs-3750	3	48	for	for	ADP
iajs-3750	3	49	women	woman	NOUN
iajs-3750	3	50	,	,	PUNCT
iajs-3750	3	51	university	university	NOUN
iajs-3750	3	52	of	of	ADP
iajs-3750	3	53	baghdad	baghdad	PROPN
iajs-3750	3	54	,	,	PUNCT
iajs-3750	3	55	baghdad	baghdad	PROPN
iajs-3750	3	56	,	,	PUNCT
iajs-3750	3	57	iraq	iraq	PROPN
iajs-3750	3	58	.	.	PUNCT
iajs-3750	4	1	*	*	PUNCT
iajs-3750	4	2	corresponding	correspond	VERB
iajs-3750	4	3	author	author	NOUN
iajs-3750	4	4	.	.	PUNCT
iajs-3750	5	1	received	receive	VERB
iajs-3750	5	2	:	:	PUNCT
iajs-3750	5	3	32	32	NUM
iajs-3750	5	4	september	september	PROPN
iajs-3750	5	5	2023	2023	NUM
iajs-3750	5	6	accepted	accept	VERB
iajs-3750	5	7	:	:	PUNCT
iajs-3750	5	8	2	2	NUM
iajs-3750	5	9	january	january	NOUN
iajs-3750	5	10	2024	2024	NUM
iajs-3750	5	11	published	publish	VERB
iajs-3750	5	12	:	:	PUNCT
iajs-3750	5	13	20	20	NUM
iajs-3750	5	14	july	july	NOUN
iajs-3750	5	15	2025	2025	NUM
iajs-3750	5	16	doi.org/10.30526/38.3.3750	doi.org/10.30526/38.3.3750	NOUN
iajs-3750	5	17	abstract	abstract	ADJ
iajs-3750	5	18	patients	patient	NOUN
iajs-3750	5	19	with	with	ADP
iajs-3750	5	20	diabetes	diabetes	NOUN
iajs-3750	5	21	,	,	PUNCT
iajs-3750	5	22	high	high	ADJ
iajs-3750	5	23	blood	blood	NOUN
iajs-3750	5	24	pressure	pressure	NOUN
iajs-3750	5	25	(	(	PUNCT
iajs-3750	5	26	bp	bp	PROPN
iajs-3750	5	27	)	)	PUNCT
iajs-3750	5	28	,	,	PUNCT
iajs-3750	5	29	and	and	CCONJ
iajs-3750	5	30	obesity	obesity	NOUN
iajs-3750	5	31	have	have	VERB
iajs-3750	5	32	metabolic	metabolic	NOUN
iajs-3750	5	33	syndrome	syndrome	NOUN
iajs-3750	5	34	(	(	PUNCT
iajs-3750	5	35	mets	met	NOUN
iajs-3750	5	36	)	)	PUNCT
iajs-3750	5	37	.	.	PUNCT
iajs-3750	6	1	the	the	DET
iajs-3750	6	2	study	study	NOUN
iajs-3750	6	3	aims	aim	VERB
iajs-3750	6	4	to	to	PART
iajs-3750	6	5	evaluate	evaluate	VERB
iajs-3750	6	6	the	the	DET
iajs-3750	6	7	levels	level	NOUN
iajs-3750	6	8	of	of	ADP
iajs-3750	6	9	obestatin	obestatin	NOUN
iajs-3750	6	10	and	and	CCONJ
iajs-3750	6	11	osteopontin	osteopontin	PROPN
iajs-3750	6	12	(	(	PUNCT
iajs-3750	6	13	opn	opn	PROPN
iajs-3750	6	14	)	)	PUNCT
iajs-3750	6	15	as	as	ADP
iajs-3750	6	16	markers	marker	NOUN
iajs-3750	6	17	for	for	ADP
iajs-3750	6	18	detecting	detect	VERB
iajs-3750	6	19	mets	met	NOUN
iajs-3750	6	20	and	and	CCONJ
iajs-3750	6	21	their	their	PRON
iajs-3750	6	22	relationship	relationship	NOUN
iajs-3750	6	23	with	with	ADP
iajs-3750	6	24	other	other	ADJ
iajs-3750	6	25	biomarker	biomarker	NOUN
iajs-3750	6	26	parameters	parameter	NOUN
iajs-3750	6	27	at	at	ADP
iajs-3750	6	28	al	al	PROPN
iajs-3750	6	29	-	-	PUNCT
iajs-3750	6	30	yarmuk	yarmuk	ADJ
iajs-3750	6	31	teaching	teaching	NOUN
iajs-3750	6	32	hospital	hospital	NOUN
iajs-3750	6	33	in	in	ADP
iajs-3750	6	34	baghdad	baghdad	PROPN
iajs-3750	6	35	.	.	PUNCT
iajs-3750	7	1	a	a	DET
iajs-3750	7	2	total	total	NOUN
iajs-3750	7	3	of	of	ADP
iajs-3750	7	4	165	165	NUM
iajs-3750	7	5	patients	patient	NOUN
iajs-3750	7	6	(	(	PUNCT
iajs-3750	7	7	125	125	NUM
iajs-3750	7	8	with	with	ADP
iajs-3750	7	9	mets	met	NOUN
iajs-3750	7	10	and	and	CCONJ
iajs-3750	7	11	40	40	NUM
iajs-3750	7	12	healthy	healthy	ADJ
iajs-3750	7	13	subjects	subject	NOUN
iajs-3750	7	14	as	as	ADP
iajs-3750	7	15	a	a	DET
iajs-3750	7	16	control	control	NOUN
iajs-3750	7	17	group	group	NOUN
iajs-3750	7	18	)	)	PUNCT
iajs-3750	7	19	whose	whose	DET
iajs-3750	7	20	ages	age	NOUN
iajs-3750	7	21	ranged	range	VERB
iajs-3750	7	22	from	from	ADP
iajs-3750	7	23	20	20	NUM
iajs-3750	7	24	to	to	PART
iajs-3750	7	25	80	80	NUM
iajs-3750	7	26	years	year	NOUN
iajs-3750	7	27	were	be	AUX
iajs-3750	7	28	examined	examine	VERB
iajs-3750	7	29	and	and	CCONJ
iajs-3750	7	30	participated	participate	VERB
iajs-3750	7	31	in	in	ADP
iajs-3750	7	32	this	this	DET
iajs-3750	7	33	study	study	NOUN
iajs-3750	7	34	.	.	PUNCT
iajs-3750	8	1	body	body	NOUN
iajs-3750	8	2	mass	mass	PROPN
iajs-3750	8	3	index	index	NOUN
iajs-3750	8	4	(	(	PUNCT
iajs-3750	8	5	bmi	bmi	PROPN
iajs-3750	8	6	)	)	PUNCT
iajs-3750	8	7	,	,	PUNCT
iajs-3750	8	8	bp	bp	PROPN
iajs-3750	8	9	,	,	PUNCT
iajs-3750	8	10	fasting	fast	VERB
iajs-3750	8	11	serum	serum	NOUN
iajs-3750	8	12	glucose	glucose	NOUN
iajs-3750	8	13	(	(	PUNCT
iajs-3750	8	14	fsg	fsg	PROPN
iajs-3750	8	15	)	)	PUNCT
iajs-3750	8	16	,	,	PUNCT
iajs-3750	8	17	liver	liver	NOUN
iajs-3750	8	18	enzymes	enzyme	NOUN
iajs-3750	8	19	,	,	PUNCT
iajs-3750	8	20	total	total	ADJ
iajs-3750	8	21	protein	protein	NOUN
iajs-3750	8	22	,	,	PUNCT
iajs-3750	8	23	and	and	CCONJ
iajs-3750	8	24	serum	serum	NOUN
iajs-3750	8	25	lipid	lipid	PROPN
iajs-3750	8	26	profile	profile	NOUN
iajs-3750	8	27	were	be	AUX
iajs-3750	8	28	evaluated	evaluate	VERB
iajs-3750	8	29	in	in	ADP
iajs-3750	8	30	each	each	DET
iajs-3750	8	31	patient	patient	NOUN
iajs-3750	8	32	and	and	CCONJ
iajs-3750	8	33	control	control	NOUN
iajs-3750	8	34	.	.	PUNCT
iajs-3750	9	1	in	in	ADP
iajs-3750	9	2	addition	addition	NOUN
iajs-3750	9	3	,	,	PUNCT
iajs-3750	9	4	obestatin	obestatin	NOUN
iajs-3750	9	5	and	and	CCONJ
iajs-3750	9	6	opn	opn	PROPN
iajs-3750	9	7	were	be	AUX
iajs-3750	9	8	used	use	VERB
iajs-3750	9	9	with	with	ADP
iajs-3750	9	10	commercial	commercial	ADJ
iajs-3750	9	11	elisa	elisa	PROPN
iajs-3750	9	12	kits	kit	NOUN
iajs-3750	9	13	according	accord	VERB
iajs-3750	9	14	to	to	ADP
iajs-3750	9	15	the	the	DET
iajs-3750	9	16	manufacturer	manufacturer	NOUN
iajs-3750	9	17	's	's	PART
iajs-3750	9	18	instructions	instruction	NOUN
iajs-3750	9	19	.	.	PUNCT
iajs-3750	10	1	the	the	DET
iajs-3750	10	2	study	study	NOUN
iajs-3750	10	3	's	's	PART
iajs-3750	10	4	results	result	NOUN
iajs-3750	10	5	showed	show	VERB
iajs-3750	10	6	significant	significant	ADJ
iajs-3750	10	7	differences	difference	NOUN
iajs-3750	10	8	(	(	PUNCT
iajs-3750	10	9	p	p	X
iajs-3750	10	10	<	<	X
iajs-3750	10	11	0.05	0.05	NUM
iajs-3750	10	12	)	)	PUNCT
iajs-3750	10	13	in	in	ADP
iajs-3750	10	14	bmi	bmi	PROPN
iajs-3750	10	15	,	,	PUNCT
iajs-3750	10	16	bp	bp	PROPN
iajs-3750	10	17	,	,	PUNCT
iajs-3750	10	18	fsg	fsg	PROPN
iajs-3750	10	19	,	,	PUNCT
iajs-3750	10	20	liver	liver	NOUN
iajs-3750	10	21	enzymes	enzyme	NOUN
iajs-3750	10	22	,	,	PUNCT
iajs-3750	10	23	and	and	CCONJ
iajs-3750	10	24	lipid	lipid	NOUN
iajs-3750	10	25	profile	profile	NOUN
iajs-3750	10	26	between	between	ADP
iajs-3750	10	27	the	the	DET
iajs-3750	10	28	mets	mets	PROPN
iajs-3750	10	29	and	and	CCONJ
iajs-3750	10	30	control	control	NOUN
iajs-3750	10	31	groups	group	NOUN
iajs-3750	10	32	.	.	PUNCT
iajs-3750	11	1	the	the	DET
iajs-3750	11	2	levels	level	NOUN
iajs-3750	11	3	of	of	ADP
iajs-3750	11	4	obestatin	obestatin	NOUN
iajs-3750	11	5	were	be	AUX
iajs-3750	11	6	notably	notably	ADV
iajs-3750	11	7	decreased	decrease	VERB
iajs-3750	11	8	in	in	ADP
iajs-3750	11	9	the	the	DET
iajs-3750	11	10	mets	met	NOUN
iajs-3750	11	11	group	group	NOUN
iajs-3750	11	12	compared	compare	VERB
iajs-3750	11	13	to	to	ADP
iajs-3750	11	14	the	the	DET
iajs-3750	11	15	control	control	NOUN
iajs-3750	11	16	group	group	NOUN
iajs-3750	11	17	(	(	PUNCT
iajs-3750	11	18	280.8	280.8	NUM
iajs-3750	11	19	pg	pg	NOUN
iajs-3750	11	20	/	/	SYM
iajs-3750	11	21	ml	ml	X
iajs-3750	11	22	vs.	vs.	ADP
iajs-3750	11	23	1082.1	1082.1	NUM
iajs-3750	11	24	pg	pg	NOUN
iajs-3750	11	25	/	/	SYM
iajs-3750	11	26	ml	ml	NOUN
iajs-3750	11	27	)	)	PUNCT
iajs-3750	11	28	.	.	PUNCT
iajs-3750	12	1	the	the	DET
iajs-3750	12	2	level	level	NOUN
iajs-3750	12	3	of	of	ADP
iajs-3750	12	4	opn	opn	PROPN
iajs-3750	12	5	in	in	ADP
iajs-3750	12	6	patients	patient	NOUN
iajs-3750	12	7	was	be	AUX
iajs-3750	12	8	significantly	significantly	ADV
iajs-3750	12	9	higher	high	ADJ
iajs-3750	12	10	than	than	ADP
iajs-3750	12	11	in	in	ADP
iajs-3750	12	12	controls	control	NOUN
iajs-3750	12	13	(	(	PUNCT
iajs-3750	12	14	17.96	17.96	NUM
iajs-3750	12	15	ng	ng	NOUN
iajs-3750	12	16	/	/	SYM
iajs-3750	12	17	ml	ml	X
iajs-3750	12	18	vs.	vs.	ADP
iajs-3750	12	19	5.47	5.47	NUM
iajs-3750	12	20	ng	ng	NOUN
iajs-3750	12	21	/	/	SYM
iajs-3750	12	22	ml	ml	PROPN
iajs-3750	12	23	)	)	PUNCT
iajs-3750	12	24	,	,	PUNCT
iajs-3750	12	25	respectively	respectively	ADV
iajs-3750	12	26	.	.	PUNCT
iajs-3750	13	1	the	the	DET
iajs-3750	13	2	receiver	receiver	NOUN
iajs-3750	13	3	operating	operate	VERB
iajs-3750	13	4	characteristic	characteristic	NOUN
iajs-3750	13	5	(	(	PUNCT
iajs-3750	13	6	roc	roc	PROPN
iajs-3750	13	7	)	)	PUNCT
iajs-3750	13	8	curve	curve	NOUN
iajs-3750	13	9	tests	test	NOUN
iajs-3750	13	10	for	for	ADP
iajs-3750	13	11	obestatin	obestatin	NOUN
iajs-3750	13	12	and	and	CCONJ
iajs-3750	13	13	opn	opn	PROPN
iajs-3750	13	14	are	be	AUX
iajs-3750	13	15	0.981	0.981	NUM
iajs-3750	13	16	and	and	CCONJ
iajs-3750	13	17	0.999	0.999	NUM
iajs-3750	13	18	,	,	PUNCT
iajs-3750	13	19	respectively	respectively	ADV
iajs-3750	13	20	,	,	PUNCT
iajs-3750	13	21	which	which	PRON
iajs-3750	13	22	indicate	indicate	VERB
iajs-3750	13	23	that	that	SCONJ
iajs-3750	13	24	obestatin	obestatin	NOUN
iajs-3750	13	25	and	and	CCONJ
iajs-3750	13	26	opn	opn	PROPN
iajs-3750	13	27	are	be	AUX
iajs-3750	13	28	considered	consider	VERB
iajs-3750	13	29	good	good	ADJ
iajs-3750	13	30	diagnostic	diagnostic	ADJ
iajs-3750	13	31	markers	marker	NOUN
iajs-3750	13	32	for	for	ADP
iajs-3750	13	33	subjects	subject	NOUN
iajs-3750	13	34	with	with	ADP
iajs-3750	13	35	mets	met	NOUN
iajs-3750	13	36	.	.	PUNCT
iajs-3750	14	1	it	it	PRON
iajs-3750	14	2	can	can	AUX
iajs-3750	14	3	be	be	AUX
iajs-3750	14	4	proposed	propose	VERB
iajs-3750	14	5	that	that	SCONJ
iajs-3750	14	6	decreased	decrease	VERB
iajs-3750	14	7	levels	level	NOUN
iajs-3750	14	8	of	of	ADP
iajs-3750	14	9	obestatin	obestatin	NOUN
iajs-3750	14	10	and	and	CCONJ
iajs-3750	14	11	increased	increase	VERB
iajs-3750	14	12	levels	level	NOUN
iajs-3750	14	13	of	of	ADP
iajs-3750	14	14	opn	opn	PROPN
iajs-3750	14	15	in	in	ADP
iajs-3750	14	16	obese	obese	ADJ
iajs-3750	14	17	individuals	individual	NOUN
iajs-3750	14	18	may	may	AUX
iajs-3750	14	19	contribute	contribute	VERB
iajs-3750	14	20	to	to	ADP
iajs-3750	14	21	the	the	DET
iajs-3750	14	22	onset	onset	NOUN
iajs-3750	14	23	of	of	ADP
iajs-3750	14	24	mets	met	NOUN
iajs-3750	14	25	and	and	CCONJ
iajs-3750	14	26	disrupted	disrupt	VERB
iajs-3750	14	27	lipoprotein	lipoprotein	ADJ
iajs-3750	14	28	metabolism	metabolism	NOUN
iajs-3750	14	29	.	.	PUNCT
iajs-3750	15	1	keywords	keyword	NOUN
iajs-3750	15	2	:	:	PUNCT
iajs-3750	15	3	lipid	lipid	NOUN
iajs-3750	15	4	profile	profile	NOUN
iajs-3750	15	5	,	,	PUNCT
iajs-3750	15	6	liver	liver	NOUN
iajs-3750	15	7	enzymes	enzyme	NOUN
iajs-3750	15	8	,	,	PUNCT
iajs-3750	15	9	metabolic	metabolic	NOUN
iajs-3750	15	10	syndrome	syndrome	NOUN
iajs-3750	15	11	,	,	PUNCT
iajs-3750	15	12	obestatin	obestatin	PROPN
iajs-3750	15	13	,	,	PUNCT
iajs-3750	15	14	osteopontin	osteopontin	ADJ
iajs-3750	15	15	.	.	NOUN
iajs-3750	15	16	1	1	X
iajs-3750	15	17	.	.	X
iajs-3750	15	18	introduction	introduction	NOUN
iajs-3750	15	19	metabolic	metabolic	NOUN
iajs-3750	15	20	syndrome	syndrome	PROPN
iajs-3750	15	21	(	(	PUNCT
iajs-3750	15	22	mets	met	NOUN
iajs-3750	15	23	)	)	PUNCT
iajs-3750	15	24	,	,	PUNCT
iajs-3750	15	25	also	also	ADV
iajs-3750	15	26	known	know	VERB
iajs-3750	15	27	as	as	ADP
iajs-3750	15	28	insulin	insulin	NOUN
iajs-3750	15	29	resistance	resistance	NOUN
iajs-3750	15	30	(	(	PUNCT
iajs-3750	15	31	ir	ir	NOUN
iajs-3750	15	32	)	)	PUNCT
iajs-3750	15	33	syndrome	syndrome	NOUN
iajs-3750	15	34	or	or	CCONJ
iajs-3750	15	35	syndrome	syndrome	NOUN
iajs-3750	15	36	x	x	X
iajs-3750	15	37	,	,	PUNCT
iajs-3750	15	38	is	be	AUX
iajs-3750	15	39	a	a	DET
iajs-3750	15	40	group	group	NOUN
iajs-3750	15	41	of	of	ADP
iajs-3750	15	42	characteristics	characteristic	NOUN
iajs-3750	15	43	that	that	PRON
iajs-3750	15	44	together	together	ADV
iajs-3750	15	45	increase	increase	VERB
iajs-3750	15	46	the	the	DET
iajs-3750	15	47	risk	risk	NOUN
iajs-3750	15	48	of	of	ADP
iajs-3750	15	49	type	type	NOUN
iajs-3750	15	50	2	2	NUM
iajs-3750	15	51	diabetes	diabetes	NOUN
iajs-3750	15	52	mellitus	mellitus	NOUN
iajs-3750	15	53	(	(	PUNCT
iajs-3750	15	54	t2	t2	NOUN
iajs-3750	15	55	dm	dm	PROPN
iajs-3750	15	56	)	)	PUNCT
iajs-3750	15	57	and	and	CCONJ
iajs-3750	15	58	heart	heart	NOUN
iajs-3750	15	59	disease	disease	NOUN
iajs-3750	15	60	.	.	PUNCT
iajs-3750	16	1	these	these	DET
iajs-3750	16	2	characteristics	characteristic	NOUN
iajs-3750	16	3	include	include	VERB
iajs-3750	16	4	obesity	obesity	NOUN
iajs-3750	16	5	,	,	PUNCT
iajs-3750	16	6	high	high	ADJ
iajs-3750	16	7	blood	blood	NOUN
iajs-3750	16	8	pressure	pressure	NOUN
iajs-3750	16	9	(	(	PUNCT
iajs-3750	16	10	bp	bp	PROPN
iajs-3750	16	11	)	)	PUNCT
iajs-3750	16	12	,	,	PUNCT
iajs-3750	16	13	elevated	elevate	VERB
iajs-3750	16	14	blood	blood	NOUN
iajs-3750	16	15	sugar	sugar	NOUN
iajs-3750	16	16	levels	level	NOUN
iajs-3750	16	17	,	,	PUNCT
iajs-3750	16	18	and	and	CCONJ
iajs-3750	16	19	high	high	ADJ
iajs-3750	16	20	triglycerides	triglyceride	NOUN
iajs-3750	16	21	(	(	PUNCT
iajs-3750	16	22	tg	tg	NOUN
iajs-3750	16	23	)	)	PUNCT
iajs-3750	16	24	.	.	PUNCT
iajs-3750	17	1	controlling	control	VERB
iajs-3750	17	2	weight	weight	NOUN
iajs-3750	17	3	,	,	PUNCT
iajs-3750	17	4	blood	blood	NOUN
iajs-3750	17	5	sugar	sugar	NOUN
iajs-3750	17	6	levels	level	NOUN
iajs-3750	17	7	,	,	PUNCT
iajs-3750	17	8	total	total	ADJ
iajs-3750	17	9	cholesterol	cholesterol	NOUN
iajs-3750	17	10	(	(	PUNCT
iajs-3750	17	11	tc	tc	NOUN
iajs-3750	17	12	)	)	PUNCT
iajs-3750	17	13	,	,	PUNCT
iajs-3750	17	14	and	and	CCONJ
iajs-3750	17	15	tg	tg	PROPN
iajs-3750	17	16	levels	level	NOUN
iajs-3750	17	17	can	can	AUX
iajs-3750	17	18	help	help	VERB
iajs-3750	17	19	extend	extend	VERB
iajs-3750	17	20	life	life	NOUN
iajs-3750	17	21	and	and	CCONJ
iajs-3750	17	22	reduce	reduce	VERB
iajs-3750	17	23	the	the	DET
iajs-3750	17	24	risk	risk	NOUN
iajs-3750	17	25	of	of	ADP
iajs-3750	17	26	heart	heart	NOUN
iajs-3750	17	27	attacks	attack	NOUN
iajs-3750	17	28	and	and	CCONJ
iajs-3750	17	29	strokes	stroke	NOUN
iajs-3750	17	30	(	(	PUNCT
iajs-3750	17	31	1	1	NUM
iajs-3750	17	32	)	)	PUNCT
iajs-3750	17	33	.	.	PUNCT
iajs-3750	18	1	a	a	DET
iajs-3750	18	2	significant	significant	ADJ
iajs-3750	18	3	waist	waist	NOUN
iajs-3750	18	4	circumference	circumference	NOUN
iajs-3750	18	5	or	or	CCONJ
iajs-3750	18	6	an	an	DET
iajs-3750	18	7	"	"	PUNCT
iajs-3750	18	8	apple	apple	NOUN
iajs-3750	18	9	-	-	PUNCT
iajs-3750	18	10	shaped	shape	VERB
iajs-3750	18	11	"	"	PUNCT
iajs-3750	18	12	body	body	NOUN
iajs-3750	18	13	,	,	PUNCT
iajs-3750	18	14	and	and	CCONJ
iajs-3750	18	15	elevated	elevated	ADJ
iajs-3750	18	16	bp	bp	PROPN
iajs-3750	18	17	,	,	PUNCT
iajs-3750	18	18	they	they	PRON
iajs-3750	18	19	are	be	AUX
iajs-3750	18	20	diagnosed	diagnose	VERB
iajs-3750	18	21	with	with	ADP
iajs-3750	18	22	hypertension	hypertension	NOUN
iajs-3750	18	23	.	.	PUNCT
iajs-3750	19	1	they	they	PRON
iajs-3750	19	2	are	be	AUX
iajs-3750	19	3	currently	currently	ADV
iajs-3750	19	4	experiencing	experience	VERB
iajs-3750	19	5	mets	met	NOUN
iajs-3750	19	6	(	(	PUNCT
iajs-3750	19	7	2	2	NUM
iajs-3750	19	8	)	)	PUNCT
iajs-3750	19	9	.	.	PUNCT
iajs-3750	20	1	the	the	DET
iajs-3750	20	2	underlying	underlie	VERB
iajs-3750	20	3	factors	factor	NOUN
iajs-3750	20	4	contributing	contribute	VERB
iajs-3750	20	5	to	to	ADP
iajs-3750	20	6	mets	met	NOUN
iajs-3750	20	7	include	include	VERB
iajs-3750	20	8	obesity	obesity	NOUN
iajs-3750	20	9	,	,	PUNCT
iajs-3750	20	10	ir	ir	PROPN
iajs-3750	20	11	,	,	PUNCT
iajs-3750	20	12	physical	physical	ADJ
iajs-3750	20	13	inactivity	inactivity	NOUN
iajs-3750	20	14	,	,	PUNCT
iajs-3750	20	15	genetic	genetic	ADJ
iajs-3750	20	16	predisposition	predisposition	NOUN
iajs-3750	20	17	,	,	PUNCT
iajs-3750	20	18	and	and	CCONJ
iajs-3750	20	19	advancing	advance	VERB
iajs-3750	20	20	age	age	NOUN
iajs-3750	20	21	(	(	PUNCT
iajs-3750	20	22	3,4	3,4	NUM
iajs-3750	20	23	)	)	PUNCT
iajs-3750	20	24	.	.	PUNCT
iajs-3750	21	1	a	a	DET
iajs-3750	21	2	peptide	peptide	ADJ
iajs-3750	21	3	hormone	hormone	NOUN
iajs-3750	21	4	called	call	VERB
iajs-3750	21	5	obestatin	obestatin	NOUN
iajs-3750	21	6	is	be	AUX
iajs-3750	21	7	a	a	DET
iajs-3750	21	8	23amino	23amino	NUM
iajs-3750	21	9	acid	acid	NOUN
iajs-3750	21	10	peptide	peptide	NOUN
iajs-3750	21	11	and	and	CCONJ
iajs-3750	21	12	is	be	AUX
iajs-3750	21	13	secreted	secrete	VERB
iajs-3750	21	14	from	from	ADP
iajs-3750	21	15	the	the	DET
iajs-3750	21	16	stomach	stomach	NOUN
iajs-3750	21	17	and	and	CCONJ
iajs-3750	21	18	acts	act	NOUN
iajs-3750	21	19	in	in	ADP
iajs-3750	21	20	the	the	DET
iajs-3750	21	21	spleen	spleen	NOUN
iajs-3750	21	22	,	,	PUNCT
iajs-3750	21	23	intestine	intestine	NOUN
iajs-3750	21	24	,	,	PUNCT
iajs-3750	21	25	breast	breast	NOUN
iajs-3750	21	26	https://orcid.org/0009-0001-4966-0160	https://orcid.org/0009-0001-4966-0160	NOUN
iajs-3750	21	27	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	28	https://orcid.org/0000-0002-0793-6659	https://orcid.org/0000-0002-0793-6659	NOUN
iajs-3750	21	29	mailto:israafa_chem@csw.uobaghdad.edu.iq	mailto:israafa_chem@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	30	https://orcid.org/0009-0001-4966-0160	https://orcid.org/0009-0001-4966-0160	PROPN
iajs-3750	21	31	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	32	https://orcid.org/0000-0002-0793-6659	https://orcid.org/0000-0002-0793-6659	NOUN
iajs-3750	21	33	mailto:israafa_chem@csw.uobaghdad.edu.iq	mailto:israafa_chem@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	34	https://orcid.org/0009-0001-4966-0160	https://orcid.org/0009-0001-4966-0160	PROPN
iajs-3750	21	35	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	36	https://orcid.org/0000-0002-0793-6659	https://orcid.org/0000-0002-0793-6659	NOUN
iajs-3750	21	37	mailto:israafa_chem@csw.uobaghdad.edu.iq	mailto:israafa_chem@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	38	https://orcid.org/0009-0001-4966-0160	https://orcid.org/0009-0001-4966-0160	PROPN
iajs-3750	21	39	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	40	https://orcid.org/0000-0002-0793-6659	https://orcid.org/0000-0002-0793-6659	NOUN
iajs-3750	21	41	mailto:israafa_chem@csw.uobaghdad.edu.iq	mailto:israafa_chem@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	42	https://orcid.org/0009-0001-4966-0160	https://orcid.org/0009-0001-4966-0160	PROPN
iajs-3750	21	43	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	44	https://orcid.org/0000-0002-0793-6659	https://orcid.org/0000-0002-0793-6659	NOUN
iajs-3750	21	45	mailto:israafa_chem@csw.uobaghdad.edu.iq	mailto:israafa_chem@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	46	https://orcid.org/0009-0001-4966-0160	https://orcid.org/0009-0001-4966-0160	PROPN
iajs-3750	21	47	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	mailto:sohair.abd2305m@csw.uobaghdad.edu.iq	PROPN
iajs-3750	21	48	https://orcid.org/0000-0002-0793-6659	https://orcid.org/0000-0002-0793-6659	NOUN
iajs-3750	21	49	mailto:israafa_chem@csw.uobaghdad.edu.iq	mailto:israafa_chem@csw.uobaghdad.edu.iq	NOUN
iajs-3750	21	50	ihjpas	ihjpa	NOUN
iajs-3750	21	51	.	.	PUNCT
iajs-3750	22	1	2025	2025	NUM
iajs-3750	22	2	,	,	PUNCT
iajs-3750	22	3	38(3	38(3	NUM
iajs-3750	22	4	)	)	PUNCT
iajs-3750	22	5	257	257	NUM
iajs-3750	22	6	milk	milk	NOUN
iajs-3750	22	7	,	,	PUNCT
iajs-3750	22	8	mammary	mammary	ADJ
iajs-3750	22	9	gland	gland	NOUN
iajs-3750	22	10	,	,	PUNCT
iajs-3750	22	11	as	as	ADV
iajs-3750	22	12	well	well	ADV
iajs-3750	22	13	as	as	ADP
iajs-3750	22	14	plasma	plasma	NOUN
iajs-3750	22	15	(	(	PUNCT
iajs-3750	22	16	5	5	NUM
iajs-3750	22	17	)	)	PUNCT
iajs-3750	22	18	.	.	PUNCT
iajs-3750	23	1	it	it	PRON
iajs-3750	23	2	was	be	AUX
iajs-3750	23	3	first	first	ADV
iajs-3750	23	4	discovered	discover	VERB
iajs-3750	23	5	to	to	PART
iajs-3750	23	6	interact	interact	VERB
iajs-3750	23	7	with	with	ADP
iajs-3750	23	8	the	the	DET
iajs-3750	23	9	orphan	orphan	NOUN
iajs-3750	23	10	receptor	receptor	NOUN
iajs-3750	23	11	gpr39	gpr39	PROPN
iajs-3750	23	12	,	,	PUNCT
iajs-3750	23	13	a	a	DET
iajs-3750	23	14	receptor	receptor	NOUN
iajs-3750	23	15	related	relate	VERB
iajs-3750	23	16	to	to	ADP
iajs-3750	23	17	the	the	DET
iajs-3750	23	18	ghrelin	ghrelin	NOUN
iajs-3750	23	19	receptor	receptor	NOUN
iajs-3750	23	20	subfamily	subfamily	ADV
iajs-3750	23	21	,	,	PUNCT
iajs-3750	23	22	and	and	CCONJ
iajs-3750	23	23	is	be	AUX
iajs-3750	23	24	associated	associate	VERB
iajs-3750	23	25	with	with	ADP
iajs-3750	23	26	weight	weight	NOUN
iajs-3750	23	27	gain	gain	NOUN
iajs-3750	23	28	,	,	PUNCT
iajs-3750	23	29	decreased	decrease	VERB
iajs-3750	23	30	food	food	NOUN
iajs-3750	23	31	intake	intake	NOUN
iajs-3750	23	32	,	,	PUNCT
iajs-3750	23	33	gastric	gastric	ADJ
iajs-3750	23	34	emptying	emptying	NOUN
iajs-3750	23	35	,	,	PUNCT
iajs-3750	23	36	and	and	CCONJ
iajs-3750	23	37	reduced	reduce	VERB
iajs-3750	23	38	intestinal	intestinal	ADJ
iajs-3750	23	39	motility	motility	NOUN
iajs-3750	23	40	(	(	PUNCT
iajs-3750	23	41	6	6	NUM
iajs-3750	23	42	)	)	PUNCT
iajs-3750	23	43	.	.	PUNCT
iajs-3750	24	1	it	it	PRON
iajs-3750	24	2	can	can	AUX
iajs-3750	24	3	be	be	AUX
iajs-3750	24	4	considered	consider	VERB
iajs-3750	24	5	a	a	DET
iajs-3750	24	6	significant	significant	ADJ
iajs-3750	24	7	indicator	indicator	NOUN
iajs-3750	24	8	of	of	ADP
iajs-3750	24	9	an	an	DET
iajs-3750	24	10	individual	individual	NOUN
iajs-3750	24	11	's	's	PART
iajs-3750	24	12	nutritional	nutritional	ADJ
iajs-3750	24	13	status	status	NOUN
iajs-3750	24	14	,	,	PUNCT
iajs-3750	24	15	providing	provide	VERB
iajs-3750	24	16	insights	insight	NOUN
iajs-3750	24	17	into	into	ADP
iajs-3750	24	18	the	the	DET
iajs-3750	24	19	presence	presence	NOUN
iajs-3750	24	20	of	of	ADP
iajs-3750	24	21	obesity	obesity	NOUN
iajs-3750	24	22	and	and	CCONJ
iajs-3750	24	23	ir	ir	PROPN
iajs-3750	24	24	(	(	PUNCT
iajs-3750	24	25	7	7	NUM
iajs-3750	24	26	)	)	PUNCT
iajs-3750	24	27	.	.	PUNCT
iajs-3750	25	1	due	due	ADP
iajs-3750	25	2	to	to	ADP
iajs-3750	25	3	its	its	PRON
iajs-3750	25	4	considerable	considerable	ADJ
iajs-3750	25	5	cardiovascular	cardiovascular	ADJ
iajs-3750	25	6	disease	disease	NOUN
iajs-3750	25	7	(	(	PUNCT
iajs-3750	25	8	cvd	cvd	PROPN
iajs-3750	25	9	)	)	PUNCT
iajs-3750	25	10	as	as	ADV
iajs-3750	25	11	well	well	ADV
iajs-3750	25	12	as	as	ADP
iajs-3750	25	13	metabolic	metabolic	NOUN
iajs-3750	25	14	effects	effect	NOUN
iajs-3750	25	15	,	,	PUNCT
iajs-3750	25	16	obestatin	obestatin	NOUN
iajs-3750	25	17	is	be	AUX
iajs-3750	25	18	regarded	regard	VERB
iajs-3750	25	19	as	as	ADP
iajs-3750	25	20	a	a	DET
iajs-3750	25	21	promising	promising	ADJ
iajs-3750	25	22	therapeutic	therapeutic	ADJ
iajs-3750	25	23	target	target	NOUN
iajs-3750	25	24	for	for	ADP
iajs-3750	25	25	managing	manage	VERB
iajs-3750	25	26	obesity	obesity	NOUN
iajs-3750	25	27	in	in	ADP
iajs-3750	25	28	patients	patient	NOUN
iajs-3750	25	29	,	,	PUNCT
iajs-3750	25	30	particularly	particularly	ADV
iajs-3750	25	31	those	those	PRON
iajs-3750	25	32	with	with	ADP
iajs-3750	25	33	diabetes	diabetes	NOUN
iajs-3750	25	34	.	.	PUNCT
iajs-3750	26	1	additionally	additionally	ADV
iajs-3750	26	2	,	,	PUNCT
iajs-3750	26	3	large	large	ADJ
iajs-3750	26	4	amounts	amount	NOUN
iajs-3750	26	5	of	of	ADP
iajs-3750	26	6	these	these	DET
iajs-3750	26	7	peptides	peptide	NOUN
iajs-3750	26	8	are	be	AUX
iajs-3750	26	9	excreted	excrete	VERB
iajs-3750	26	10	in	in	ADP
iajs-3750	26	11	both	both	DET
iajs-3750	26	12	fatand	fatand	NOUN
iajs-3750	26	13	lean	lean	ADJ
iajs-3750	26	14	-	-	PUNCT
iajs-3750	26	15	forms	form	NOUN
iajs-3750	26	16	.	.	PUNCT
iajs-3750	27	1	adipose	adipose	ADJ
iajs-3750	27	2	tissue	tissue	NOUN
iajs-3750	27	3	in	in	ADP
iajs-3750	27	4	overweight	overweight	ADJ
iajs-3750	27	5	patients	patient	NOUN
iajs-3750	27	6	releases	release	VERB
iajs-3750	27	7	factors	factor	NOUN
iajs-3750	27	8	that	that	PRON
iajs-3750	27	9	promote	promote	VERB
iajs-3750	27	10	angiogenesis	angiogenesis	NOUN
iajs-3750	27	11	(	(	PUNCT
iajs-3750	27	12	8)	8)	NUM
iajs-3750	27	13	.	.	PUNCT
iajs-3750	28	1	furthermore	furthermore	ADV
iajs-3750	28	2	,	,	PUNCT
iajs-3750	28	3	it	it	PRON
iajs-3750	28	4	has	have	AUX
iajs-3750	28	5	been	be	AUX
iajs-3750	28	6	demonstrated	demonstrate	VERB
iajs-3750	28	7	that	that	SCONJ
iajs-3750	28	8	obestatin	obestatin	NOUN
iajs-3750	28	9	not	not	PART
iajs-3750	28	10	only	only	ADV
iajs-3750	28	11	upregulates	upregulate	VERB
iajs-3750	28	12	genes	gene	NOUN
iajs-3750	28	13	related	relate	VERB
iajs-3750	28	14	to	to	ADP
iajs-3750	28	15	β	β	NOUN
iajs-3750	28	16	-	-	NOUN
iajs-3750	28	17	cell	cell	NOUN
iajs-3750	28	18	regeneration	regeneration	NOUN
iajs-3750	28	19	,	,	PUNCT
iajs-3750	28	20	insulin	insulin	NOUN
iajs-3750	28	21	production	production	NOUN
iajs-3750	28	22	,	,	PUNCT
iajs-3750	28	23	and	and	CCONJ
iajs-3750	28	24	lipogenesis	lipogenesis	NOUN
iajs-3750	28	25	but	but	CCONJ
iajs-3750	28	26	also	also	ADV
iajs-3750	28	27	accelerates	accelerate	VERB
iajs-3750	28	28	lipogenesis	lipogenesis	NOUN
iajs-3750	28	29	,	,	PUNCT
iajs-3750	28	30	increases	increase	VERB
iajs-3750	28	31	β	β	NOUN
iajs-3750	28	32	-	-	NOUN
iajs-3750	28	33	cell	cell	NOUN
iajs-3750	28	34	mass	mass	NOUN
iajs-3750	28	35	,	,	PUNCT
iajs-3750	28	36	and	and	CCONJ
iajs-3750	28	37	improves	improve	VERB
iajs-3750	28	38	lipid	lipid	ADJ
iajs-3750	28	39	metabolism	metabolism	NOUN
iajs-3750	28	40	(	(	PUNCT
iajs-3750	28	41	9	9	NUM
iajs-3750	28	42	)	)	PUNCT
iajs-3750	28	43	.	.	PUNCT
iajs-3750	29	1	moreover	moreover	ADV
iajs-3750	29	2	,	,	PUNCT
iajs-3750	29	3	there	there	PRON
iajs-3750	29	4	is	be	VERB
iajs-3750	29	5	a	a	DET
iajs-3750	29	6	frequent	frequent	ADJ
iajs-3750	29	7	inverse	inverse	NOUN
iajs-3750	29	8	correlation	correlation	NOUN
iajs-3750	29	9	between	between	ADP
iajs-3750	29	10	circulating	circulate	VERB
iajs-3750	29	11	levels	level	NOUN
iajs-3750	29	12	of	of	ADP
iajs-3750	29	13	obestatin	obestatin	NOUN
iajs-3750	29	14	in	in	ADP
iajs-3750	29	15	humans	human	NOUN
iajs-3750	29	16	and	and	CCONJ
iajs-3750	29	17	the	the	DET
iajs-3750	29	18	presence	presence	NOUN
iajs-3750	29	19	of	of	ADP
iajs-3750	29	20	obesity	obesity	NOUN
iajs-3750	29	21	and	and	CCONJ
iajs-3750	29	22	dm	dm	X
iajs-3750	29	23	.	.	PUNCT
iajs-3750	30	1	additionally	additionally	ADV
iajs-3750	30	2	,	,	PUNCT
iajs-3750	30	3	studies	study	NOUN
iajs-3750	30	4	have	have	AUX
iajs-3750	30	5	demonstrated	demonstrate	VERB
iajs-3750	30	6	that	that	SCONJ
iajs-3750	30	7	this	this	DET
iajs-3750	30	8	peptide	peptide	NOUN
iajs-3750	30	9	exhibits	exhibit	VERB
iajs-3750	30	10	protective	protective	ADJ
iajs-3750	30	11	metabolic	metabolic	NOUN
iajs-3750	30	12	effects	effect	NOUN
iajs-3750	30	13	in	in	ADP
iajs-3750	30	14	diabetes	diabetes	NOUN
iajs-3750	30	15	models	model	NOUN
iajs-3750	30	16	,	,	PUNCT
iajs-3750	30	17	indicating	indicate	VERB
iajs-3750	30	18	its	its	PRON
iajs-3750	30	19	potential	potential	ADJ
iajs-3750	30	20	therapeutic	therapeutic	ADJ
iajs-3750	30	21	value	value	NOUN
iajs-3750	30	22	in	in	ADP
iajs-3750	30	23	this	this	DET
iajs-3750	30	24	context	context	NOUN
iajs-3750	30	25	(	(	PUNCT
iajs-3750	30	26	10	10	NUM
iajs-3750	30	27	)	)	PUNCT
iajs-3750	30	28	.	.	PUNCT
iajs-3750	31	1	detailed	detailed	ADJ
iajs-3750	31	2	analysis	analysis	NOUN
iajs-3750	31	3	using	use	VERB
iajs-3750	31	4	nmr	nmr	NOUN
iajs-3750	31	5	and	and	CCONJ
iajs-3750	31	6	circular	circular	ADJ
iajs-3750	31	7	dichroism	dichroism	NOUN
iajs-3750	31	8	spectroscopy	spectroscopy	NOUN
iajs-3750	31	9	revealed	reveal	VERB
iajs-3750	31	10	that	that	SCONJ
iajs-3750	31	11	human	human	NOUN
iajs-3750	31	12	and	and	CCONJ
iajs-3750	31	13	mouse	mouse	NOUN
iajs-3750	31	14	obestatin	obestatin	NOUN
iajs-3750	31	15	,	,	PUNCT
iajs-3750	31	16	as	as	ADV
iajs-3750	31	17	well	well	ADV
iajs-3750	31	18	as	as	ADP
iajs-3750	31	19	human	human	ADJ
iajs-3750	31	20	obestatin	obestatin	NOUN
iajs-3750	31	21	fragments	fragment	NOUN
iajs-3750	31	22	:	:	PUNCT
iajs-3750	31	23	(	(	PUNCT
iajs-3750	31	24	6	6	NUM
iajs-3750	31	25	-	-	SYM
iajs-3750	31	26	23	23	NUM
iajs-3750	31	27	)	)	PUNCT
iajs-3750	31	28	,	,	PUNCT
iajs-3750	31	29	(	(	PUNCT
iajs-3750	31	30	11	11	NUM
iajs-3750	31	31	-	-	SYM
iajs-3750	31	32	23	23	NUM
iajs-3750	31	33	)	)	PUNCT
iajs-3750	31	34	,	,	PUNCT
iajs-3750	31	35	and	and	CCONJ
iajs-3750	31	36	(	(	PUNCT
iajs-3750	31	37	16	16	NUM
iajs-3750	31	38	-	-	SYM
iajs-3750	31	39	23	23	NUM
iajs-3750	31	40	)	)	PUNCT
iajs-3750	31	41	,	,	PUNCT
iajs-3750	31	42	all	all	PRON
iajs-3750	31	43	adopt	adopt	VERB
iajs-3750	31	44	α	α	PRON
iajs-3750	31	45	-	-	ADJ
iajs-3750	31	46	helical	helical	ADJ
iajs-3750	31	47	secondary	secondary	ADJ
iajs-3750	31	48	structure	structure	NOUN
iajs-3750	31	49	.	.	PUNCT
iajs-3750	32	1	although	although	SCONJ
iajs-3750	32	2	their	their	PRON
iajs-3750	32	3	order	order	NOUN
iajs-3750	32	4	is	be	AUX
iajs-3750	32	5	different	different	ADJ
iajs-3750	32	6	,	,	PUNCT
iajs-3750	32	7	their	their	PRON
iajs-3750	32	8	structures	structure	NOUN
iajs-3750	32	9	are	be	AUX
iajs-3750	32	10	distinct	distinct	ADJ
iajs-3750	32	11	(	(	PUNCT
iajs-3750	32	12	11	11	NUM
iajs-3750	32	13	)	)	PUNCT
iajs-3750	32	14	.	.	PUNCT
iajs-3750	33	1	the	the	DET
iajs-3750	33	2	human	human	ADJ
iajs-3750	33	3	obestatin	obestatin	NOUN
iajs-3750	33	4	gene	gene	NOUN
iajs-3750	33	5	is	be	AUX
iajs-3750	33	6	located	locate	VERB
iajs-3750	33	7	on	on	ADP
iajs-3750	33	8	chromosome	chromosome	NOUN
iajs-3750	33	9	3	3	NUM
iajs-3750	33	10	(	(	PUNCT
iajs-3750	33	11	3p25	3p25	NUM
iajs-3750	33	12	-	-	SYM
iajs-3750	33	13	26	26	NUM
iajs-3750	33	14	)	)	PUNCT
iajs-3750	33	15	and	and	CCONJ
iajs-3750	33	16	was	be	AUX
iajs-3750	33	17	initially	initially	ADV
iajs-3750	33	18	thought	think	VERB
iajs-3750	33	19	to	to	PART
iajs-3750	33	20	consist	consist	VERB
iajs-3750	33	21	of	of	ADP
iajs-3750	33	22	four	four	NUM
iajs-3750	33	23	exons	exon	NOUN
iajs-3750	33	24	(	(	PUNCT
iajs-3750	33	25	12	12	NUM
iajs-3750	33	26	)	)	PUNCT
iajs-3750	33	27	;	;	PUNCT
iajs-3750	33	28	however	however	ADV
iajs-3750	33	29	,	,	PUNCT
iajs-3750	33	30	further	further	ADJ
iajs-3750	33	31	studies	study	NOUN
iajs-3750	33	32	identified	identify	VERB
iajs-3750	33	33	additional	additional	ADJ
iajs-3750	33	34	upstream	upstream	ADJ
iajs-3750	33	35	exons	exon	NOUN
iajs-3750	33	36	(	(	PUNCT
iajs-3750	33	37	13	13	NUM
iajs-3750	33	38	)	)	PUNCT
iajs-3750	33	39	.	.	PUNCT
iajs-3750	34	1	osteopontin	osteopontin	PROPN
iajs-3750	34	2	(	(	PUNCT
iajs-3750	34	3	opn	opn	PROPN
iajs-3750	34	4	)	)	PUNCT
iajs-3750	34	5	is	be	AUX
iajs-3750	34	6	a	a	DET
iajs-3750	34	7	glycosylated	glycosylated	ADJ
iajs-3750	34	8	and	and	CCONJ
iajs-3750	34	9	hyperphosphorylated	hyperphosphorylated	ADJ
iajs-3750	34	10	protein	protein	NOUN
iajs-3750	34	11	that	that	PRON
iajs-3750	34	12	was	be	AUX
iajs-3750	34	13	initially	initially	ADV
iajs-3750	34	14	discovered	discover	VERB
iajs-3750	34	15	in	in	ADP
iajs-3750	34	16	bone	bone	NOUN
iajs-3750	34	17	tissue	tissue	NOUN
iajs-3750	34	18	and	and	CCONJ
iajs-3750	34	19	has	have	AUX
iajs-3750	34	20	also	also	ADV
iajs-3750	34	21	been	be	AUX
iajs-3750	34	22	identified	identify	VERB
iajs-3750	34	23	in	in	ADP
iajs-3750	34	24	eggshells	eggshell	NOUN
iajs-3750	34	25	(	(	PUNCT
iajs-3750	34	26	14	14	NUM
iajs-3750	34	27	)	)	PUNCT
iajs-3750	34	28	.	.	PUNCT
iajs-3750	35	1	the	the	DET
iajs-3750	35	2	entity	entity	NOUN
iajs-3750	35	3	in	in	ADP
iajs-3750	35	4	question	question	NOUN
iajs-3750	35	5	is	be	AUX
iajs-3750	35	6	a	a	DET
iajs-3750	35	7	negatively	negatively	ADV
iajs-3750	35	8	charged	charge	VERB
iajs-3750	35	9	structure	structure	NOUN
iajs-3750	35	10	,	,	PUNCT
iajs-3750	35	11	consisting	consist	VERB
iajs-3750	35	12	of	of	ADP
iajs-3750	35	13	three	three	NUM
iajs-3750	35	14	hundred	hundred	NUM
iajs-3750	35	15	amino	amino	ADJ
iajs-3750	35	16	acids	acid	NOUN
iajs-3750	35	17	and	and	CCONJ
iajs-3750	35	18	featuring	feature	VERB
iajs-3750	35	19	a	a	DET
iajs-3750	35	20	cell	cell	NOUN
iajs-3750	35	21	-	-	PUNCT
iajs-3750	35	22	binding	bind	VERB
iajs-3750	35	23	sequence	sequence	NOUN
iajs-3750	35	24	composed	compose	VERB
iajs-3750	35	25	of	of	ADP
iajs-3750	35	26	arginine	arginine	NOUN
iajs-3750	35	27	,	,	PUNCT
iajs-3750	35	28	glycine	glycine	NOUN
iajs-3750	35	29	,	,	PUNCT
iajs-3750	35	30	and	and	CCONJ
iajs-3750	35	31	aspartate	aspartate	NOUN
iajs-3750	35	32	.	.	PUNCT
iajs-3750	36	1	the	the	DET
iajs-3750	36	2	specific	specific	ADJ
iajs-3750	36	3	location	location	NOUN
iajs-3750	36	4	can	can	AUX
iajs-3750	36	5	be	be	AUX
iajs-3750	36	6	found	find	VERB
iajs-3750	36	7	on	on	ADP
iajs-3750	36	8	the	the	DET
iajs-3750	36	9	long	long	ADJ
iajs-3750	36	10	arm	arm	NOUN
iajs-3750	36	11	of	of	ADP
iajs-3750	36	12	chromosome	chromosome	NOUN
iajs-3750	36	13	4	4	NUM
iajs-3750	36	14	,	,	PUNCT
iajs-3750	36	15	within	within	ADP
iajs-3750	36	16	the	the	DET
iajs-3750	36	17	4q13	4q13	NUM
iajs-3750	36	18	region	region	NOUN
iajs-3750	36	19	.	.	PUNCT
iajs-3750	37	1	the	the	DET
iajs-3750	37	2	opn	opn	PROPN
iajs-3750	37	3	protein	protein	NOUN
iajs-3750	37	4	is	be	AUX
iajs-3750	37	5	an	an	DET
iajs-3750	37	6	acidic	acidic	ADJ
iajs-3750	37	7	glycoprotein	glycoprotein	NOUN
iajs-3750	37	8	with	with	ADP
iajs-3750	37	9	a	a	DET
iajs-3750	37	10	molecular	molecular	ADJ
iajs-3750	37	11	weight	weight	NOUN
iajs-3750	37	12	of	of	ADP
iajs-3750	37	13	34	34	NUM
iajs-3750	37	14	kda	kda	NOUN
iajs-3750	37	15	.	.	PUNCT
iajs-3750	38	1	following	follow	VERB
iajs-3750	38	2	its	its	PRON
iajs-3750	38	3	secretion	secretion	NOUN
iajs-3750	38	4	from	from	ADP
iajs-3750	38	5	cells	cell	NOUN
iajs-3750	38	6	,	,	PUNCT
iajs-3750	38	7	it	it	PRON
iajs-3750	38	8	undergoes	undergo	VERB
iajs-3750	38	9	post	post	ADJ
iajs-3750	38	10	-	-	ADJ
iajs-3750	38	11	translational	translational	ADJ
iajs-3750	38	12	modifications	modification	NOUN
iajs-3750	38	13	,	,	PUNCT
iajs-3750	38	14	resulting	result	VERB
iajs-3750	38	15	in	in	ADP
iajs-3750	38	16	a	a	DET
iajs-3750	38	17	molecular	molecular	ADJ
iajs-3750	38	18	weight	weight	NOUN
iajs-3750	38	19	ranging	range	VERB
iajs-3750	38	20	from	from	ADP
iajs-3750	38	21	44	44	NUM
iajs-3750	38	22	to	to	PART
iajs-3750	38	23	75	75	NUM
iajs-3750	38	24	kda	kda	NOUN
iajs-3750	38	25	in	in	ADP
iajs-3750	38	26	various	various	ADJ
iajs-3750	38	27	mammalian	mammalian	ADJ
iajs-3750	38	28	cells	cell	NOUN
iajs-3750	38	29	(	(	PUNCT
iajs-3750	38	30	15	15	NUM
iajs-3750	38	31	)	)	PUNCT
iajs-3750	38	32	.	.	PUNCT
iajs-3750	39	1	the	the	DET
iajs-3750	39	2	stromal	stromal	ADJ
iajs-3750	39	3	cell	cell	NOUN
iajs-3750	39	4	protein	protein	NOUN
iajs-3750	39	5	serves	serve	VERB
iajs-3750	39	6	as	as	ADP
iajs-3750	39	7	a	a	DET
iajs-3750	39	8	mediator	mediator	NOUN
iajs-3750	39	9	for	for	ADP
iajs-3750	39	10	various	various	ADJ
iajs-3750	39	11	biological	biological	ADJ
iajs-3750	39	12	functions	function	NOUN
iajs-3750	39	13	.	.	PUNCT
iajs-3750	40	1	it	it	PRON
iajs-3750	40	2	plays	play	VERB
iajs-3750	40	3	a	a	DET
iajs-3750	40	4	role	role	NOUN
iajs-3750	40	5	in	in	ADP
iajs-3750	40	6	regular	regular	ADJ
iajs-3750	40	7	physiological	physiological	ADJ
iajs-3750	40	8	functions	function	NOUN
iajs-3750	40	9	.	.	PUNCT
iajs-3750	41	1	it	it	PRON
iajs-3750	41	2	has	have	AUX
iajs-3750	41	3	been	be	AUX
iajs-3750	41	4	linked	link	VERB
iajs-3750	41	5	to	to	ADP
iajs-3750	41	6	the	the	DET
iajs-3750	41	7	development	development	NOUN
iajs-3750	41	8	of	of	ADP
iajs-3750	41	9	different	different	ADJ
iajs-3750	41	10	disease	disease	NOUN
iajs-3750	41	11	conditions	condition	NOUN
iajs-3750	41	12	,	,	PUNCT
iajs-3750	41	13	such	such	ADJ
iajs-3750	41	14	as	as	ADP
iajs-3750	41	15	atherosclerosis	atherosclerosis	NOUN
iajs-3750	41	16	,	,	PUNCT
iajs-3750	41	17	cancer	cancer	NOUN
iajs-3750	41	18	,	,	PUNCT
iajs-3750	41	19	glomerulonephritis	glomerulonephritis	NOUN
iajs-3750	41	20	,	,	PUNCT
iajs-3750	41	21	as	as	ADV
iajs-3750	41	22	well	well	ADV
iajs-3750	41	23	as	as	ADP
iajs-3750	41	24	several	several	ADJ
iajs-3750	41	25	chronic	chronic	ADJ
iajs-3750	41	26	inflammatory	inflammatory	ADJ
iajs-3750	41	27	disorders	disorder	NOUN
iajs-3750	41	28	(	(	PUNCT
iajs-3750	41	29	16	16	NUM
iajs-3750	41	30	)	)	PUNCT
iajs-3750	41	31	.	.	PUNCT
iajs-3750	42	1	this	this	DET
iajs-3750	42	2	study	study	NOUN
iajs-3750	42	3	aims	aim	VERB
iajs-3750	42	4	to	to	PART
iajs-3750	42	5	examine	examine	VERB
iajs-3750	42	6	the	the	DET
iajs-3750	42	7	correlation	correlation	NOUN
iajs-3750	42	8	between	between	ADP
iajs-3750	42	9	serum	serum	NOUN
iajs-3750	42	10	levels	level	NOUN
iajs-3750	42	11	of	of	ADP
iajs-3750	42	12	obestatin	obestatin	NOUN
iajs-3750	42	13	and	and	CCONJ
iajs-3750	42	14	opn	opn	PROPN
iajs-3750	42	15	in	in	ADP
iajs-3750	42	16	patients	patient	NOUN
iajs-3750	42	17	with	with	ADP
iajs-3750	42	18	mets	met	NOUN
iajs-3750	42	19	.	.	PUNCT
iajs-3750	43	1	2	2	X
iajs-3750	43	2	.	.	X
iajs-3750	43	3	materials	material	NOUN
iajs-3750	43	4	and	and	CCONJ
iajs-3750	43	5	methods	method	NOUN
iajs-3750	43	6	this	this	DET
iajs-3750	43	7	study	study	NOUN
iajs-3750	43	8	recruited	recruit	VERB
iajs-3750	43	9	125	125	NUM
iajs-3750	43	10	patients	patient	NOUN
iajs-3750	43	11	with	with	ADP
iajs-3750	43	12	a	a	DET
iajs-3750	43	13	clinical	clinical	ADJ
iajs-3750	43	14	diagnosis	diagnosis	NOUN
iajs-3750	43	15	of	of	ADP
iajs-3750	43	16	mets	met	NOUN
iajs-3750	43	17	and	and	CCONJ
iajs-3750	43	18	40	40	NUM
iajs-3750	43	19	healthy	healthy	ADJ
iajs-3750	43	20	volunteers	volunteer	NOUN
iajs-3750	43	21	aged	age	VERB
iajs-3750	43	22	20	20	NUM
iajs-3750	43	23	-	-	SYM
iajs-3750	43	24	80	80	NUM
iajs-3750	43	25	years	year	NOUN
iajs-3750	43	26	from	from	ADP
iajs-3750	43	27	december	december	PROPN
iajs-3750	43	28	2022	2022	NUM
iajs-3750	43	29	to	to	ADP
iajs-3750	43	30	may	may	PROPN
iajs-3750	43	31	2023	2023	NUM
iajs-3750	43	32	at	at	ADP
iajs-3750	43	33	al	al	PROPN
iajs-3750	43	34	-	-	PUNCT
iajs-3750	43	35	yarmuk	yarmuk	ADJ
iajs-3750	43	36	teaching	teaching	NOUN
iajs-3750	43	37	hospital	hospital	NOUN
iajs-3750	43	38	in	in	ADP
iajs-3750	43	39	baghdad	baghdad	PROPN
iajs-3750	43	40	.	.	PUNCT
iajs-3750	44	1	blood	blood	NOUN
iajs-3750	44	2	samples	sample	NOUN
iajs-3750	44	3	were	be	AUX
iajs-3750	44	4	collected	collect	VERB
iajs-3750	44	5	from	from	ADP
iajs-3750	44	6	40	40	NUM
iajs-3750	44	7	healthy	healthy	ADJ
iajs-3750	44	8	individuals	individual	NOUN
iajs-3750	44	9	and	and	CCONJ
iajs-3750	44	10	125	125	NUM
iajs-3750	44	11	patients	patient	NOUN
iajs-3750	44	12	with	with	ADP
iajs-3750	44	13	mets	met	NOUN
iajs-3750	44	14	.	.	PUNCT
iajs-3750	45	1	blood	blood	NOUN
iajs-3750	45	2	samples	sample	NOUN
iajs-3750	45	3	were	be	AUX
iajs-3750	45	4	obtained	obtain	VERB
iajs-3750	45	5	in	in	ADP
iajs-3750	45	6	sterile	sterile	ADJ
iajs-3750	45	7	gel	gel	NOUN
iajs-3750	45	8	tubes	tube	NOUN
iajs-3750	45	9	and	and	CCONJ
iajs-3750	45	10	centrifuged	centrifuge	VERB
iajs-3750	45	11	at	at	ADP
iajs-3750	45	12	1000	1000	NUM
iajs-3750	45	13	x	x	SYM
iajs-3750	45	14	g	g	NOUN
iajs-3750	45	15	for	for	ADP
iajs-3750	45	16	15	15	NUM
iajs-3750	45	17	minutes	minute	NOUN
iajs-3750	45	18	.	.	PUNCT
iajs-3750	46	1	a	a	DET
iajs-3750	46	2	small	small	ADJ
iajs-3750	46	3	aliquot	aliquot	NOUN
iajs-3750	46	4	of	of	ADP
iajs-3750	46	5	the	the	DET
iajs-3750	46	6	obtained	obtain	VERB
iajs-3750	46	7	serum	serum	NOUN
iajs-3750	46	8	was	be	AUX
iajs-3750	46	9	then	then	ADV
iajs-3750	46	10	isolated	isolate	VERB
iajs-3750	46	11	and	and	CCONJ
iajs-3750	46	12	stored	store	VERB
iajs-3750	46	13	at	at	ADP
iajs-3750	46	14	20	20	NUM
iajs-3750	46	15	°	°	ADP
iajs-3750	46	16	c	c	NOUN
iajs-3750	46	17	until	until	ADP
iajs-3750	46	18	the	the	DET
iajs-3750	46	19	analysis	analysis	NOUN
iajs-3750	46	20	time	time	NOUN
iajs-3750	46	21	to	to	PART
iajs-3750	46	22	measure	measure	VERB
iajs-3750	46	23	biomarker	biomarker	NOUN
iajs-3750	46	24	parameters	parameter	NOUN
iajs-3750	46	25	.	.	PUNCT
iajs-3750	47	1	the	the	DET
iajs-3750	47	2	height	height	NOUN
iajs-3750	47	3	and	and	CCONJ
iajs-3750	47	4	weight	weight	NOUN
iajs-3750	47	5	of	of	ADP
iajs-3750	47	6	each	each	DET
iajs-3750	47	7	subject	subject	NOUN
iajs-3750	47	8	were	be	AUX
iajs-3750	47	9	measured	measure	VERB
iajs-3750	47	10	,	,	PUNCT
iajs-3750	47	11	and	and	CCONJ
iajs-3750	47	12	then	then	ADV
iajs-3750	47	13	used	use	VERB
iajs-3750	47	14	to	to	PART
iajs-3750	47	15	calculate	calculate	VERB
iajs-3750	47	16	the	the	DET
iajs-3750	47	17	body	body	NOUN
iajs-3750	47	18	mass	mass	NOUN
iajs-3750	47	19	index	index	NOUN
iajs-3750	47	20	(	(	PUNCT
iajs-3750	47	21	bmi	bmi	PROPN
iajs-3750	47	22	)	)	PUNCT
iajs-3750	47	23	in	in	ADP
iajs-3750	47	24	kilograms	kilogram	NOUN
iajs-3750	47	25	per	per	ADP
iajs-3750	47	26	square	square	ADJ
iajs-3750	47	27	meter	meter	NOUN
iajs-3750	47	28	(	(	PUNCT
iajs-3750	47	29	kg	kg	NOUN
iajs-3750	47	30	/	/	SYM
iajs-3750	47	31	m²	m²	PROPN
iajs-3750	47	32	)	)	PUNCT
iajs-3750	47	33	according	accord	VERB
iajs-3750	47	34	to	to	ADP
iajs-3750	47	35	the	the	DET
iajs-3750	47	36	following	follow	VERB
iajs-3750	47	37	equation	equation	NOUN
iajs-3750	47	38	:	:	PUNCT
iajs-3750	47	39	bmi	bmi	PROPN
iajs-3750	47	40	=	=	SYM
iajs-3750	47	41	mass	mass	PROPN
iajs-3750	47	42	/	/	SYM
iajs-3750	47	43	(	(	PUNCT
iajs-3750	47	44	height)²	height)²	X
iajs-3750	47	45	.	.	PUNCT
iajs-3750	48	1	systolic	systolic	ADJ
iajs-3750	48	2	and	and	CCONJ
iajs-3750	48	3	diastolic	diastolic	ADJ
iajs-3750	48	4	bp	bp	PROPN
iajs-3750	48	5	(	(	PUNCT
iajs-3750	48	6	sbp	sbp	NOUN
iajs-3750	48	7	and	and	CCONJ
iajs-3750	48	8	dbp	dbp	PROPN
iajs-3750	48	9	)	)	PUNCT
iajs-3750	48	10	respectively	respectively	ADV
iajs-3750	48	11	,	,	PUNCT
iajs-3750	48	12	fasting	fast	VERB
iajs-3750	48	13	serum	serum	NOUN
iajs-3750	48	14	glucose	glucose	NOUN
iajs-3750	48	15	(	(	PUNCT
iajs-3750	48	16	fsg	fsg	PROPN
iajs-3750	48	17	)	)	PUNCT
iajs-3750	48	18	,	,	PUNCT
iajs-3750	48	19	liver	liver	NOUN
iajs-3750	48	20	enzyme	enzyme	NOUN
iajs-3750	48	21	[	[	X
iajs-3750	48	22	alanine	alanine	NOUN
iajs-3750	48	23	aminotransferase	aminotransferase	NOUN
iajs-3750	48	24	(	(	PUNCT
iajs-3750	48	25	alt	alt	PROPN
iajs-3750	48	26	)	)	PUNCT
iajs-3750	48	27	,	,	PUNCT
iajs-3750	48	28	aspartate	aspartate	NOUN
iajs-3750	48	29	aminotransferase	aminotransferase	NOUN
iajs-3750	48	30	(	(	PUNCT
iajs-3750	48	31	ast	ast	PROPN
iajs-3750	48	32	)	)	PUNCT
iajs-3750	48	33	,	,	PUNCT
iajs-3750	48	34	alkaline	alkaline	NOUN
iajs-3750	48	35	phosphatase	phosphatase	NOUN
iajs-3750	48	36	(	(	PUNCT
iajs-3750	48	37	alp	alp	PROPN
iajs-3750	48	38	)	)	PUNCT
iajs-3750	48	39	in	in	ADP
iajs-3750	48	40	u	u	NOUN
iajs-3750	48	41	/	/	SYM
iajs-3750	48	42	l	l	NOUN
iajs-3750	48	43	units	unit	NOUN
iajs-3750	48	44	]	]	PUNCT
iajs-3750	48	45	,	,	PUNCT
iajs-3750	48	46	total	total	ADJ
iajs-3750	48	47	protein	protein	NOUN
iajs-3750	48	48	in	in	ADP
iajs-3750	48	49	g	g	PROPN
iajs-3750	48	50	/	/	SYM
iajs-3750	48	51	dl	dl	PROPN
iajs-3750	48	52	units	unit	NOUN
iajs-3750	48	53	,	,	PUNCT
iajs-3750	48	54	and	and	CCONJ
iajs-3750	48	55	lipid	lipid	NOUN
iajs-3750	48	56	profile	profile	PROPN
iajs-3750	48	57	test	test	NOUN
iajs-3750	48	58	including	include	VERB
iajs-3750	48	59	:	:	PUNCT
iajs-3750	48	60	ihjpas	ihjpas	PROPN
iajs-3750	48	61	.	.	PUNCT
iajs-3750	49	1	2025	2025	NUM
iajs-3750	49	2	,	,	PUNCT
iajs-3750	49	3	38(3	38(3	NUM
iajs-3750	49	4	)	)	PUNCT
iajs-3750	49	5	258	258	NUM
iajs-3750	49	6	tc	tc	NOUN
iajs-3750	49	7	,	,	PUNCT
iajs-3750	49	8	tg	tg	PROPN
iajs-3750	49	9	,	,	PUNCT
iajs-3750	49	10	high	high	ADJ
iajs-3750	49	11	density	density	NOUN
iajs-3750	49	12	lipoprotein	lipoprotein	ADJ
iajs-3750	49	13	cholesterol	cholesterol	NOUN
iajs-3750	49	14	(	(	PUNCT
iajs-3750	49	15	hdl	hdl	NOUN
iajs-3750	49	16	-	-	PUNCT
iajs-3750	49	17	c	c	NOUN
iajs-3750	49	18	)	)	PUNCT
iajs-3750	49	19	,	,	PUNCT
iajs-3750	49	20	low	low	ADJ
iajs-3750	49	21	density	density	NOUN
iajs-3750	49	22	lipoprotein	lipoprotein	ADJ
iajs-3750	49	23	cholesterol	cholesterol	NOUN
iajs-3750	49	24	(	(	PUNCT
iajs-3750	49	25	ldl	ldl	NOUN
iajs-3750	49	26	-	-	PUNCT
iajs-3750	49	27	c	c	NOUN
iajs-3750	49	28	)	)	PUNCT
iajs-3750	49	29	,	,	PUNCT
iajs-3750	49	30	and	and	CCONJ
iajs-3750	49	31	very	very	ADV
iajs-3750	49	32	low	low	ADJ
iajs-3750	49	33	density	density	NOUN
iajs-3750	49	34	lipoprotein	lipoprotein	ADJ
iajs-3750	49	35	(	(	PUNCT
iajs-3750	49	36	vldl	vldl	NOUN
iajs-3750	49	37	)	)	PUNCT
iajs-3750	49	38	using	use	VERB
iajs-3750	49	39	(	(	PUNCT
iajs-3750	49	40	linear	linear	PROPN
iajs-3750	49	41	,	,	PUNCT
iajs-3750	49	42	spain	spain	PROPN
iajs-3750	49	43	)	)	PUNCT
iajs-3750	49	44	kits	kit	NOUN
iajs-3750	49	45	were	be	AUX
iajs-3750	49	46	measured	measure	VERB
iajs-3750	49	47	for	for	ADP
iajs-3750	49	48	each	each	DET
iajs-3750	49	49	patient	patient	NOUN
iajs-3750	49	50	and	and	CCONJ
iajs-3750	49	51	control	control	NOUN
iajs-3750	49	52	.	.	PUNCT
iajs-3750	50	1	determination	determination	NOUN
iajs-3750	50	2	of	of	ADP
iajs-3750	50	3	obestatin	obestatin	NOUN
iajs-3750	50	4	and	and	CCONJ
iajs-3750	50	5	opn	opn	PROPN
iajs-3750	50	6	levels	level	NOUN
iajs-3750	50	7	was	be	AUX
iajs-3750	50	8	performed	perform	VERB
iajs-3750	50	9	using	use	VERB
iajs-3750	50	10	commercial	commercial	ADJ
iajs-3750	50	11	elisa	elisa	NOUN
iajs-3750	50	12	kits	kit	NOUN
iajs-3750	50	13	according	accord	VERB
iajs-3750	50	14	to	to	ADP
iajs-3750	50	15	the	the	DET
iajs-3750	50	16	manufacturer	manufacturer	NOUN
iajs-3750	50	17	's	's	PART
iajs-3750	50	18	recommendations	recommendation	NOUN
iajs-3750	50	19	,	,	PUNCT
iajs-3750	50	20	usa	usa	PROPN
iajs-3750	50	21	.	.	PROPN
iajs-3750	50	22	2.1	2.1	NUM
iajs-3750	50	23	.	.	PUNCT
iajs-3750	51	1	statistical	statistical	ADJ
iajs-3750	51	2	analysis	analysis	NOUN
iajs-3750	51	3	data	datum	NOUN
iajs-3750	51	4	were	be	AUX
iajs-3750	51	5	expressed	express	VERB
iajs-3750	51	6	as	as	ADP
iajs-3750	51	7	median	median	NOUN
iajs-3750	51	8	(	(	PUNCT
iajs-3750	51	9	25	25	NUM
iajs-3750	51	10	th	th	X
iajs-3750	51	11	and	and	CCONJ
iajs-3750	51	12	75	75	NUM
iajs-3750	51	13	th	th	NUM
iajs-3750	51	14	percentiles	percentile	NOUN
iajs-3750	51	15	)	)	PUNCT
iajs-3750	51	16	for	for	ADP
iajs-3750	51	17	irregularly	irregularly	ADV
iajs-3750	51	18	distributed	distribute	VERB
iajs-3750	51	19	numerical	numerical	ADJ
iajs-3750	51	20	variables	variable	NOUN
iajs-3750	51	21	.	.	PUNCT
iajs-3750	52	1	the	the	DET
iajs-3750	52	2	mann	mann	PROPN
iajs-3750	52	3	-	-	PUNCT
iajs-3750	52	4	whitney	whitney	PROPN
iajs-3750	52	5	test	test	NOUN
iajs-3750	52	6	was	be	AUX
iajs-3750	52	7	used	use	VERB
iajs-3750	52	8	to	to	PART
iajs-3750	52	9	describe	describe	VERB
iajs-3750	52	10	numerical	numerical	ADJ
iajs-3750	52	11	variables	variable	NOUN
iajs-3750	52	12	that	that	PRON
iajs-3750	52	13	were	be	AUX
iajs-3750	52	14	not	not	PART
iajs-3750	52	15	normally	normally	ADV
iajs-3750	52	16	distributed	distribute	VERB
iajs-3750	52	17	.	.	PUNCT
iajs-3750	53	1	the	the	DET
iajs-3750	53	2	significance	significance	NOUN
iajs-3750	53	3	level	level	NOUN
iajs-3750	53	4	was	be	AUX
iajs-3750	53	5	set	set	VERB
iajs-3750	53	6	at	at	ADP
iajs-3750	53	7	a	a	DET
iajs-3750	53	8	p	p	NOUN
iajs-3750	53	9	-	-	PUNCT
iajs-3750	53	10	value	value	NOUN
iajs-3750	53	11	of	of	ADP
iajs-3750	53	12	0.05	0.05	NUM
iajs-3750	53	13	,	,	PUNCT
iajs-3750	53	14	using	use	VERB
iajs-3750	53	15	receiver	receiver	NOUN
iajs-3750	53	16	operating	operate	VERB
iajs-3750	53	17	characteristic	characteristic	NOUN
iajs-3750	53	18	(	(	PUNCT
iajs-3750	53	19	roc	roc	PROPN
iajs-3750	53	20	)	)	PUNCT
iajs-3750	53	21	curve	curve	NOUN
iajs-3750	53	22	analysis	analysis	NOUN
iajs-3750	53	23	;	;	PUNCT
iajs-3750	53	24	obestatin	obestatin	NOUN
iajs-3750	53	25	and	and	CCONJ
iajs-3750	53	26	opn	opn	PROPN
iajs-3750	53	27	cut	cut	PROPN
iajs-3750	53	28	-	-	PUNCT
iajs-3750	53	29	off	off	ADP
iajs-3750	53	30	values	value	NOUN
iajs-3750	53	31	were	be	AUX
iajs-3750	53	32	assessed	assess	VERB
iajs-3750	53	33	.	.	PUNCT
iajs-3750	54	1	3	3	X
iajs-3750	54	2	.	.	X
iajs-3750	54	3	results	result	NOUN
iajs-3750	54	4	as	as	SCONJ
iajs-3750	54	5	shown	show	VERB
iajs-3750	54	6	in	in	ADP
iajs-3750	54	7	table	table	NOUN
iajs-3750	54	8	(	(	PUNCT
iajs-3750	54	9	1	1	NUM
iajs-3750	54	10	)	)	PUNCT
iajs-3750	54	11	,	,	PUNCT
iajs-3750	54	12	there	there	PRON
iajs-3750	54	13	were	be	VERB
iajs-3750	54	14	no	no	DET
iajs-3750	54	15	notable	notable	ADJ
iajs-3750	54	16	changes	change	NOUN
iajs-3750	54	17	in	in	ADP
iajs-3750	54	18	age	age	NOUN
iajs-3750	54	19	.	.	PUNCT
iajs-3750	55	1	however	however	ADV
iajs-3750	55	2	,	,	PUNCT
iajs-3750	55	3	significant	significant	ADJ
iajs-3750	55	4	differences	difference	NOUN
iajs-3750	55	5	in	in	ADP
iajs-3750	55	6	bmi	bmi	NOUN
iajs-3750	55	7	were	be	AUX
iajs-3750	55	8	observed	observe	VERB
iajs-3750	55	9	among	among	ADP
iajs-3750	55	10	the	the	DET
iajs-3750	55	11	study	study	NOUN
iajs-3750	55	12	groups	group	NOUN
iajs-3750	55	13	.	.	PUNCT
iajs-3750	56	1	table	table	NOUN
iajs-3750	56	2	1	1	NUM
iajs-3750	56	3	.	.	PUNCT
iajs-3750	57	1	the	the	DET
iajs-3750	57	2	demographic	demographic	ADJ
iajs-3750	57	3	characteristics	characteristic	NOUN
iajs-3750	57	4	of	of	ADP
iajs-3750	57	5	mets	met	NOUN
iajs-3750	57	6	and	and	CCONJ
iajs-3750	57	7	controls	control	VERB
iajs-3750	57	8	p	p	NOUN
iajs-3750	57	9	-	-	PUNCT
iajs-3750	57	10	value	value	NOUN
iajs-3750	57	11	control	control	NOUN
iajs-3750	57	12	(	(	PUNCT
iajs-3750	57	13	n=	n=	ADJ
iajs-3750	57	14	40	40	NUM
iajs-3750	57	15	)	)	PUNCT
iajs-3750	57	16	mets	met	NOUN
iajs-3750	57	17	(	(	PUNCT
iajs-3750	57	18	n=	n=	ADJ
iajs-3750	57	19	125	125	NUM
iajs-3750	57	20	)	)	PUNCT
iajs-3750	57	21	variables	variable	NOUN
iajs-3750	57	22	n.s	n.s	PROPN
iajs-3750	57	23	49.5	49.5	NUM
iajs-3750	57	24	(	(	PUNCT
iajs-3750	57	25	61	61	NUM
iajs-3750	57	26	-	-	SYM
iajs-3750	57	27	35.00	35.00	NUM
iajs-3750	57	28	)	)	PUNCT
iajs-3750	57	29	53	53	NUM
iajs-3750	57	30	(	(	PUNCT
iajs-3750	57	31	68	68	NUM
iajs-3750	57	32	-	-	SYM
iajs-3750	57	33	42.00	42.00	NUM
iajs-3750	57	34	)	)	PUNCT
iajs-3750	57	35	age	age	NOUN
iajs-3750	57	36	(	(	PUNCT
iajs-3750	57	37	year	year	NOUN
iajs-3750	57	38	)	)	PUNCT
iajs-3750	58	1	0.001	0.001	NUM
iajs-3750	58	2	20.00	20.00	NUM
iajs-3750	58	3	(	(	PUNCT
iajs-3750	58	4	22	22	NUM
iajs-3750	58	5	-19	-19	NUM
iajs-3750	58	6	)	)	PUNCT
iajs-3750	58	7	39.5	39.5	NUM
iajs-3750	58	8	(	(	PUNCT
iajs-3750	58	9	44.5035.42	44.5035.42	X
iajs-3750	58	10	)	)	PUNCT
iajs-3750	58	11	bmi	bmi	NOUN
iajs-3750	58	12	(	(	PUNCT
iajs-3750	58	13	kg	kg	NOUN
iajs-3750	58	14	/	/	SYM
iajs-3750	58	15	m	m	PROPN
iajs-3750	58	16	2	2	NUM
iajs-3750	58	17	)	)	PUNCT
iajs-3750	58	18	0.001	0.001	NUM
iajs-3750	58	19	12.00	12.00	NUM
iajs-3750	58	20	(	(	PUNCT
iajs-3750	58	21	12	12	NUM
iajs-3750	58	22	-12	-12	NOUN
iajs-3750	58	23	)	)	PUNCT
iajs-3750	58	24	16	16	NUM
iajs-3750	58	25	(	(	PUNCT
iajs-3750	58	26	16	16	NUM
iajs-3750	58	27	-	-	SYM
iajs-3750	58	28	15	15	NUM
iajs-3750	58	29	)	)	PUNCT
iajs-3750	58	30	sbp	sbp	NOUN
iajs-3750	58	31	(	(	PUNCT
iajs-3750	58	32	mmhg	mmhg	PROPN
iajs-3750	58	33	)	)	PUNCT
iajs-3750	58	34	0.001	0.001	NUM
iajs-3750	58	35	8	8	NUM
iajs-3750	58	36	(	(	PUNCT
iajs-3750	58	37	8	8	NUM
iajs-3750	58	38	-8	-8	NUM
iajs-3750	58	39	)	)	PUNCT
iajs-3750	58	40	9	9	NUM
iajs-3750	58	41	(	(	PUNCT
iajs-3750	58	42	9.50	9.50	NUM
iajs-3750	58	43	-	-	SYM
iajs-3750	58	44	9.00	9.00	NUM
iajs-3750	58	45	)	)	PUNCT
iajs-3750	58	46	dbp	dbp	PROPN
iajs-3750	58	47	(	(	PUNCT
iajs-3750	58	48	mmhg	mmhg	PROPN
iajs-3750	58	49	)	)	PUNCT
iajs-3750	58	50	*	*	PUNCT
iajs-3750	58	51	the	the	DET
iajs-3750	58	52	collected	collect	VERB
iajs-3750	58	53	data	datum	NOUN
iajs-3750	58	54	were	be	AUX
iajs-3750	58	55	analyzed	analyze	VERB
iajs-3750	58	56	by	by	ADP
iajs-3750	58	57	median	median	PROPN
iajs-3750	58	58	(	(	PUNCT
iajs-3750	58	59	25	25	NUM
iajs-3750	58	60	th	th	X
iajs-3750	58	61	and	and	CCONJ
iajs-3750	58	62	75	75	NUM
iajs-3750	58	63	th	th	NUM
iajs-3750	58	64	percentiles	percentile	NOUN
iajs-3750	58	65	)	)	PUNCT
iajs-3750	58	66	via	via	ADP
iajs-3750	58	67	the	the	DET
iajs-3750	58	68	man	man	NOUN
iajs-3750	58	69	whitney	whitney	PROPN
iajs-3750	58	70	test	test	NOUN
iajs-3750	58	71	at	at	ADP
iajs-3750	58	72	the	the	DET
iajs-3750	58	73	0.05	0.05	NUM
iajs-3750	58	74	level	level	NOUN
iajs-3750	58	75	.	.	PUNCT
iajs-3750	59	1	findings	finding	NOUN
iajs-3750	59	2	showed	show	VERB
iajs-3750	59	3	a	a	DET
iajs-3750	59	4	significant	significant	ADJ
iajs-3750	59	5	difference	difference	NOUN
iajs-3750	59	6	in	in	ADP
iajs-3750	59	7	bmi	bmi	NOUN
iajs-3750	59	8	between	between	ADP
iajs-3750	59	9	the	the	DET
iajs-3750	59	10	mets	mets	PROPN
iajs-3750	59	11	group	group	NOUN
iajs-3750	59	12	(	(	PUNCT
iajs-3750	59	13	39.5	39.5	NUM
iajs-3750	59	14	kg	kg	NOUN
iajs-3750	59	15	/	/	SYM
iajs-3750	59	16	m²	m²	PROPN
iajs-3750	59	17	)	)	PUNCT
iajs-3750	59	18	and	and	CCONJ
iajs-3750	59	19	the	the	DET
iajs-3750	59	20	control	control	NOUN
iajs-3750	59	21	group	group	NOUN
iajs-3750	59	22	(	(	PUNCT
iajs-3750	59	23	20	20	NUM
iajs-3750	59	24	kg	kg	NOUN
iajs-3750	59	25	/	/	SYM
iajs-3750	59	26	m²	m²	PROPN
iajs-3750	59	27	)	)	PUNCT
iajs-3750	59	28	,	,	PUNCT
iajs-3750	59	29	but	but	CCONJ
iajs-3750	59	30	not	not	PART
iajs-3750	59	31	between	between	ADP
iajs-3750	59	32	the	the	DET
iajs-3750	59	33	ages	age	NOUN
iajs-3750	59	34	of	of	ADP
iajs-3750	59	35	the	the	DET
iajs-3750	59	36	two	two	NUM
iajs-3750	59	37	groups	group	NOUN
iajs-3750	59	38	(	(	PUNCT
iajs-3750	59	39	53	53	NUM
iajs-3750	59	40	and	and	CCONJ
iajs-3750	59	41	49.5	49.5	NUM
iajs-3750	59	42	years	year	NOUN
iajs-3750	59	43	,	,	PUNCT
iajs-3750	59	44	respectively	respectively	ADV
iajs-3750	59	45	)	)	PUNCT
iajs-3750	59	46	.	.	PUNCT
iajs-3750	60	1	also	also	ADV
iajs-3750	60	2	,	,	PUNCT
iajs-3750	60	3	sbp	sbp	PROPN
iajs-3750	60	4	and	and	CCONJ
iajs-3750	60	5	dbp	dbp	PROPN
iajs-3750	60	6	were	be	AUX
iajs-3750	60	7	16	16	NUM
iajs-3750	60	8	mmhg	mmhg	NOUN
iajs-3750	60	9	and	and	CCONJ
iajs-3750	60	10	9	9	NUM
iajs-3750	60	11	mmhg	mmhg	NOUN
iajs-3750	60	12	,	,	PUNCT
iajs-3750	60	13	respectively	respectively	ADV
iajs-3750	60	14	,	,	PUNCT
iajs-3750	60	15	for	for	ADP
iajs-3750	60	16	the	the	DET
iajs-3750	60	17	mets	met	NOUN
iajs-3750	60	18	group	group	NOUN
iajs-3750	60	19	(	(	PUNCT
iajs-3750	60	20	p	p	NOUN
iajs-3750	60	21	=	=	NOUN
iajs-3750	60	22	0.001	0.001	NUM
iajs-3750	60	23	)	)	PUNCT
iajs-3750	60	24	.	.	PUNCT
iajs-3750	61	1	the	the	DET
iajs-3750	61	2	results	result	NOUN
iajs-3750	61	3	in	in	ADP
iajs-3750	61	4	table	table	NOUN
iajs-3750	61	5	(	(	PUNCT
iajs-3750	61	6	2	2	NUM
iajs-3750	61	7	)	)	PUNCT
iajs-3750	61	8	show	show	VERB
iajs-3750	61	9	that	that	SCONJ
iajs-3750	61	10	the	the	DET
iajs-3750	61	11	fsg	fsg	PROPN
iajs-3750	61	12	for	for	ADP
iajs-3750	61	13	mets	met	NOUN
iajs-3750	61	14	was	be	AUX
iajs-3750	61	15	117	117	NUM
iajs-3750	61	16	mg	mg	PROPN
iajs-3750	61	17	/	/	SYM
iajs-3750	61	18	dl	dl	PROPN
iajs-3750	61	19	,	,	PUNCT
iajs-3750	61	20	which	which	PRON
iajs-3750	61	21	was	be	AUX
iajs-3750	61	22	significantly	significantly	ADV
iajs-3750	61	23	different	different	ADJ
iajs-3750	61	24	(	(	PUNCT
iajs-3750	61	25	p=	p=	NOUN
iajs-3750	61	26	0.001	0.001	NUM
iajs-3750	61	27	)	)	PUNCT
iajs-3750	61	28	from	from	ADP
iajs-3750	61	29	that	that	PRON
iajs-3750	61	30	of	of	ADP
iajs-3750	61	31	the	the	DET
iajs-3750	61	32	control	control	NOUN
iajs-3750	61	33	group	group	NOUN
iajs-3750	61	34	,	,	PUNCT
iajs-3750	61	35	99	99	NUM
iajs-3750	61	36	mg	mg	PROPN
iajs-3750	61	37	/	/	SYM
iajs-3750	61	38	dl	dl	PROPN
iajs-3750	61	39	.	.	PUNCT
iajs-3750	62	1	there	there	PRON
iajs-3750	62	2	were	be	VERB
iajs-3750	62	3	significant	significant	ADJ
iajs-3750	62	4	differences	difference	NOUN
iajs-3750	62	5	(	(	PUNCT
iajs-3750	62	6	p=	p=	NOUN
iajs-3750	62	7	0.001	0.001	NUM
iajs-3750	62	8	)	)	PUNCT
iajs-3750	62	9	in	in	ADP
iajs-3750	62	10	the	the	DET
iajs-3750	62	11	levels	level	NOUN
iajs-3750	62	12	of	of	ADP
iajs-3750	62	13	alt	alt	ADJ
iajs-3750	62	14	,	,	PUNCT
iajs-3750	62	15	ast	ast	ADJ
iajs-3750	62	16	,	,	PUNCT
iajs-3750	62	17	and	and	CCONJ
iajs-3750	62	18	alp	alp	NOUN
iajs-3750	62	19	in	in	ADP
iajs-3750	62	20	the	the	DET
iajs-3750	62	21	mets	met	NOUN
iajs-3750	62	22	group	group	NOUN
iajs-3750	62	23	,	,	PUNCT
iajs-3750	62	24	which	which	PRON
iajs-3750	62	25	were	be	AUX
iajs-3750	62	26	recorded	record	VERB
iajs-3750	62	27	as	as	ADP
iajs-3750	62	28	38.6	38.6	NUM
iajs-3750	62	29	,	,	PUNCT
iajs-3750	62	30	36.4	36.4	NUM
iajs-3750	62	31	,	,	PUNCT
iajs-3750	62	32	and	and	CCONJ
iajs-3750	62	33	83.4	83.4	NUM
iajs-3750	62	34	u	u	NOUN
iajs-3750	62	35	/	/	SYM
iajs-3750	62	36	l	l	NOUN
iajs-3750	62	37	,	,	PUNCT
iajs-3750	62	38	compared	compare	VERB
iajs-3750	62	39	to	to	ADP
iajs-3750	62	40	29.8	29.8	NUM
iajs-3750	62	41	,	,	PUNCT
iajs-3750	62	42	28.9	28.9	NUM
iajs-3750	62	43	,	,	PUNCT
iajs-3750	62	44	and	and	CCONJ
iajs-3750	62	45	70.6	70.6	NUM
iajs-3750	62	46	u	u	NOUN
iajs-3750	62	47	/	/	SYM
iajs-3750	62	48	l	l	NOUN
iajs-3750	62	49	in	in	ADP
iajs-3750	62	50	the	the	DET
iajs-3750	62	51	healthy	healthy	ADJ
iajs-3750	62	52	control	control	NOUN
iajs-3750	62	53	group	group	NOUN
iajs-3750	62	54	.	.	PUNCT
iajs-3750	63	1	the	the	DET
iajs-3750	63	2	exception	exception	NOUN
iajs-3750	63	3	was	be	AUX
iajs-3750	63	4	total	total	ADJ
iajs-3750	63	5	protein	protein	NOUN
iajs-3750	63	6	,	,	PUNCT
iajs-3750	63	7	which	which	PRON
iajs-3750	63	8	was	be	AUX
iajs-3750	63	9	slightly	slightly	ADV
iajs-3750	63	10	higher	high	ADJ
iajs-3750	63	11	in	in	ADP
iajs-3750	63	12	the	the	DET
iajs-3750	63	13	healthy	healthy	ADJ
iajs-3750	63	14	group	group	NOUN
iajs-3750	63	15	(	(	PUNCT
iajs-3750	63	16	6.20	6.20	NUM
iajs-3750	63	17	g	g	NOUN
iajs-3750	63	18	/	/	SYM
iajs-3750	63	19	dl	dl	NOUN
iajs-3750	63	20	)	)	PUNCT
iajs-3750	63	21	than	than	ADP
iajs-3750	63	22	in	in	ADP
iajs-3750	63	23	the	the	DET
iajs-3750	63	24	mets	met	NOUN
iajs-3750	63	25	group	group	NOUN
iajs-3750	63	26	(	(	PUNCT
iajs-3750	63	27	5.89	5.89	NUM
iajs-3750	63	28	g	g	NOUN
iajs-3750	63	29	/	/	SYM
iajs-3750	63	30	dl	dl	NOUN
iajs-3750	63	31	)	)	PUNCT
iajs-3750	63	32	.	.	PUNCT
iajs-3750	64	1	table	table	NOUN
iajs-3750	64	2	2	2	NUM
iajs-3750	64	3	.	.	PUNCT
iajs-3750	64	4	serum	serum	NOUN
iajs-3750	64	5	glucose	glucose	NOUN
iajs-3750	64	6	,	,	PUNCT
iajs-3750	64	7	liver	liver	NOUN
iajs-3750	64	8	enzymes	enzyme	NOUN
iajs-3750	64	9	,	,	PUNCT
iajs-3750	64	10	and	and	CCONJ
iajs-3750	64	11	total	total	ADJ
iajs-3750	64	12	proteins	protein	NOUN
iajs-3750	64	13	levels	level	NOUN
iajs-3750	64	14	of	of	ADP
iajs-3750	64	15	mets	met	NOUN
iajs-3750	64	16	and	and	CCONJ
iajs-3750	64	17	control	control	NOUN
iajs-3750	64	18	group	group	NOUN
iajs-3750	64	19	variables	variable	NOUN
iajs-3750	64	20	mets	met	NOUN
iajs-3750	64	21	(	(	PUNCT
iajs-3750	64	22	n=	n=	ADJ
iajs-3750	64	23	125	125	NUM
iajs-3750	64	24	)	)	PUNCT
iajs-3750	64	25	control	control	NOUN
iajs-3750	64	26	(	(	PUNCT
iajs-3750	64	27	n=	n=	ADJ
iajs-3750	64	28	40	40	NUM
iajs-3750	64	29	)	)	PUNCT
iajs-3750	64	30	p	p	X
iajs-3750	64	31	-	-	PUNCT
iajs-3750	64	32	value	value	NOUN
iajs-3750	64	33	fsg	fsg	NOUN
iajs-3750	64	34	(	(	PUNCT
iajs-3750	64	35	mg	mg	PROPN
iajs-3750	64	36	/	/	SYM
iajs-3750	64	37	dl	dl	NOUN
iajs-3750	64	38	)	)	PUNCT
iajs-3750	64	39	117	117	NUM
iajs-3750	64	40	(	(	PUNCT
iajs-3750	64	41	136	136	NUM
iajs-3750	64	42	-	-	SYM
iajs-3750	64	43	101	101	NUM
iajs-3750	64	44	)	)	PUNCT
iajs-3750	64	45	99	99	NUM
iajs-3750	64	46	(	(	PUNCT
iajs-3750	64	47	104	104	NUM
iajs-3750	64	48	-	-	SYM
iajs-3750	64	49	96	96	NUM
iajs-3750	64	50	)	)	PUNCT
iajs-3750	64	51	0.001	0.001	NUM
iajs-3750	64	52	alt(u	alt(u	PROPN
iajs-3750	64	53	/	/	SYM
iajs-3750	64	54	l	l	NOUN
iajs-3750	64	55	)	)	PUNCT
iajs-3750	64	56	38.60	38.60	NUM
iajs-3750	64	57	(	(	PUNCT
iajs-3750	64	58	42.38	42.38	NUM
iajs-3750	64	59	-	-	SYM
iajs-3750	64	60	32.55	32.55	NUM
iajs-3750	64	61	)	)	PUNCT
iajs-3750	64	62	29.80	29.80	NUM
iajs-3750	64	63	(	(	PUNCT
iajs-3750	64	64	39.55	39.55	NUM
iajs-3750	64	65	-	-	SYM
iajs-3750	64	66	22.65	22.65	NUM
iajs-3750	64	67	)	)	PUNCT
iajs-3750	64	68	0.001	0.001	NUM
iajs-3750	64	69	ast(u	ast(u	PROPN
iajs-3750	64	70	/	/	SYM
iajs-3750	64	71	l	l	NOUN
iajs-3750	64	72	)	)	PUNCT
iajs-3750	64	73	36.40(42.00	36.40(42.00	NUM
iajs-3750	64	74	-	-	SYM
iajs-3750	64	75	31.00	31.00	NUM
iajs-3750	64	76	)	)	PUNCT
iajs-3750	64	77	28.90	28.90	NUM
iajs-3750	64	78	(	(	PUNCT
iajs-3750	64	79	37.35	37.35	NUM
iajs-3750	64	80	-	-	SYM
iajs-3750	64	81	21.95	21.95	NUM
iajs-3750	64	82	)	)	PUNCT
iajs-3750	64	83	0.001	0.001	NUM
iajs-3750	64	84	alp	alp	NOUN
iajs-3750	64	85	(	(	PUNCT
iajs-3750	64	86	u	u	NOUN
iajs-3750	64	87	/	/	SYM
iajs-3750	64	88	l	l	NOUN
iajs-3750	64	89	)	)	PUNCT
iajs-3750	64	90	83.40(90.65	83.40(90.65	NUM
iajs-3750	64	91	-	-	SYM
iajs-3750	64	92	74.63	74.63	NUM
iajs-3750	64	93	)	)	PUNCT
iajs-3750	64	94	70.60	70.60	NUM
iajs-3750	64	95	(	(	PUNCT
iajs-3750	64	96	90.85	90.85	NUM
iajs-3750	64	97	-	-	SYM
iajs-3750	64	98	59.75	59.75	NUM
iajs-3750	64	99	)	)	PUNCT
iajs-3750	64	100	0.001	0.001	NUM
iajs-3750	64	101	total	total	ADJ
iajs-3750	64	102	protein	protein	NOUN
iajs-3750	64	103	(	(	PUNCT
iajs-3750	64	104	g	g	PROPN
iajs-3750	64	105	/	/	SYM
iajs-3750	64	106	dl	dl	NOUN
iajs-3750	64	107	)	)	PUNCT
iajs-3750	64	108	5.89(6.04	5.89(6.04	NUM
iajs-3750	64	109	-	-	SYM
iajs-3750	64	110	5.49	5.49	NUM
iajs-3750	64	111	)	)	PUNCT
iajs-3750	64	112	6.20	6.20	NUM
iajs-3750	64	113	(	(	PUNCT
iajs-3750	64	114	6.64	6.64	NUM
iajs-3750	64	115	-	-	SYM
iajs-3750	64	116	6.04	6.04	NUM
iajs-3750	64	117	)	)	PUNCT
iajs-3750	64	118	0.001	0.001	NUM
iajs-3750	64	119	fsg	fsg	NOUN
iajs-3750	64	120	:	:	PUNCT
iajs-3750	64	121	fasting	fast	VERB
iajs-3750	64	122	serum	serum	NOUN
iajs-3750	64	123	glucose	glucose	NOUN
iajs-3750	64	124	,	,	PUNCT
iajs-3750	64	125	alt	alt	ADJ
iajs-3750	64	126	:	:	PUNCT
iajs-3750	64	127	alanine	alanine	NOUN
iajs-3750	64	128	aminotransferase	aminotransferase	PROPN
iajs-3750	64	129	,	,	PUNCT
iajs-3750	64	130	ast	ast	NOUN
iajs-3750	64	131	:	:	PUNCT
iajs-3750	64	132	aspartate	aspartate	NOUN
iajs-3750	64	133	aminotransferase	aminotransferase	PROPN
iajs-3750	64	134	,	,	PUNCT
iajs-3750	64	135	alp	alp	PROPN
iajs-3750	64	136	:	:	PUNCT
iajs-3750	64	137	alkaline	alkaline	NOUN
iajs-3750	64	138	phosphatase	phosphatase	NOUN
iajs-3750	64	139	the	the	DET
iajs-3750	64	140	serum	serum	NOUN
iajs-3750	64	141	lipid	lipid	NOUN
iajs-3750	64	142	profile	profile	NOUN
iajs-3750	64	143	results	result	VERB
iajs-3750	64	144	for	for	ADP
iajs-3750	64	145	patients	patient	NOUN
iajs-3750	64	146	and	and	CCONJ
iajs-3750	64	147	healthy	healthy	ADJ
iajs-3750	64	148	groups	group	NOUN
iajs-3750	64	149	are	be	AUX
iajs-3750	64	150	shown	show	VERB
iajs-3750	64	151	in	in	ADP
iajs-3750	64	152	table	table	NOUN
iajs-3750	64	153	(	(	PUNCT
iajs-3750	64	154	3	3	NUM
iajs-3750	64	155	)	)	PUNCT
iajs-3750	64	156	.	.	PUNCT
iajs-3750	65	1	there	there	PRON
iajs-3750	65	2	were	be	VERB
iajs-3750	65	3	significant	significant	ADJ
iajs-3750	65	4	differences	difference	NOUN
iajs-3750	65	5	(	(	PUNCT
iajs-3750	65	6	p=	p=	NOUN
iajs-3750	65	7	0.001	0.001	NUM
iajs-3750	65	8	)	)	PUNCT
iajs-3750	65	9	between	between	ADP
iajs-3750	65	10	the	the	DET
iajs-3750	65	11	mets	met	NOUN
iajs-3750	65	12	group	group	NOUN
iajs-3750	65	13	and	and	CCONJ
iajs-3750	65	14	the	the	DET
iajs-3750	65	15	control	control	NOUN
iajs-3750	65	16	group	group	NOUN
iajs-3750	65	17	regarding	regard	VERB
iajs-3750	65	18	serum	serum	NOUN
iajs-3750	65	19	cholesterol	cholesterol	PROPN
iajs-3750	65	20	,	,	PUNCT
iajs-3750	65	21	tg	tg	PRON
iajs-3750	65	22	,	,	PUNCT
iajs-3750	65	23	ldl	ldl	NOUN
iajs-3750	65	24	-	-	PUNCT
iajs-3750	65	25	c	c	NOUN
iajs-3750	65	26	,	,	PUNCT
iajs-3750	65	27	and	and	CCONJ
iajs-3750	65	28	vldl	vldl	PROPN
iajs-3750	65	29	.	.	PUNCT
iajs-3750	66	1	while	while	SCONJ
iajs-3750	66	2	hdl	hdl	PROPN
iajs-3750	66	3	-	-	PUNCT
iajs-3750	66	4	c	c	PROPN
iajs-3750	66	5	was	be	AUX
iajs-3750	66	6	significantly	significantly	ADV
iajs-3750	66	7	ihjpas	ihjpas	ADJ
iajs-3750	66	8	.	.	PUNCT
iajs-3750	67	1	2025	2025	NUM
iajs-3750	67	2	,	,	PUNCT
iajs-3750	67	3	38(3	38(3	NUM
iajs-3750	67	4	)	)	PUNCT
iajs-3750	67	5	259	259	NUM
iajs-3750	67	6	decreased	decrease	VERB
iajs-3750	67	7	(	(	PUNCT
iajs-3750	67	8	p=0.001	p=0.001	NUM
iajs-3750	67	9	)	)	PUNCT
iajs-3750	67	10	in	in	ADP
iajs-3750	67	11	the	the	DET
iajs-3750	67	12	mets	met	NOUN
iajs-3750	67	13	group	group	NOUN
iajs-3750	67	14	compared	compare	VERB
iajs-3750	67	15	to	to	ADP
iajs-3750	67	16	the	the	DET
iajs-3750	67	17	healthy	healthy	ADJ
iajs-3750	67	18	group	group	NOUN
iajs-3750	67	19	.	.	PUNCT
iajs-3750	68	1	table	table	NOUN
iajs-3750	68	2	3	3	NUM
iajs-3750	68	3	.	.	X
iajs-3750	68	4	serum	serum	NOUN
iajs-3750	68	5	lipid	lipid	PROPN
iajs-3750	68	6	profile	profile	NOUN
iajs-3750	68	7	of	of	ADP
iajs-3750	68	8	mets	met	NOUN
iajs-3750	68	9	and	and	CCONJ
iajs-3750	68	10	control	control	NOUN
iajs-3750	68	11	group	group	NOUN
iajs-3750	68	12	p	p	NOUN
iajs-3750	68	13	-	-	PUNCT
iajs-3750	68	14	value	value	NOUN
iajs-3750	68	15	control	control	NOUN
iajs-3750	68	16	(	(	PUNCT
iajs-3750	68	17	n=	n=	ADJ
iajs-3750	68	18	40	40	NUM
iajs-3750	68	19	)	)	PUNCT
iajs-3750	68	20	mets	met	NOUN
iajs-3750	68	21	(	(	PUNCT
iajs-3750	68	22	n=	n=	ADJ
iajs-3750	68	23	125	125	NUM
iajs-3750	68	24	)	)	PUNCT
iajs-3750	68	25	variables	variable	VERB
iajs-3750	68	26	0.001	0.001	NUM
iajs-3750	68	27	151.00	151.00	NUM
iajs-3750	68	28	(	(	PUNCT
iajs-3750	68	29	158	158	NUM
iajs-3750	68	30	-	-	SYM
iajs-3750	68	31	135	135	NUM
iajs-3750	68	32	)	)	PUNCT
iajs-3750	68	33	237.00	237.00	NUM
iajs-3750	68	34	(	(	PUNCT
iajs-3750	68	35	257.00	257.00	NUM
iajs-3750	68	36	-	-	SYM
iajs-3750	68	37	229.00	229.00	NUM
iajs-3750	68	38	)	)	PUNCT
iajs-3750	68	39	cholesterol	cholesterol	NOUN
iajs-3750	68	40	(	(	PUNCT
iajs-3750	68	41	mg	mg	PROPN
iajs-3750	68	42	/	/	SYM
iajs-3750	68	43	dl	dl	PROPN
iajs-3750	68	44	)	)	PUNCT
iajs-3750	68	45	0.001	0.001	NUM
iajs-3750	68	46	111.00	111.00	NUM
iajs-3750	68	47	(	(	PUNCT
iajs-3750	68	48	145.00	145.00	NUM
iajs-3750	68	49	-	-	SYM
iajs-3750	68	50	97.00	97.00	NUM
iajs-3750	68	51	)	)	PUNCT
iajs-3750	68	52	282.00	282.00	NUM
iajs-3750	68	53	(	(	PUNCT
iajs-3750	68	54	304.00	304.00	NUM
iajs-3750	68	55	-	-	SYM
iajs-3750	68	56	265.50	265.50	NUM
iajs-3750	68	57	)	)	PUNCT
iajs-3750	69	1	tg	tg	PROPN
iajs-3750	70	1	(	(	PUNCT
iajs-3750	70	2	mg	mg	PROPN
iajs-3750	70	3	/	/	SYM
iajs-3750	70	4	dl	dl	PROPN
iajs-3750	70	5	)	)	PUNCT
iajs-3750	70	6	0.001	0.001	NUM
iajs-3750	70	7	47.5	47.5	NUM
iajs-3750	70	8	(	(	PUNCT
iajs-3750	70	9	48.50	48.50	NUM
iajs-3750	70	10	-	-	SYM
iajs-3750	70	11	4600	4600	NUM
iajs-3750	70	12	)	)	PUNCT
iajs-3750	70	13	29	29	NUM
iajs-3750	70	14	(	(	PUNCT
iajs-3750	70	15	30.50	30.50	NUM
iajs-3750	70	16	-	-	SYM
iajs-3750	70	17	27.50	27.50	NUM
iajs-3750	70	18	)	)	PUNCT
iajs-3750	70	19	hdl	hdl	PROPN
iajs-3750	70	20	-	-	PUNCT
iajs-3750	70	21	c	c	PROPN
iajs-3750	70	22	(	(	PUNCT
iajs-3750	70	23	mg	mg	PROPN
iajs-3750	70	24	/	/	SYM
iajs-3750	70	25	dl	dl	PROPN
iajs-3750	70	26	)	)	PUNCT
iajs-3750	70	27	0.001	0.001	NUM
iajs-3750	70	28	72.00	72.00	NUM
iajs-3750	70	29	(	(	PUNCT
iajs-3750	70	30	86.00	86.00	NUM
iajs-3750	70	31	-	-	SYM
iajs-3750	70	32	64.00	64.00	NUM
iajs-3750	70	33	)	)	PUNCT
iajs-3750	70	34	150.00(168.00	150.00(168.00	NUM
iajs-3750	70	35	-	-	SYM
iajs-3750	70	36	142.00	142.00	NUM
iajs-3750	70	37	)	)	PUNCT
iajs-3750	70	38	ldl	ldl	NOUN
iajs-3750	70	39	-	-	PUNCT
iajs-3750	70	40	c	c	NOUN
iajs-3750	70	41	(	(	PUNCT
iajs-3750	70	42	mg	mg	PROPN
iajs-3750	70	43	/	/	SYM
iajs-3750	70	44	dl	dl	PROPN
iajs-3750	70	45	)	)	PUNCT
iajs-3750	70	46	0.001	0.001	NUM
iajs-3750	70	47	23.50(31.50	23.50(31.50	NUM
iajs-3750	70	48	-	-	SYM
iajs-3750	70	49	20.00	20.00	NUM
iajs-3750	70	50	)	)	PUNCT
iajs-3750	70	51	56.00(60.00	56.00(60.00	NUM
iajs-3750	70	52	-	-	SYM
iajs-3750	70	53	53.00	53.00	NUM
iajs-3750	70	54	)	)	PUNCT
iajs-3750	70	55	vldl	vldl	NOUN
iajs-3750	70	56	(	(	PUNCT
iajs-3750	70	57	mg	mg	PROPN
iajs-3750	70	58	/	/	SYM
iajs-3750	70	59	dl	dl	NOUN
iajs-3750	70	60	)	)	PUNCT
iajs-3750	70	61	*	*	PUNCT
iajs-3750	71	1	the	the	DET
iajs-3750	71	2	collected	collect	VERB
iajs-3750	71	3	data	datum	NOUN
iajs-3750	71	4	were	be	AUX
iajs-3750	71	5	analyzed	analyze	VERB
iajs-3750	71	6	by	by	ADP
iajs-3750	71	7	median	median	PROPN
iajs-3750	71	8	at	at	ADP
iajs-3750	71	9	the	the	DET
iajs-3750	71	10	p	p	X
iajs-3750	71	11	<	<	X
iajs-3750	71	12	0.05	0.05	NUM
iajs-3750	71	13	level	level	NOUN
iajs-3750	71	14	.	.	PUNCT
iajs-3750	72	1	tg	tg	PRON
iajs-3750	72	2	:	:	PUNCT
iajs-3750	72	3	triglycerides	triglyceride	NOUN
iajs-3750	72	4	:	:	PUNCT
iajs-3750	72	5	ldl	ldl	NOUN
iajs-3750	72	6	-	-	PUNCT
iajs-3750	72	7	c	c	NOUN
iajs-3750	72	8	:	:	PUNCT
iajs-3750	72	9	low	low	ADJ
iajs-3750	72	10	-	-	PUNCT
iajs-3750	72	11	density	density	NOUN
iajs-3750	72	12	lipoprotein	lipoprotein	ADJ
iajs-3750	72	13	cholesterol	cholesterol	NOUN
iajs-3750	72	14	,	,	PUNCT
iajs-3750	72	15	hdl	hdl	PROPN
iajs-3750	72	16	-	-	PUNCT
iajs-3750	72	17	c	c	NOUN
iajs-3750	72	18	:	:	PUNCT
iajs-3750	72	19	high	high	ADJ
iajs-3750	72	20	-	-	PUNCT
iajs-3750	72	21	density	density	NOUN
iajs-3750	72	22	lipoprotein	lipoprotein	ADJ
iajs-3750	72	23	cholesterol	cholesterol	NOUN
iajs-3750	72	24	,	,	PUNCT
iajs-3750	72	25	vldl	vldl	NOUN
iajs-3750	72	26	:	:	PUNCT
iajs-3750	72	27	very	very	ADV
iajs-3750	72	28	low	low	ADJ
iajs-3750	72	29	-	-	PUNCT
iajs-3750	72	30	density	density	NOUN
iajs-3750	72	31	lipoprotein	lipoprotein	NOUN
iajs-3750	72	32	.	.	PUNCT
iajs-3750	73	1	the	the	DET
iajs-3750	73	2	results	result	NOUN
iajs-3750	73	3	of	of	ADP
iajs-3750	73	4	table	table	NOUN
iajs-3750	73	5	(	(	PUNCT
iajs-3750	73	6	4	4	NUM
iajs-3750	73	7	)	)	PUNCT
iajs-3750	73	8	and	and	CCONJ
iajs-3750	73	9	figure	figure	NOUN
iajs-3750	73	10	(	(	PUNCT
iajs-3750	73	11	1	1	X
iajs-3750	73	12	)	)	PUNCT
iajs-3750	73	13	showed	show	VERB
iajs-3750	73	14	a	a	DET
iajs-3750	73	15	significant	significant	ADJ
iajs-3750	73	16	(	(	PUNCT
iajs-3750	73	17	p=	p=	NOUN
iajs-3750	73	18	0.001	0.001	NUM
iajs-3750	73	19	)	)	PUNCT
iajs-3750	73	20	decrease	decrease	NOUN
iajs-3750	73	21	in	in	ADP
iajs-3750	73	22	obestatin	obestatin	NOUN
iajs-3750	73	23	level	level	NOUN
iajs-3750	73	24	in	in	ADP
iajs-3750	73	25	the	the	DET
iajs-3750	73	26	mets	met	NOUN
iajs-3750	73	27	group	group	NOUN
iajs-3750	73	28	(	(	PUNCT
iajs-3750	73	29	280.82	280.82	NUM
iajs-3750	73	30	pg	pg	NOUN
iajs-3750	73	31	/	/	SYM
iajs-3750	73	32	ml	ml	VERB
iajs-3750	73	33	)	)	PUNCT
iajs-3750	73	34	compared	compare	VERB
iajs-3750	73	35	to	to	ADP
iajs-3750	73	36	the	the	DET
iajs-3750	73	37	control	control	NOUN
iajs-3750	73	38	group	group	NOUN
iajs-3750	73	39	(	(	PUNCT
iajs-3750	73	40	1082.1	1082.1	NUM
iajs-3750	73	41	pg	pg	NOUN
iajs-3750	73	42	/	/	SYM
iajs-3750	73	43	ml	ml	NOUN
iajs-3750	73	44	)	)	PUNCT
iajs-3750	73	45	.	.	PUNCT
iajs-3750	74	1	while	while	SCONJ
iajs-3750	74	2	the	the	DET
iajs-3750	74	3	opn	opn	PROPN
iajs-3750	74	4	level	level	NOUN
iajs-3750	74	5	was	be	AUX
iajs-3750	74	6	significantly	significantly	ADV
iajs-3750	74	7	(	(	PUNCT
iajs-3750	74	8	p=	p=	NOUN
iajs-3750	74	9	0.001	0.001	NUM
iajs-3750	74	10	)	)	PUNCT
iajs-3750	74	11	higher	high	ADJ
iajs-3750	74	12	in	in	ADP
iajs-3750	74	13	the	the	DET
iajs-3750	74	14	mets	met	NOUN
iajs-3750	74	15	group	group	NOUN
iajs-3750	74	16	(	(	PUNCT
iajs-3750	74	17	17.96	17.96	NUM
iajs-3750	74	18	ng	ng	NOUN
iajs-3750	74	19	/	/	SYM
iajs-3750	74	20	ml	ml	NOUN
iajs-3750	74	21	)	)	PUNCT
iajs-3750	74	22	as	as	SCONJ
iajs-3750	74	23	compared	compare	VERB
iajs-3750	74	24	to	to	ADP
iajs-3750	74	25	the	the	DET
iajs-3750	74	26	healthy	healthy	ADJ
iajs-3750	74	27	control	control	NOUN
iajs-3750	74	28	group	group	NOUN
iajs-3750	74	29	(	(	PUNCT
iajs-3750	74	30	5.47	5.47	NUM
iajs-3750	74	31	ng	ng	PROPN
iajs-3750	74	32	/	/	SYM
iajs-3750	74	33	ml	ml	PROPN
iajs-3750	74	34	)	)	PUNCT
iajs-3750	74	35	,	,	PUNCT
iajs-3750	74	36	as	as	SCONJ
iajs-3750	74	37	shown	show	VERB
iajs-3750	74	38	in	in	ADP
iajs-3750	74	39	figure	figure	NOUN
iajs-3750	74	40	(	(	PUNCT
iajs-3750	74	41	2	2	NUM
iajs-3750	74	42	)	)	PUNCT
iajs-3750	74	43	.	.	PUNCT
iajs-3750	75	1	the	the	DET
iajs-3750	75	2	roc	roc	PROPN
iajs-3750	75	3	test	test	NOUN
iajs-3750	75	4	results	result	NOUN
iajs-3750	75	5	for	for	ADP
iajs-3750	75	6	the	the	DET
iajs-3750	75	7	obestatin	obestatin	NOUN
iajs-3750	75	8	levels	level	NOUN
iajs-3750	75	9	demonstrated	demonstrate	VERB
iajs-3750	75	10	ideal	ideal	ADJ
iajs-3750	75	11	cut	cut	NOUN
iajs-3750	75	12	-	-	PUNCT
iajs-3750	75	13	off	off	ADP
iajs-3750	75	14	values	value	NOUN
iajs-3750	75	15	,	,	PUNCT
iajs-3750	75	16	with	with	ADP
iajs-3750	75	17	a	a	DET
iajs-3750	75	18	sensitivity	sensitivity	NOUN
iajs-3750	75	19	of	of	ADP
iajs-3750	75	20	97.58	97.58	NUM
iajs-3750	75	21	%	%	NOUN
iajs-3750	75	22	and	and	CCONJ
iajs-3750	75	23	a	a	DET
iajs-3750	75	24	specificity	specificity	NOUN
iajs-3750	75	25	of	of	ADP
iajs-3750	75	26	100.00	100.00	NUM
iajs-3750	75	27	%	%	NOUN
iajs-3750	75	28	.	.	PUNCT
iajs-3750	76	1	the	the	DET
iajs-3750	76	2	area	area	NOUN
iajs-3750	76	3	under	under	ADP
iajs-3750	76	4	the	the	DET
iajs-3750	76	5	curve	curve	NOUN
iajs-3750	76	6	(	(	PUNCT
iajs-3750	76	7	auc	auc	NOUN
iajs-3750	76	8	)	)	PUNCT
iajs-3750	76	9	was	be	AUX
iajs-3750	76	10	calculated	calculate	VERB
iajs-3750	76	11	to	to	PART
iajs-3750	76	12	be	be	AUX
iajs-3750	76	13	0.981	0.981	NUM
iajs-3750	76	14	,	,	PUNCT
iajs-3750	76	15	indicating	indicate	VERB
iajs-3750	76	16	a	a	DET
iajs-3750	76	17	high	high	ADJ
iajs-3750	76	18	level	level	NOUN
iajs-3750	76	19	of	of	ADP
iajs-3750	76	20	accuracy	accuracy	NOUN
iajs-3750	76	21	in	in	ADP
iajs-3750	76	22	diagnosing	diagnose	VERB
iajs-3750	76	23	the	the	DET
iajs-3750	76	24	condition	condition	NOUN
iajs-3750	76	25	(	(	PUNCT
iajs-3750	76	26	figure	figure	NOUN
iajs-3750	76	27	3	3	NUM
iajs-3750	76	28	)	)	PUNCT
iajs-3750	76	29	.	.	PUNCT
iajs-3750	77	1	similarly	similarly	ADV
iajs-3750	77	2	,	,	PUNCT
iajs-3750	77	3	the	the	DET
iajs-3750	77	4	opn	opn	PROPN
iajs-3750	77	5	levels	level	NOUN
iajs-3750	77	6	exhibited	exhibit	VERB
iajs-3750	77	7	a	a	DET
iajs-3750	77	8	sensitivity	sensitivity	NOUN
iajs-3750	77	9	of	of	ADP
iajs-3750	77	10	98.39	98.39	NUM
iajs-3750	77	11	%	%	NOUN
iajs-3750	77	12	and	and	CCONJ
iajs-3750	77	13	a	a	DET
iajs-3750	77	14	specificity	specificity	NOUN
iajs-3750	77	15	of	of	ADP
iajs-3750	77	16	100.00	100.00	NUM
iajs-3750	77	17	%	%	NOUN
iajs-3750	77	18	,	,	PUNCT
iajs-3750	77	19	with	with	ADP
iajs-3750	77	20	an	an	DET
iajs-3750	77	21	auc	auc	NOUN
iajs-3750	77	22	of	of	ADP
iajs-3750	77	23	0.999	0.999	NUM
iajs-3750	77	24	(	(	PUNCT
iajs-3750	77	25	figure	figure	NOUN
iajs-3750	77	26	4	4	NUM
iajs-3750	77	27	)	)	PUNCT
iajs-3750	77	28	.	.	PUNCT
iajs-3750	78	1	these	these	DET
iajs-3750	78	2	findings	finding	NOUN
iajs-3750	78	3	suggest	suggest	VERB
iajs-3750	78	4	that	that	SCONJ
iajs-3750	78	5	both	both	DET
iajs-3750	78	6	obestatin	obestatin	NOUN
iajs-3750	78	7	and	and	CCONJ
iajs-3750	78	8	opn	opn	PROPN
iajs-3750	78	9	are	be	AUX
iajs-3750	78	10	reliable	reliable	ADJ
iajs-3750	78	11	diagnostic	diagnostic	ADJ
iajs-3750	78	12	factors	factor	NOUN
iajs-3750	78	13	.	.	PUNCT
iajs-3750	79	1	the	the	DET
iajs-3750	79	2	cut	cut	VERB
iajs-3750	79	3	-	-	PUNCT
iajs-3750	79	4	off	off	ADP
iajs-3750	79	5	value	value	NOUN
iajs-3750	79	6	for	for	ADP
iajs-3750	79	7	the	the	DET
iajs-3750	79	8	obestatin	obestatin	NOUN
iajs-3750	79	9	level	level	NOUN
iajs-3750	79	10	was	be	AUX
iajs-3750	79	11	determined	determine	VERB
iajs-3750	79	12	to	to	PART
iajs-3750	79	13	be	be	AUX
iajs-3750	79	14	≤	≤	NUM
iajs-3750	79	15	577.871	577.871	NUM
iajs-3750	79	16	,	,	PUNCT
iajs-3750	79	17	while	while	SCONJ
iajs-3750	79	18	for	for	ADP
iajs-3750	79	19	the	the	DET
iajs-3750	79	20	opn	opn	PROPN
iajs-3750	79	21	level	level	NOUN
iajs-3750	79	22	it	it	PRON
iajs-3750	79	23	was	be	AUX
iajs-3750	79	24	>	>	X
iajs-3750	79	25	6.974	6.974	NUM
iajs-3750	79	26	.	.	PUNCT
iajs-3750	80	1	values	value	NOUN
iajs-3750	80	2	below	below	ADP
iajs-3750	80	3	these	these	DET
iajs-3750	80	4	thresholds	threshold	NOUN
iajs-3750	80	5	are	be	AUX
iajs-3750	80	6	indicative	indicative	ADJ
iajs-3750	80	7	of	of	ADP
iajs-3750	80	8	patients	patient	NOUN
iajs-3750	80	9	with	with	ADP
iajs-3750	80	10	the	the	DET
iajs-3750	80	11	condition	condition	NOUN
iajs-3750	80	12	being	be	AUX
iajs-3750	80	13	tested	test	VERB
iajs-3750	80	14	.	.	PUNCT
iajs-3750	81	1	table	table	NOUN
iajs-3750	81	2	4	4	NUM
iajs-3750	81	3	.	.	X
iajs-3750	81	4	serum	serum	PROPN
iajs-3750	81	5	obestatin	obestatin	PROPN
iajs-3750	81	6	and	and	CCONJ
iajs-3750	81	7	opn	opn	PROPN
iajs-3750	81	8	of	of	ADP
iajs-3750	81	9	mets	mets	PROPN
iajs-3750	81	10	and	and	CCONJ
iajs-3750	81	11	control	control	NOUN
iajs-3750	81	12	group	group	NOUN
iajs-3750	81	13	p	p	NOUN
iajs-3750	81	14	-	-	PUNCT
iajs-3750	81	15	value	value	NOUN
iajs-3750	81	16	control	control	NOUN
iajs-3750	81	17	(	(	PUNCT
iajs-3750	81	18	n=	n=	ADJ
iajs-3750	81	19	40	40	NUM
iajs-3750	81	20	)	)	PUNCT
iajs-3750	81	21	mets	met	NOUN
iajs-3750	81	22	(	(	PUNCT
iajs-3750	81	23	n=	n=	ADJ
iajs-3750	81	24	125	125	NUM
iajs-3750	81	25	)	)	PUNCT
iajs-3750	81	26	variables	variable	VERB
iajs-3750	81	27	0.001	0.001	NUM
iajs-3750	81	28	1082.10	1082.10	NUM
iajs-3750	81	29	(	(	PUNCT
iajs-3750	81	30	1305.66	1305.66	NUM
iajs-3750	81	31	-	-	SYM
iajs-3750	81	32	720.79	720.79	NUM
iajs-3750	81	33	)	)	PUNCT
iajs-3750	81	34	280.82	280.82	NUM
iajs-3750	81	35	(	(	PUNCT
iajs-3750	81	36	441.89	441.89	NUM
iajs-3750	81	37	-	-	SYM
iajs-3750	81	38	174.90	174.90	NUM
iajs-3750	81	39	)	)	PUNCT
iajs-3750	81	40	obestatin	obestatin	NOUN
iajs-3750	81	41	(	(	PUNCT
iajs-3750	81	42	pg	pg	NOUN
iajs-3750	81	43	/	/	SYM
iajs-3750	81	44	ml	ml	NOUN
iajs-3750	81	45	)	)	PUNCT
iajs-3750	81	46	0.001	0.001	NUM
iajs-3750	81	47	5.47(5.68	5.47(5.68	NUM
iajs-3750	81	48	-	-	SYM
iajs-3750	81	49	5.15	5.15	NUM
iajs-3750	81	50	)	)	PUNCT
iajs-3750	81	51	17.96	17.96	NUM
iajs-3750	81	52	(	(	PUNCT
iajs-3750	81	53	20.7410.00	20.7410.00	NUM
iajs-3750	81	54	)	)	PUNCT
iajs-3750	81	55	opn	opn	PROPN
iajs-3750	81	56	(	(	PUNCT
iajs-3750	81	57	ng	ng	PROPN
iajs-3750	81	58	/	/	SYM
iajs-3750	81	59	ml	ml	PROPN
iajs-3750	81	60	)	)	PUNCT
iajs-3750	81	61	the	the	DET
iajs-3750	81	62	collected	collect	VERB
iajs-3750	81	63	data	datum	NOUN
iajs-3750	81	64	were	be	AUX
iajs-3750	81	65	analyzed	analyze	VERB
iajs-3750	81	66	by	by	ADP
iajs-3750	81	67	the	the	DET
iajs-3750	81	68	median	median	NOUN
iajs-3750	81	69	at	at	ADP
iajs-3750	81	70	the	the	DET
iajs-3750	81	71	p	p	X
iajs-3750	81	72	<	<	X
iajs-3750	81	73	0.05	0.05	NUM
iajs-3750	81	74	level	level	NOUN
iajs-3750	81	75	.	.	PUNCT
iajs-3750	82	1	opn	opn	PROPN
iajs-3750	82	2	:	:	PUNCT
iajs-3750	82	3	osteopontin	osteopontin	PROPN
iajs-3750	82	4	.	.	PUNCT
iajs-3750	82	5	figure	figure	NOUN
iajs-3750	82	6	1	1	NUM
iajs-3750	82	7	.	.	PUNCT
iajs-3750	83	1	median	median	ADJ
iajs-3750	83	2	serum	serum	NOUN
iajs-3750	83	3	obestatin	obestatin	NOUN
iajs-3750	83	4	of	of	ADP
iajs-3750	83	5	mets	met	NOUN
iajs-3750	83	6	and	and	CCONJ
iajs-3750	83	7	control	control	PROPN
iajs-3750	83	8	group	group	PROPN
iajs-3750	83	9	ihjpas	ihjpas	PROPN
iajs-3750	83	10	.	.	PUNCT
iajs-3750	84	1	2025	2025	NUM
iajs-3750	84	2	,	,	PUNCT
iajs-3750	84	3	38(3	38(3	NUM
iajs-3750	84	4	)	)	PUNCT
iajs-3750	84	5	260	260	NUM
iajs-3750	84	6	figure	figure	NOUN
iajs-3750	84	7	2	2	NUM
iajs-3750	84	8	.	.	PUNCT
iajs-3750	85	1	median	median	PROPN
iajs-3750	85	2	serum	serum	PROPN
iajs-3750	85	3	opn	opn	PROPN
iajs-3750	85	4	of	of	ADP
iajs-3750	85	5	mets	mets	PROPN
iajs-3750	85	6	and	and	CCONJ
iajs-3750	85	7	control	control	NOUN
iajs-3750	85	8	group	group	NOUN
iajs-3750	85	9	.	.	PUNCT
iajs-3750	86	1	figure	figure	NOUN
iajs-3750	86	2	3	3	NUM
iajs-3750	86	3	.	.	PUNCT
iajs-3750	87	1	the	the	DET
iajs-3750	87	2	roc	roc	PROPN
iajs-3750	87	3	curve	curve	NOUN
iajs-3750	87	4	of	of	ADP
iajs-3750	87	5	obestatin	obestatin	PROPN
iajs-3750	87	6	.	.	PUNCT
iajs-3750	87	7	figure	figure	NOUN
iajs-3750	87	8	4	4	NUM
iajs-3750	87	9	.	.	PUNCT
iajs-3750	88	1	the	the	DET
iajs-3750	88	2	roc	roc	PROPN
iajs-3750	88	3	curve	curve	NOUN
iajs-3750	88	4	of	of	ADP
iajs-3750	88	5	opn	opn	PROPN
iajs-3750	88	6	4	4	NUM
iajs-3750	88	7	.	.	PUNCT
iajs-3750	88	8	discussion	discussion	NOUN
iajs-3750	88	9	it	it	PRON
iajs-3750	88	10	has	have	AUX
iajs-3750	88	11	been	be	AUX
iajs-3750	88	12	proposed	propose	VERB
iajs-3750	88	13	that	that	SCONJ
iajs-3750	88	14	mets	met	NOUN
iajs-3750	88	15	is	be	AUX
iajs-3750	88	16	a	a	DET
iajs-3750	88	17	result	result	NOUN
iajs-3750	88	18	of	of	ADP
iajs-3750	88	19	a	a	DET
iajs-3750	88	20	complicated	complicated	ADJ
iajs-3750	88	21	interplay	interplay	NOUN
iajs-3750	88	22	between	between	ADP
iajs-3750	88	23	hereditary	hereditary	ADJ
iajs-3750	88	24	and	and	CCONJ
iajs-3750	88	25	environmental	environmental	ADJ
iajs-3750	88	26	variables	variable	NOUN
iajs-3750	88	27	.	.	PUNCT
iajs-3750	89	1	distress	distress	NOUN
iajs-3750	89	2	's	's	PART
iajs-3750	89	3	pathophysiological	pathophysiological	ADJ
iajs-3750	89	4	causes	cause	NOUN
iajs-3750	89	5	important	important	ADJ
iajs-3750	89	6	changes	change	NOUN
iajs-3750	89	7	in	in	ADP
iajs-3750	89	8	metabolic	metabolic	NOUN
iajs-3750	89	9	processes	process	NOUN
iajs-3750	89	10	.	.	PUNCT
iajs-3750	90	1	numerous	numerous	ADJ
iajs-3750	90	2	chronic	chronic	ADJ
iajs-3750	90	3	disorders	disorder	NOUN
iajs-3750	90	4	,	,	PUNCT
iajs-3750	90	5	including	include	VERB
iajs-3750	90	6	hypertension	hypertension	NOUN
iajs-3750	90	7	,	,	PUNCT
iajs-3750	90	8	chronic	chronic	ADJ
iajs-3750	90	9	inflammation	inflammation	NOUN
iajs-3750	90	10	,	,	PUNCT
iajs-3750	90	11	oxidative	oxidative	ADJ
iajs-3750	90	12	stress	stress	NOUN
iajs-3750	90	13	,	,	PUNCT
iajs-3750	90	14	and	and	CCONJ
iajs-3750	90	15	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-3750	90	16	,	,	PUNCT
iajs-3750	90	17	have	have	AUX
iajs-3750	90	18	been	be	AUX
iajs-3750	90	19	linked	link	VERB
iajs-3750	90	20	to	to	ADP
iajs-3750	90	21	these	these	DET
iajs-3750	90	22	changes	change	NOUN
iajs-3750	90	23	.	.	PUNCT
iajs-3750	91	1	concern	concern	NOUN
iajs-3750	91	2	for	for	ADP
iajs-3750	91	3	t2	t2	NOUN
iajs-3750	91	4	dm	dm	PROPN
iajs-3750	91	5	risk	risk	NOUN
iajs-3750	91	6	factors	factor	NOUN
iajs-3750	91	7	,	,	PUNCT
iajs-3750	91	8	i.e.	i.e.	X
iajs-3750	91	9	,	,	PUNCT
iajs-3750	91	10	obesity	obesity	NOUN
iajs-3750	91	11	,	,	PUNCT
iajs-3750	91	12	ir	ir	NOUN
iajs-3750	91	13	,	,	PUNCT
iajs-3750	91	14	and	and	CCONJ
iajs-3750	91	15	fatty	fatty	NOUN
iajs-3750	91	16	liver	liver	NOUN
iajs-3750	91	17	will	will	AUX
iajs-3750	91	18	arise	arise	VERB
iajs-3750	91	19	from	from	ADP
iajs-3750	91	20	disruption	disruption	NOUN
iajs-3750	91	21	of	of	ADP
iajs-3750	91	22	0	0	NUM
iajs-3750	91	23	20	20	NUM
iajs-3750	91	24	40	40	NUM
iajs-3750	91	25	60	60	NUM
iajs-3750	91	26	80	80	NUM
iajs-3750	91	27	100	100	NUM
iajs-3750	91	28	obestatin_pg_ml	obestatin_pg_ml	NOUN
iajs-3750	91	29	_	_	NOUN
iajs-3750	91	30	0	0	NUM
iajs-3750	91	31	20	20	NUM
iajs-3750	91	32	40	40	NUM
iajs-3750	91	33	60	60	NUM
iajs-3750	91	34	80	80	NUM
iajs-3750	91	35	100	100	NUM
iajs-3750	91	36	100	100	NUM
iajs-3750	91	37	-	-	PUNCT
iajs-3750	91	38	specificity	specificity	NOUN
iajs-3750	91	39	se	se	X
iajs-3750	92	1	ns	ns	PROPN
iajs-3750	93	1	itiv	itiv	PROPN
iajs-3750	93	2	ity	ity	PROPN
iajs-3750	93	3	auc	auc	NOUN
iajs-3750	93	4	=	=	PUNCT
iajs-3750	93	5	0.981	0.981	NUM
iajs-3750	93	6	p	p	X
iajs-3750	93	7	<	<	X
iajs-3750	93	8	0.001	0.001	NUM
iajs-3750	93	9	sensitivity	sensitivity	NOUN
iajs-3750	93	10	:	:	PUNCT
iajs-3750	93	11	97.6	97.6	NUM
iajs-3750	93	12	specificity	specificity	NOUN
iajs-3750	93	13	:	:	PUNCT
iajs-3750	93	14	100.0	100.0	NUM
iajs-3750	93	15	criterion	criterion	NOUN
iajs-3750	93	16	:	:	PUNCT
iajs-3750	93	17	≤577.871	≤577.871	PROPN
iajs-3750	93	18	0	0	NUM
iajs-3750	93	19	20	20	NUM
iajs-3750	93	20	40	40	NUM
iajs-3750	93	21	60	60	NUM
iajs-3750	93	22	80	80	NUM
iajs-3750	93	23	100	100	NUM
iajs-3750	93	24	osteopontin_ng_ml	osteopontin_ng_ml	ADP
iajs-3750	93	25	_	_	NOUN
iajs-3750	93	26	0	0	NUM
iajs-3750	93	27	20	20	NUM
iajs-3750	93	28	40	40	NUM
iajs-3750	93	29	60	60	NUM
iajs-3750	93	30	80	80	NUM
iajs-3750	93	31	100	100	NUM
iajs-3750	93	32	100	100	NUM
iajs-3750	93	33	-	-	PUNCT
iajs-3750	93	34	specificity	specificity	NOUN
iajs-3750	93	35	se	se	X
iajs-3750	93	36	ns	ns	PROPN
iajs-3750	93	37	iti	iti	PROPN
iajs-3750	93	38	vi	vi	PROPN
iajs-3750	93	39	ty	ty	INTJ
iajs-3750	93	40	auc	auc	NOUN
iajs-3750	93	41	=	=	NOUN
iajs-3750	93	42	0.999	0.999	NUM
iajs-3750	93	43	p	p	X
iajs-3750	93	44	<	<	X
iajs-3750	93	45	0.001	0.001	NUM
iajs-3750	93	46	sensitivity	sensitivity	NOUN
iajs-3750	93	47	:	:	PUNCT
iajs-3750	93	48	98.4	98.4	NUM
iajs-3750	93	49	specificity	specificity	NOUN
iajs-3750	93	50	:	:	PUNCT
iajs-3750	93	51	100.0	100.0	NUM
iajs-3750	93	52	criterion	criterion	NOUN
iajs-3750	93	53	:	:	PUNCT
iajs-3750	93	54	>	>	X
iajs-3750	93	55	6.974	6.974	NUM
iajs-3750	93	56	ihjpas	ihjpa	NOUN
iajs-3750	93	57	.	.	PUNCT
iajs-3750	94	1	2025	2025	NUM
iajs-3750	94	2	,	,	PUNCT
iajs-3750	94	3	38(3	38(3	NUM
iajs-3750	94	4	)	)	PUNCT
iajs-3750	94	5	261	261	NUM
iajs-3750	94	6	cellular	cellular	ADJ
iajs-3750	94	7	metabolic	metabolic	NOUN
iajs-3750	94	8	pathways	pathway	NOUN
iajs-3750	94	9	,	,	PUNCT
iajs-3750	94	10	commonly	commonly	ADV
iajs-3750	94	11	known	know	VERB
iajs-3750	94	12	as	as	ADP
iajs-3750	94	13	mets	met	NOUN
iajs-3750	94	14	,	,	PUNCT
iajs-3750	94	15	which	which	PRON
iajs-3750	94	16	is	be	AUX
iajs-3750	94	17	particularly	particularly	ADV
iajs-3750	94	18	caused	cause	VERB
iajs-3750	94	19	by	by	ADP
iajs-3750	94	20	abnormalities	abnormality	NOUN
iajs-3750	94	21	in	in	ADP
iajs-3750	94	22	carbohydrate	carbohydrate	ADJ
iajs-3750	94	23	metabolism	metabolism	NOUN
iajs-3750	94	24	(	(	PUNCT
iajs-3750	94	25	17,18	17,18	NUM
iajs-3750	94	26	)	)	PUNCT
iajs-3750	94	27	.	.	PUNCT
iajs-3750	95	1	a	a	DET
iajs-3750	95	2	person	person	NOUN
iajs-3750	95	3	's	's	PART
iajs-3750	95	4	bmi	bmi	NOUN
iajs-3750	95	5	,	,	PUNCT
iajs-3750	95	6	serves	serve	VERB
iajs-3750	95	7	as	as	ADP
iajs-3750	95	8	a	a	DET
iajs-3750	95	9	measure	measure	NOUN
iajs-3750	95	10	of	of	ADP
iajs-3750	95	11	overall	overall	ADJ
iajs-3750	95	12	health	health	NOUN
iajs-3750	95	13	and	and	CCONJ
iajs-3750	95	14	is	be	AUX
iajs-3750	95	15	often	often	ADV
iajs-3750	95	16	associated	associate	VERB
iajs-3750	95	17	with	with	ADP
iajs-3750	95	18	metabolic	metabolic	NOUN
iajs-3750	95	19	disease	disease	NOUN
iajs-3750	95	20	(	(	PUNCT
iajs-3750	95	21	19	19	NUM
iajs-3750	95	22	)	)	PUNCT
iajs-3750	95	23	.	.	PUNCT
iajs-3750	96	1	this	this	DET
iajs-3750	96	2	result	result	NOUN
iajs-3750	96	3	is	be	AUX
iajs-3750	96	4	consistent	consistent	ADJ
iajs-3750	96	5	with	with	ADP
iajs-3750	96	6	previous	previous	ADJ
iajs-3750	96	7	research	research	NOUN
iajs-3750	96	8	(	(	PUNCT
iajs-3750	96	9	20	20	NUM
iajs-3750	96	10	)	)	PUNCT
iajs-3750	96	11	,	,	PUNCT
iajs-3750	96	12	which	which	PRON
iajs-3750	96	13	found	find	VERB
iajs-3750	96	14	that	that	SCONJ
iajs-3750	96	15	the	the	DET
iajs-3750	96	16	patient	patient	ADJ
iajs-3750	96	17	group	group	NOUN
iajs-3750	96	18	had	have	VERB
iajs-3750	96	19	a	a	DET
iajs-3750	96	20	bmi	bmi	NOUN
iajs-3750	96	21	of	of	ADP
iajs-3750	96	22	27.5	27.5	NUM
iajs-3750	96	23	kg	kg	NOUN
iajs-3750	96	24	/	/	SYM
iajs-3750	96	25	m	m	PROPN
iajs-3750	96	26	2	2	NUM
iajs-3750	96	27	,	,	PUNCT
iajs-3750	96	28	while	while	SCONJ
iajs-3750	96	29	the	the	DET
iajs-3750	96	30	control	control	NOUN
iajs-3750	96	31	group	group	NOUN
iajs-3750	96	32	had	have	VERB
iajs-3750	96	33	a	a	DET
iajs-3750	96	34	bmi	bmi	NOUN
iajs-3750	96	35	of	of	ADP
iajs-3750	96	36	22.6	22.6	NUM
iajs-3750	96	37	kg	kg	NOUN
iajs-3750	96	38	/	/	SYM
iajs-3750	96	39	m	m	PROPN
iajs-3750	96	40	2	2	NUM
iajs-3750	96	41	.	.	PUNCT
iajs-3750	97	1	the	the	DET
iajs-3750	97	2	hypertension	hypertension	NOUN
iajs-3750	97	3	is	be	AUX
iajs-3750	97	4	a	a	DET
iajs-3750	97	5	serious	serious	ADJ
iajs-3750	97	6	health	health	NOUN
iajs-3750	97	7	risk	risk	NOUN
iajs-3750	97	8	factor	factor	NOUN
iajs-3750	97	9	with	with	ADP
iajs-3750	97	10	disproportionate	disproportionate	ADJ
iajs-3750	97	11	prevalence	prevalence	NOUN
iajs-3750	97	12	in	in	ADP
iajs-3750	97	13	emerging	emerge	VERB
iajs-3750	97	14	countries	country	NOUN
iajs-3750	97	15	,	,	PUNCT
iajs-3750	97	16	contributing	contribute	VERB
iajs-3750	97	17	to	to	ADP
iajs-3750	97	18	increased	increase	VERB
iajs-3750	97	19	mortality	mortality	NOUN
iajs-3750	97	20	in	in	ADP
iajs-3750	97	21	both	both	CCONJ
iajs-3750	97	22	developed	developed	ADJ
iajs-3750	97	23	and	and	CCONJ
iajs-3750	97	24	developing	develop	VERB
iajs-3750	97	25	countries	country	NOUN
iajs-3750	97	26	globally	globally	ADV
iajs-3750	97	27	(	(	PUNCT
iajs-3750	97	28	21	21	NUM
iajs-3750	97	29	)	)	PUNCT
iajs-3750	97	30	.	.	PUNCT
iajs-3750	98	1	due	due	ADP
iajs-3750	98	2	to	to	ADP
iajs-3750	98	3	changed	change	VERB
iajs-3750	98	4	lipid	lipid	NOUN
iajs-3750	98	5	excretion	excretion	NOUN
iajs-3750	98	6	,	,	PUNCT
iajs-3750	98	7	metabolic	metabolic	NOUN
iajs-3750	98	8	illnesses	illness	NOUN
iajs-3750	98	9	,	,	PUNCT
iajs-3750	98	10	and	and	CCONJ
iajs-3750	98	11	disorders	disorder	NOUN
iajs-3750	98	12	,	,	PUNCT
iajs-3750	98	13	bp	bp	PROPN
iajs-3750	98	14	is	be	AUX
iajs-3750	98	15	intimately	intimately	ADV
iajs-3750	98	16	related	relate	VERB
iajs-3750	98	17	to	to	ADP
iajs-3750	98	18	metabolic	metabolic	NOUN
iajs-3750	98	19	alterations	alteration	NOUN
iajs-3750	98	20	and	and	CCONJ
iajs-3750	98	21	occurs	occur	VERB
iajs-3750	98	22	in	in	ADP
iajs-3750	98	23	obesity	obesity	NOUN
iajs-3750	98	24	(	(	PUNCT
iajs-3750	98	25	22	22	NUM
iajs-3750	98	26	)	)	PUNCT
iajs-3750	98	27	,	,	PUNCT
iajs-3750	98	28	which	which	PRON
iajs-3750	98	29	is	be	AUX
iajs-3750	98	30	in	in	ADP
iajs-3750	98	31	a	a	DET
iajs-3750	98	32	greement	greement	NOUN
iajs-3750	98	33	with	with	ADP
iajs-3750	98	34	previous	previous	ADJ
iajs-3750	98	35	study	study	NOUN
iajs-3750	98	36	(	(	PUNCT
iajs-3750	98	37	23	23	NUM
iajs-3750	98	38	)	)	PUNCT
iajs-3750	98	39	.	.	PUNCT
iajs-3750	99	1	so	so	ADV
iajs-3750	99	2	,	,	PUNCT
iajs-3750	99	3	it	it	PRON
iajs-3750	99	4	found	find	VERB
iajs-3750	99	5	an	an	DET
iajs-3750	99	6	association	association	NOUN
iajs-3750	99	7	between	between	ADP
iajs-3750	99	8	mets	met	NOUN
iajs-3750	99	9	and	and	CCONJ
iajs-3750	99	10	hypertension	hypertension	NOUN
iajs-3750	99	11	.	.	PUNCT
iajs-3750	100	1	a	a	DET
iajs-3750	100	2	straightforward	straightforward	ADJ
iajs-3750	100	3	equation	equation	NOUN
iajs-3750	100	4	may	may	AUX
iajs-3750	100	5	be	be	AUX
iajs-3750	100	6	used	use	VERB
iajs-3750	100	7	to	to	PART
iajs-3750	100	8	determine	determine	VERB
iajs-3750	100	9	how	how	SCONJ
iajs-3750	100	10	metabolism	metabolism	NOUN
iajs-3750	100	11	is	be	AUX
iajs-3750	100	12	directly	directly	ADV
iajs-3750	100	13	impacted	impact	VERB
iajs-3750	100	14	by	by	ADP
iajs-3750	100	15	ir	ir	PROPN
iajs-3750	100	16	and	and	CCONJ
iajs-3750	100	17	how	how	SCONJ
iajs-3750	100	18	much	much	ADV
iajs-3750	100	19	more	more	ADJ
iajs-3750	100	20	vldl	vldl	NOUN
iajs-3750	100	21	is	be	AUX
iajs-3750	100	22	produced	produce	VERB
iajs-3750	100	23	(	(	PUNCT
iajs-3750	100	24	24	24	NUM
iajs-3750	100	25	)	)	PUNCT
iajs-3750	100	26	.	.	PUNCT
iajs-3750	101	1	the	the	DET
iajs-3750	101	2	liver	liver	NOUN
iajs-3750	101	3	excretes	excrete	NOUN
iajs-3750	101	4	vldl	vldl	PROPN
iajs-3750	101	5	,	,	PUNCT
iajs-3750	101	6	which	which	PRON
iajs-3750	101	7	prevents	prevent	VERB
iajs-3750	101	8	the	the	DET
iajs-3750	101	9	apolipoprotein	apolipoprotein	ADJ
iajs-3750	101	10	b	b	NOUN
iajs-3750	101	11	protein	protein	NOUN
iajs-3750	101	12	from	from	ADP
iajs-3750	101	13	being	be	AUX
iajs-3750	101	14	broken	break	VERB
iajs-3750	101	15	down	down	ADP
iajs-3750	101	16	and	and	CCONJ
iajs-3750	101	17	raises	raise	VERB
iajs-3750	101	18	tg	tg	PROPN
iajs-3750	101	19	levels	level	NOUN
iajs-3750	101	20	.	.	PUNCT
iajs-3750	102	1	when	when	SCONJ
iajs-3750	102	2	lipoprotein	lipoprotein	ADJ
iajs-3750	102	3	lipase	lipase	NOUN
iajs-3750	102	4	secretion	secretion	NOUN
iajs-3750	102	5	is	be	AUX
iajs-3750	102	6	reduced	reduce	VERB
iajs-3750	102	7	due	due	ADP
iajs-3750	102	8	to	to	ADP
iajs-3750	102	9	a	a	DET
iajs-3750	102	10	high	high	ADJ
iajs-3750	102	11	proportion	proportion	NOUN
iajs-3750	102	12	of	of	ADP
iajs-3750	102	13	vldl	vldl	NOUN
iajs-3750	102	14	,	,	PUNCT
iajs-3750	102	15	the	the	DET
iajs-3750	102	16	ratio	ratio	NOUN
iajs-3750	102	17	of	of	ADP
iajs-3750	102	18	tg	tg	PROPN
iajs-3750	102	19	is	be	AUX
iajs-3750	102	20	seen	see	VERB
iajs-3750	102	21	to	to	PART
iajs-3750	102	22	rise	rise	VERB
iajs-3750	102	23	as	as	SCONJ
iajs-3750	102	24	the	the	DET
iajs-3750	102	25	body	body	NOUN
iajs-3750	102	26	fills	fill	VERB
iajs-3750	102	27	with	with	ADP
iajs-3750	102	28	these	these	DET
iajs-3750	102	29	particles	particle	NOUN
iajs-3750	102	30	.	.	PUNCT
iajs-3750	103	1	low	low	ADJ
iajs-3750	103	2	-	-	PUNCT
iajs-3750	103	3	density	density	NOUN
iajs-3750	103	4	lipoprotein	lipoprotein	ADJ
iajs-3750	103	5	cholesterol	cholesterol	NOUN
iajs-3750	103	6	counts	count	NOUN
iajs-3750	103	7	sharply	sharply	ADV
iajs-3750	103	8	increase	increase	VERB
iajs-3750	103	9	,	,	PUNCT
iajs-3750	103	10	offsetting	offset	VERB
iajs-3750	103	11	a	a	DET
iajs-3750	103	12	startling	startling	ADJ
iajs-3750	103	13	decline	decline	NOUN
iajs-3750	103	14	in	in	ADP
iajs-3750	103	15	hdl	hdl	PROPN
iajs-3750	103	16	-	-	PUNCT
iajs-3750	103	17	c	c	NOUN
iajs-3750	103	18	values	value	NOUN
iajs-3750	103	19	(	(	PUNCT
iajs-3750	103	20	25	25	NUM
iajs-3750	103	21	,	,	PUNCT
iajs-3750	103	22	26	26	NUM
iajs-3750	103	23	)	)	PUNCT
iajs-3750	103	24	.	.	PUNCT
iajs-3750	104	1	it	it	PRON
iajs-3750	104	2	has	have	AUX
iajs-3750	104	3	been	be	AUX
iajs-3750	104	4	confirmed	confirm	VERB
iajs-3750	104	5	that	that	SCONJ
iajs-3750	104	6	individuals	individual	NOUN
iajs-3750	104	7	with	with	ADP
iajs-3750	104	8	mets	met	NOUN
iajs-3750	104	9	exhibit	exhibit	VERB
iajs-3750	104	10	significantly	significantly	ADV
iajs-3750	104	11	elevated	elevated	ADJ
iajs-3750	104	12	liver	liver	NOUN
iajs-3750	104	13	enzyme	enzyme	NOUN
iajs-3750	104	14	levels	level	NOUN
iajs-3750	104	15	compared	compare	VERB
iajs-3750	104	16	to	to	ADP
iajs-3750	104	17	healthy	healthy	ADJ
iajs-3750	104	18	individuals	individual	NOUN
iajs-3750	104	19	.	.	PUNCT
iajs-3750	105	1	this	this	DET
iajs-3750	105	2	finding	find	VERB
iajs-3750	105	3	further	far	ADV
iajs-3750	105	4	strengthens	strengthen	VERB
iajs-3750	105	5	the	the	DET
iajs-3750	105	6	association	association	NOUN
iajs-3750	105	7	between	between	ADP
iajs-3750	105	8	liver	liver	NOUN
iajs-3750	105	9	enzymes	enzyme	NOUN
iajs-3750	105	10	and	and	CCONJ
iajs-3750	105	11	the	the	DET
iajs-3750	105	12	risk	risk	NOUN
iajs-3750	105	13	of	of	ADP
iajs-3750	105	14	developing	develop	VERB
iajs-3750	105	15	mets	met	NOUN
iajs-3750	105	16	.	.	PUNCT
iajs-3750	106	1	this	this	DET
iajs-3750	106	2	result	result	NOUN
iajs-3750	106	3	is	be	AUX
iajs-3750	106	4	consistent	consistent	ADJ
iajs-3750	106	5	with	with	ADP
iajs-3750	106	6	the	the	DET
iajs-3750	106	7	results	result	NOUN
iajs-3750	106	8	of	of	ADP
iajs-3750	106	9	the	the	DET
iajs-3750	106	10	literature	literature	NOUN
iajs-3750	106	11	(	(	PUNCT
iajs-3750	106	12	27	27	NUM
iajs-3750	106	13	)	)	PUNCT
iajs-3750	106	14	,	,	PUNCT
iajs-3750	106	15	which	which	PRON
iajs-3750	106	16	confirmed	confirm	VERB
iajs-3750	106	17	that	that	SCONJ
iajs-3750	106	18	the	the	DET
iajs-3750	106	19	liver	liver	NOUN
iajs-3750	106	20	enzyme	enzyme	NOUN
iajs-3750	106	21	levels	level	NOUN
iajs-3750	106	22	in	in	ADP
iajs-3750	106	23	patients	patient	NOUN
iajs-3750	106	24	with	with	ADP
iajs-3750	106	25	metabolic	metabolic	NOUN
iajs-3750	106	26	syndrome	syndrome	NOUN
iajs-3750	106	27	were	be	AUX
iajs-3750	106	28	much	much	ADV
iajs-3750	106	29	higher	high	ADJ
iajs-3750	106	30	than	than	ADP
iajs-3750	106	31	those	those	PRON
iajs-3750	106	32	in	in	ADP
iajs-3750	106	33	healthy	healthy	ADJ
iajs-3750	106	34	people	people	NOUN
iajs-3750	106	35	,	,	PUNCT
iajs-3750	106	36	further	far	ADV
iajs-3750	106	37	confirming	confirm	VERB
iajs-3750	106	38	the	the	DET
iajs-3750	106	39	link	link	NOUN
iajs-3750	106	40	between	between	ADP
iajs-3750	106	41	liver	liver	NOUN
iajs-3750	106	42	enzymes	enzyme	NOUN
iajs-3750	106	43	and	and	CCONJ
iajs-3750	106	44	mets	met	NOUN
iajs-3750	106	45	risk.patients	risk.patient	NOUN
iajs-3750	106	46	with	with	ADP
iajs-3750	106	47	mets	met	NOUN
iajs-3750	106	48	are	be	AUX
iajs-3750	106	49	at	at	ADP
iajs-3750	106	50	high	high	ADJ
iajs-3750	106	51	risk	risk	NOUN
iajs-3750	106	52	for	for	ADP
iajs-3750	106	53	cvd	cvd	PROPN
iajs-3750	106	54	and	and	CCONJ
iajs-3750	106	55	have	have	AUX
iajs-3750	106	56	elevated	elevate	VERB
iajs-3750	106	57	tg	tg	PROPN
iajs-3750	106	58	levels	level	NOUN
iajs-3750	106	59	in	in	ADP
iajs-3750	106	60	addition	addition	NOUN
iajs-3750	106	61	to	to	ADP
iajs-3750	106	62	elevated	elevated	ADJ
iajs-3750	106	63	ldl	ldl	NOUN
iajs-3750	106	64	-	-	PUNCT
iajs-3750	106	65	c.	c.	NOUN
iajs-3750	106	66	they	they	PRON
iajs-3750	106	67	also	also	ADV
iajs-3750	106	68	have	have	VERB
iajs-3750	106	69	low	low	ADJ
iajs-3750	106	70	hdl	hdl	PROPN
iajs-3750	106	71	-	-	PUNCT
iajs-3750	106	72	c	c	NOUN
iajs-3750	106	73	levels	level	NOUN
iajs-3750	106	74	and	and	CCONJ
iajs-3750	106	75	large	large	ADJ
iajs-3750	106	76	numbers	number	NOUN
iajs-3750	106	77	of	of	ADP
iajs-3750	106	78	small	small	ADJ
iajs-3750	106	79	,	,	PUNCT
iajs-3750	106	80	dense	dense	ADJ
iajs-3750	106	81	ldl	ldl	NOUN
iajs-3750	106	82	(	(	PUNCT
iajs-3750	106	83	sd	sd	NOUN
iajs-3750	106	84	-	-	PUNCT
iajs-3750	106	85	ldl	ldl	NOUN
iajs-3750	106	86	)	)	PUNCT
iajs-3750	106	87	particles	particle	NOUN
iajs-3750	106	88	(	(	PUNCT
iajs-3750	106	89	28	28	NUM
iajs-3750	106	90	)	)	PUNCT
iajs-3750	106	91	.	.	PUNCT
iajs-3750	107	1	the	the	DET
iajs-3750	107	2	obestatin	obestatin	NOUN
iajs-3750	107	3	is	be	AUX
iajs-3750	107	4	an	an	DET
iajs-3750	107	5	appetite	appetite	NOUN
iajs-3750	107	6	-	-	PUNCT
iajs-3750	107	7	suppressing	suppress	VERB
iajs-3750	107	8	hormone	hormone	NOUN
iajs-3750	107	9	that	that	PRON
iajs-3750	107	10	reduces	reduce	VERB
iajs-3750	107	11	food	food	NOUN
iajs-3750	107	12	intake	intake	NOUN
iajs-3750	107	13	and	and	CCONJ
iajs-3750	107	14	delays	delay	VERB
iajs-3750	107	15	gastrointestinal	gastrointestinal	ADJ
iajs-3750	107	16	motility	motility	NOUN
iajs-3750	107	17	,	,	PUNCT
iajs-3750	107	18	thereby	thereby	ADV
iajs-3750	107	19	preventing	prevent	VERB
iajs-3750	107	20	weight	weight	NOUN
iajs-3750	107	21	gain	gain	NOUN
iajs-3750	107	22	(	(	PUNCT
iajs-3750	107	23	29	29	NUM
iajs-3750	107	24	)	)	PUNCT
iajs-3750	107	25	.	.	PUNCT
iajs-3750	108	1	this	this	DET
iajs-3750	108	2	result	result	NOUN
iajs-3750	108	3	is	be	AUX
iajs-3750	108	4	agreed	agree	VERB
iajs-3750	108	5	with	with	ADP
iajs-3750	108	6	results	result	NOUN
iajs-3750	108	7	of	of	ADP
iajs-3750	108	8	(	(	PUNCT
iajs-3750	108	9	30	30	NUM
iajs-3750	108	10	)	)	PUNCT
iajs-3750	108	11	,	,	PUNCT
iajs-3750	108	12	who	who	PRON
iajs-3750	108	13	found	find	VERB
iajs-3750	108	14	that	that	SCONJ
iajs-3750	108	15	the	the	DET
iajs-3750	108	16	serum	serum	NOUN
iajs-3750	108	17	level	level	NOUN
iajs-3750	108	18	of	of	ADP
iajs-3750	108	19	obestatin	obestatin	NOUN
iajs-3750	108	20	was	be	AUX
iajs-3750	108	21	lower	low	ADJ
iajs-3750	108	22	significantly	significantly	ADV
iajs-3750	108	23	in	in	ADP
iajs-3750	108	24	mets	met	NOUN
iajs-3750	108	25	patients	patient	NOUN
iajs-3750	108	26	as	as	SCONJ
iajs-3750	108	27	compared	compare	VERB
iajs-3750	108	28	to	to	ADP
iajs-3750	108	29	the	the	DET
iajs-3750	108	30	controls	control	NOUN
iajs-3750	108	31	.	.	PUNCT
iajs-3750	109	1	while	while	SCONJ
iajs-3750	109	2	opn	opn	PROPN
iajs-3750	109	3	is	be	AUX
iajs-3750	109	4	a	a	DET
iajs-3750	109	5	versatile	versatile	ADJ
iajs-3750	109	6	protein	protein	NOUN
iajs-3750	109	7	that	that	PRON
iajs-3750	109	8	plays	play	VERB
iajs-3750	109	9	a	a	DET
iajs-3750	109	10	crucial	crucial	ADJ
iajs-3750	109	11	role	role	NOUN
iajs-3750	109	12	in	in	ADP
iajs-3750	109	13	the	the	DET
iajs-3750	109	14	regulation	regulation	NOUN
iajs-3750	109	15	of	of	ADP
iajs-3750	109	16	inflammatory	inflammatory	ADJ
iajs-3750	109	17	processes	process	NOUN
iajs-3750	109	18	,	,	PUNCT
iajs-3750	109	19	which	which	PRON
iajs-3750	109	20	have	have	AUX
iajs-3750	109	21	been	be	AUX
iajs-3750	109	22	implicated	implicate	VERB
iajs-3750	109	23	in	in	ADP
iajs-3750	109	24	the	the	DET
iajs-3750	109	25	pathogenesis	pathogenesis	NOUN
iajs-3750	109	26	of	of	ADP
iajs-3750	109	27	atherosclerosis	atherosclerosis	NOUN
iajs-3750	109	28	and	and	CCONJ
iajs-3750	109	29	mets	met	NOUN
iajs-3750	109	30	(	(	PUNCT
iajs-3750	109	31	31	31	NUM
iajs-3750	109	32	)	)	PUNCT
iajs-3750	109	33	.	.	PUNCT
iajs-3750	110	1	this	this	DET
iajs-3750	110	2	result	result	NOUN
iajs-3750	110	3	is	be	AUX
iajs-3750	110	4	consistent	consistent	ADJ
iajs-3750	110	5	with	with	ADP
iajs-3750	110	6	that	that	PRON
iajs-3750	110	7	of	of	ADP
iajs-3750	110	8	(	(	PUNCT
iajs-3750	110	9	32	32	NUM
iajs-3750	110	10	)	)	PUNCT
iajs-3750	110	11	,	,	PUNCT
iajs-3750	110	12	who	who	PRON
iajs-3750	110	13	found	find	VERB
iajs-3750	110	14	elevated	elevated	ADJ
iajs-3750	110	15	expression	expression	NOUN
iajs-3750	110	16	of	of	ADP
iajs-3750	110	17	opn	opn	PROPN
iajs-3750	110	18	in	in	ADP
iajs-3750	110	19	obese	obese	ADJ
iajs-3750	110	20	individuals	individual	NOUN
iajs-3750	110	21	compared	compare	VERB
iajs-3750	110	22	with	with	ADP
iajs-3750	110	23	healthy	healthy	ADJ
iajs-3750	110	24	controls.the	controls.the	NOUN
iajs-3750	110	25	opn	opn	PROPN
iajs-3750	110	26	levels	level	NOUN
iajs-3750	110	27	are	be	AUX
iajs-3750	110	28	thought	think	VERB
iajs-3750	110	29	to	to	PART
iajs-3750	110	30	be	be	AUX
iajs-3750	110	31	elevated	elevate	VERB
iajs-3750	110	32	in	in	ADP
iajs-3750	110	33	obesity	obesity	NOUN
iajs-3750	110	34	-	-	PUNCT
iajs-3750	110	35	related	relate	VERB
iajs-3750	110	36	diseases	disease	NOUN
iajs-3750	110	37	,	,	PUNCT
iajs-3750	110	38	suggesting	suggest	VERB
iajs-3750	110	39	that	that	SCONJ
iajs-3750	110	40	opn	opn	PROPN
iajs-3750	110	41	may	may	AUX
iajs-3750	110	42	affect	affect	VERB
iajs-3750	110	43	lipid	lipid	ADJ
iajs-3750	110	44	absorption	absorption	NOUN
iajs-3750	110	45	and	and	CCONJ
iajs-3750	110	46	metabolism	metabolism	NOUN
iajs-3750	110	47	(	(	PUNCT
iajs-3750	110	48	33	33	NUM
iajs-3750	110	49	)	)	PUNCT
iajs-3750	110	50	.	.	PUNCT
iajs-3750	111	1	the	the	DET
iajs-3750	111	2	roc	roc	PROPN
iajs-3750	111	3	analysis	analysis	NOUN
iajs-3750	111	4	,	,	PUNCT
iajs-3750	111	5	is	be	AUX
iajs-3750	111	6	a	a	DET
iajs-3750	111	7	curve	curve	NOUN
iajs-3750	111	8	showing	show	VERB
iajs-3750	111	9	the	the	DET
iajs-3750	111	10	discriminative	discriminative	NOUN
iajs-3750	111	11	power	power	NOUN
iajs-3750	111	12	of	of	ADP
iajs-3750	111	13	a	a	DET
iajs-3750	111	14	dual	dual	ADJ
iajs-3750	111	15	classifier	classifier	NOUN
iajs-3750	111	16	as	as	ADP
iajs-3750	111	17	a	a	DET
iajs-3750	111	18	function	function	NOUN
iajs-3750	111	19	of	of	ADP
iajs-3750	111	20	the	the	DET
iajs-3750	111	21	discriminative	discriminative	NOUN
iajs-3750	111	22	threshold	threshold	NOUN
iajs-3750	111	23	(	(	PUNCT
iajs-3750	111	24	34	34	NUM
iajs-3750	111	25	)	)	PUNCT
iajs-3750	111	26	.	.	PUNCT
iajs-3750	112	1	results	result	NOUN
iajs-3750	112	2	obtained	obtain	VERB
iajs-3750	112	3	from	from	ADP
iajs-3750	112	4	the	the	DET
iajs-3750	112	5	roc	roc	PROPN
iajs-3750	112	6	analysis	analysis	NOUN
iajs-3750	112	7	suggest	suggest	VERB
iajs-3750	112	8	that	that	SCONJ
iajs-3750	112	9	these	these	DET
iajs-3750	112	10	parameters	parameter	NOUN
iajs-3750	112	11	are	be	AUX
iajs-3750	112	12	considered	consider	VERB
iajs-3750	112	13	good	good	ADJ
iajs-3750	112	14	diagnostic	diagnostic	ADJ
iajs-3750	112	15	markers	marker	NOUN
iajs-3750	112	16	for	for	ADP
iajs-3750	112	17	mets	met	NOUN
iajs-3750	112	18	.	.	PUNCT
iajs-3750	113	1	5	5	X
iajs-3750	113	2	.	.	X
iajs-3750	113	3	conclusion	conclusion	VERB
iajs-3750	113	4	the	the	DET
iajs-3750	113	5	results	result	NOUN
iajs-3750	113	6	of	of	ADP
iajs-3750	113	7	this	this	DET
iajs-3750	113	8	study	study	NOUN
iajs-3750	113	9	indicate	indicate	VERB
iajs-3750	113	10	that	that	SCONJ
iajs-3750	113	11	alterations	alteration	NOUN
iajs-3750	113	12	in	in	ADP
iajs-3750	113	13	metabolic	metabolic	NOUN
iajs-3750	113	14	status	status	NOUN
iajs-3750	113	15	may	may	AUX
iajs-3750	113	16	impact	impact	VERB
iajs-3750	113	17	the	the	DET
iajs-3750	113	18	concentrations	concentration	NOUN
iajs-3750	113	19	of	of	ADP
iajs-3750	113	20	serum	serum	NOUN
iajs-3750	113	21	obestatin	obestatin	NOUN
iajs-3750	113	22	and	and	CCONJ
iajs-3750	113	23	opn	opn	PROPN
iajs-3750	113	24	.	.	PROPN
iajs-3750	114	1	hence	hence	ADV
iajs-3750	114	2	,	,	PUNCT
iajs-3750	114	3	assessing	assess	VERB
iajs-3750	114	4	this	this	DET
iajs-3750	114	5	parameter	parameter	NOUN
iajs-3750	114	6	can	can	AUX
iajs-3750	114	7	provide	provide	VERB
iajs-3750	114	8	valuable	valuable	ADJ
iajs-3750	114	9	insights	insight	NOUN
iajs-3750	114	10	into	into	ADP
iajs-3750	114	11	the	the	DET
iajs-3750	114	12	diagnosis	diagnosis	NOUN
iajs-3750	114	13	of	of	ADP
iajs-3750	114	14	mets	met	NOUN
iajs-3750	114	15	and	and	CCONJ
iajs-3750	114	16	the	the	DET
iajs-3750	114	17	dysregulation	dysregulation	NOUN
iajs-3750	114	18	of	of	ADP
iajs-3750	114	19	lipoprotein	lipoprotein	ADJ
iajs-3750	114	20	metabolism	metabolism	NOUN
iajs-3750	114	21	in	in	ADP
iajs-3750	114	22	individuals	individual	NOUN
iajs-3750	114	23	with	with	ADP
iajs-3750	114	24	obesity	obesity	NOUN
iajs-3750	114	25	.	.	PUNCT
iajs-3750	115	1	acknowledgment	acknowledgment	NOUN
iajs-3750	115	2	the	the	DET
iajs-3750	115	3	authors	author	NOUN
iajs-3750	115	4	thank	thank	VERB
iajs-3750	115	5	the	the	DET
iajs-3750	115	6	medical	medical	ADJ
iajs-3750	115	7	staff	staff	NOUN
iajs-3750	115	8	at	at	ADP
iajs-3750	115	9	al	al	PROPN
iajs-3750	115	10	-	-	PUNCT
iajs-3750	115	11	yarmuk	yarmuk	ADJ
iajs-3750	115	12	teaching	teaching	NOUN
iajs-3750	115	13	hospital	hospital	NOUN
iajs-3750	115	14	in	in	ADP
iajs-3750	115	15	baghdad	baghdad	PROPN
iajs-3750	115	16	for	for	ADP
iajs-3750	115	17	their	their	PRON
iajs-3750	115	18	assistance	assistance	NOUN
iajs-3750	115	19	in	in	ADP
iajs-3750	115	20	completing	complete	VERB
iajs-3750	115	21	this	this	DET
iajs-3750	115	22	work	work	NOUN
iajs-3750	115	23	.	.	PUNCT
iajs-3750	116	1	ihjpas	ihjpas	PROPN
iajs-3750	116	2	.	.	PUNCT
iajs-3750	117	1	2025	2025	NUM
iajs-3750	117	2	,	,	PUNCT
iajs-3750	117	3	38(3	38(3	NUM
iajs-3750	117	4	)	)	PUNCT
iajs-3750	117	5	262	262	NUM
iajs-3750	117	6	conflict	conflict	NOUN
iajs-3750	117	7	of	of	ADP
iajs-3750	117	8	interest	interest	NOUN
iajs-3750	117	9	the	the	DET
iajs-3750	117	10	authors	author	NOUN
iajs-3750	117	11	declare	declare	VERB
iajs-3750	117	12	that	that	SCONJ
iajs-3750	117	13	they	they	PRON
iajs-3750	117	14	have	have	VERB
iajs-3750	117	15	no	no	DET
iajs-3750	117	16	conflicts	conflict	NOUN
iajs-3750	117	17	of	of	ADP
iajs-3750	117	18	interest	interest	NOUN
iajs-3750	117	19	.	.	PUNCT
iajs-3750	118	1	funding	fund	VERB
iajs-3750	118	2	none	none	NOUN
iajs-3750	118	3	.	.	PUNCT
iajs-3750	119	1	ethical	ethical	ADJ
iajs-3750	119	2	clearance	clearance	NOUN
iajs-3750	119	3	this	this	DET
iajs-3750	119	4	research	research	NOUN
iajs-3750	119	5	was	be	AUX
iajs-3750	119	6	approved	approve	VERB
iajs-3750	119	7	by	by	ADP
iajs-3750	119	8	the	the	DET
iajs-3750	119	9	scientific	scientific	ADJ
iajs-3750	119	10	committee	committee	NOUN
iajs-3750	119	11	in	in	ADP
iajs-3750	119	12	college	college	NOUN
iajs-3750	119	13	of	of	ADP
iajs-3750	119	14	science	science	NOUN
iajs-3750	119	15	for	for	ADP
iajs-3750	119	16	women	woman	NOUN
iajs-3750	119	17	,	,	PUNCT
iajs-3750	119	18	and	and	CCONJ
iajs-3750	119	19	this	this	PRON
iajs-3750	119	20	is	be	AUX
iajs-3750	119	21	consistent	consistent	ADJ
iajs-3750	119	22	with	with	ADP
iajs-3750	119	23	the	the	DET
iajs-3750	119	24	instructions	instruction	NOUN
iajs-3750	119	25	of	of	ADP
iajs-3750	119	26	the	the	DET
iajs-3750	119	27	iraqi	iraqi	ADJ
iajs-3750	119	28	ministry	ministry	PROPN
iajs-3750	119	29	of	of	ADP
iajs-3750	119	30	health	health	PROPN
iajs-3750	119	31	and	and	CCONJ
iajs-3750	119	32	environment	environment	NOUN
iajs-3750	119	33	.	.	PUNCT
iajs-3750	120	1	a	a	DET
iajs-3750	120	2	verbal	verbal	ADJ
iajs-3750	120	3	agreement	agreement	NOUN
iajs-3750	120	4	was	be	AUX
iajs-3750	120	5	obtained	obtain	VERB
iajs-3750	120	6	from	from	ADP
iajs-3750	120	7	each	each	DET
iajs-3750	120	8	person	person	NOUN
iajs-3750	120	9	included	include	VERB
iajs-3750	120	10	in	in	ADP
iajs-3750	120	11	the	the	DET
iajs-3750	120	12	survey	survey	NOUN
iajs-3750	120	13	on	on	ADP
iajs-3750	120	14	december	december	PROPN
iajs-3750	120	15	13	13	NUM
iajs-3750	120	16	,	,	PUNCT
iajs-3750	120	17	2022	2022	NUM
iajs-3750	120	18	.	.	PUNCT
iajs-3750	121	1	references	reference	NOUN
iajs-3750	121	2	1	1	NUM
iajs-3750	121	3	.	.	PUNCT
iajs-3750	121	4	stetic	stetic	ADJ
iajs-3750	121	5	l	l	NOUN
iajs-3750	121	6	,	,	PUNCT
iajs-3750	121	7	belcic	belcic	VERB
iajs-3750	121	8	i	i	PRON
iajs-3750	121	9	,	,	PUNCT
iajs-3750	121	10	sporis	sporis	VERB
iajs-3750	121	11	g	g	PROPN
iajs-3750	121	12	,	,	PUNCT
iajs-3750	121	13	stetic	stetic	ADJ
iajs-3750	121	14	l	l	NOUN
iajs-3750	121	15	,	,	PUNCT
iajs-3750	121	16	starcevic	starcevic	ADJ
iajs-3750	121	17	n.	n.	NOUN
iajs-3750	121	18	influence	influence	NOUN
iajs-3750	121	19	of	of	ADP
iajs-3750	121	20	physical	physical	ADJ
iajs-3750	121	21	activity	activity	NOUN
iajs-3750	121	22	on	on	ADP
iajs-3750	121	23	the	the	DET
iajs-3750	121	24	regulation	regulation	NOUN
iajs-3750	121	25	of	of	ADP
iajs-3750	121	26	disease	disease	NOUN
iajs-3750	121	27	of	of	ADP
iajs-3750	121	28	elderly	elderly	ADJ
iajs-3750	121	29	persons	person	NOUN
iajs-3750	121	30	with	with	ADP
iajs-3750	121	31	metabolic	metabolic	NOUN
iajs-3750	121	32	syndrome	syndrome	NOUN
iajs-3750	121	33	.	.	PUNCT
iajs-3750	122	1	int	int	PROPN
iajs-3750	123	1	j	j	PROPN
iajs-3750	123	2	environ	environ	PROPN
iajs-3750	123	3	res	re	VERB
iajs-3750	123	4	public	public	ADJ
iajs-3750	123	5	health	health	NOUN
iajs-3750	123	6	.	.	PUNCT
iajs-3750	123	7	2021	2021	NUM
iajs-3750	123	8	;	;	PUNCT
iajs-3750	124	1	18(1):275	18(1):275	NUM
iajs-3750	124	2	.	.	PUNCT
iajs-3750	125	1	https://doi.org/10.3390/ijerph18010275	https://doi.org/10.3390/ijerph18010275	PROPN
iajs-3750	125	2	.	.	PUNCT
iajs-3750	126	1	2	2	X
iajs-3750	126	2	.	.	X
iajs-3750	126	3	shafeeq	shafeeq	PROPN
iajs-3750	126	4	nk	nk	PROPN
iajs-3750	126	5	,	,	PUNCT
iajs-3750	126	6	hussein	hussein	PROPN
iajs-3750	126	7	taa	taa	PROPN
iajs-3750	126	8	,	,	PUNCT
iajs-3750	126	9	abass	abass	PROPN
iajs-3750	126	10	eaa	eaa	PROPN
iajs-3750	126	11	.	.	PUNCT
iajs-3750	127	1	metabolic	metabolic	NOUN
iajs-3750	127	2	syndrome	syndrome	PROPN
iajs-3750	127	3	.	.	PUNCT
iajs-3750	128	1	ibn	ibn	PROPN
iajs-3750	128	2	al	al	PROPN
iajs-3750	128	3	-	-	PUNCT
iajs-3750	128	4	haitham	haitham	PROPN
iajs-3750	128	5	j	j	PROPN
iajs-3750	128	6	pure	pure	PROPN
iajs-3750	128	7	appl	appl	PROPN
iajs-3750	128	8	sci	sci	PROPN
iajs-3750	128	9	.	.	PROPN
iajs-3750	128	10	2021	2021	NUM
iajs-3750	128	11	;	;	PUNCT
iajs-3750	128	12	34(3):26–38	34(3):26–38	NUM
iajs-3750	128	13	.	.	PUNCT
iajs-3750	129	1	https://doi.org/10.30526/34.3.2675	https://doi.org/10.30526/34.3.2675	NUM
iajs-3750	129	2	.	.	NOUN
iajs-3750	130	1	3	3	X
iajs-3750	130	2	.	.	X
iajs-3750	130	3	myers	myers	PROPN
iajs-3750	130	4	j	j	PROPN
iajs-3750	130	5	,	,	PUNCT
iajs-3750	130	6	kokkinos	kokkinos	PROPN
iajs-3750	130	7	p	p	PROPN
iajs-3750	130	8	,	,	PUNCT
iajs-3750	130	9	nyelin	nyelin	PROPN
iajs-3750	130	10	e.	e.	PROPN
iajs-3750	130	11	physical	physical	PROPN
iajs-3750	130	12	activity	activity	NOUN
iajs-3750	130	13	,	,	PUNCT
iajs-3750	130	14	cardiorespiratory	cardiorespiratory	NOUN
iajs-3750	130	15	fitness	fitness	NOUN
iajs-3750	130	16	,	,	PUNCT
iajs-3750	130	17	and	and	CCONJ
iajs-3750	130	18	the	the	DET
iajs-3750	130	19	metabolic	metabolic	NOUN
iajs-3750	130	20	syndrome	syndrome	NOUN
iajs-3750	130	21	.	.	PUNCT
iajs-3750	131	1	nutrients	nutrient	NOUN
iajs-3750	131	2	.	.	PUNCT
iajs-3750	132	1	2019	2019	NUM
iajs-3750	132	2	;	;	PUNCT
iajs-3750	132	3	11(7):1652	11(7):1652	NUM
iajs-3750	132	4	.	.	PUNCT
iajs-3750	133	1	https://doi.org/10.3390/nu11071652	https://doi.org/10.3390/nu11071652	X
iajs-3750	133	2	.	.	PUNCT
iajs-3750	134	1	4	4	NUM
iajs-3750	134	2	.	.	X
iajs-3750	134	3	zamil	zamil	PROPN
iajs-3750	134	4	ah	ah	INTJ
iajs-3750	134	5	,	,	PUNCT
iajs-3750	134	6	amin	amin	PROPN
iajs-3750	134	7	ss	ss	PROPN
iajs-3750	134	8	.	.	PUNCT
iajs-3750	135	1	the	the	DET
iajs-3750	135	2	prevalence	prevalence	NOUN
iajs-3750	135	3	of	of	ADP
iajs-3750	135	4	metabolic	metabolic	NOUN
iajs-3750	135	5	syndrome	syndrome	NOUN
iajs-3750	135	6	among	among	ADP
iajs-3750	135	7	university	university	NOUN
iajs-3750	135	8	students	student	NOUN
iajs-3750	135	9	in	in	ADP
iajs-3750	135	10	wasit	wasit	PROPN
iajs-3750	135	11	,	,	PUNCT
iajs-3750	135	12	iraq	iraq	PROPN
iajs-3750	135	13	.	.	PUNCT
iajs-3750	136	1	saudi	saudi	PROPN
iajs-3750	136	2	med	med	PROPN
iajs-3750	136	3	j.	j.	PROPN
iajs-3750	136	4	2022	2022	NUM
iajs-3750	136	5	;	;	PUNCT
iajs-3750	136	6	43(11):1240–1247	43(11):1240–1247	NUM
iajs-3750	136	7	.	.	PUNCT
iajs-3750	137	1	https://doi.org/10.15537/smj.2022.43.11.20220558	https://doi.org/10.15537/smj.2022.43.11.20220558	VERB
iajs-3750	137	2	.	.	NOUN
iajs-3750	137	3	5	5	X
iajs-3750	137	4	.	.	X
iajs-3750	137	5	karakoç	karakoç	PROPN
iajs-3750	137	6	z	z	PROPN
iajs-3750	137	7	,	,	PUNCT
iajs-3750	137	8	topaloğlu	topaloğlu	NOUN
iajs-3750	137	9	u	u	PROPN
iajs-3750	137	10	,	,	PUNCT
iajs-3750	137	11	bayram	bayram	PROPN
iajs-3750	137	12	b.	b.	PROPN
iajs-3750	137	13	immunohistochemical	immunohistochemical	ADJ
iajs-3750	137	14	distributions	distribution	NOUN
iajs-3750	137	15	of	of	ADP
iajs-3750	137	16	leptin	leptin	NOUN
iajs-3750	137	17	,	,	PUNCT
iajs-3750	137	18	ghrelin	ghrelin	NOUN
iajs-3750	137	19	and	and	CCONJ
iajs-3750	137	20	obestatin	obestatin	NOUN
iajs-3750	137	21	hormones	hormone	NOUN
iajs-3750	137	22	in	in	ADP
iajs-3750	137	23	bull	bull	NOUN
iajs-3750	137	24	and	and	CCONJ
iajs-3750	137	25	ram	ram	NOUN
iajs-3750	137	26	abomasum	abomasum	NOUN
iajs-3750	137	27	.	.	PUNCT
iajs-3750	138	1	anat	anat	PROPN
iajs-3750	138	2	histol	histol	PROPN
iajs-3750	138	3	embryol	embryol	NOUN
iajs-3750	138	4	.	.	PUNCT
iajs-3750	139	1	2022	2022	NUM
iajs-3750	139	2	;	;	PUNCT
iajs-3750	139	3	51(3):411–418	51(3):411–418	PROPN
iajs-3750	139	4	.	.	PUNCT
iajs-3750	140	1	https://doi.org/10.1111/ahe.12801	https://doi.org/10.1111/ahe.12801	NOUN
iajs-3750	140	2	.	.	NOUN
iajs-3750	140	3	6	6	NUM
iajs-3750	140	4	.	.	X
iajs-3750	140	5	egido	egido	VERB
iajs-3750	140	6	em	em	PRON
iajs-3750	140	7	,	,	PUNCT
iajs-3750	140	8	hernández	hernández	PROPN
iajs-3750	140	9	r	r	PROPN
iajs-3750	140	10	,	,	PUNCT
iajs-3750	140	11	marco	marco	PROPN
iajs-3750	140	12	j	j	PROPN
iajs-3750	140	13	,	,	PUNCT
iajs-3750	140	14	silvestre	silvestre	PROPN
iajs-3750	140	15	ra	ra	PROPN
iajs-3750	140	16	.	.	PROPN
iajs-3750	141	1	effect	effect	NOUN
iajs-3750	141	2	of	of	ADP
iajs-3750	141	3	obestatin	obestatin	NOUN
iajs-3750	141	4	on	on	ADP
iajs-3750	141	5	insulin	insulin	NOUN
iajs-3750	141	6	,	,	PUNCT
iajs-3750	141	7	glucagon	glucagon	NOUN
iajs-3750	141	8	and	and	CCONJ
iajs-3750	141	9	somatostatin	somatostatin	NOUN
iajs-3750	141	10	secretion	secretion	NOUN
iajs-3750	141	11	in	in	ADP
iajs-3750	141	12	the	the	DET
iajs-3750	141	13	perfused	perfused	ADJ
iajs-3750	141	14	rat	rat	NOUN
iajs-3750	141	15	pancreas	pancrea	NOUN
iajs-3750	141	16	.	.	PUNCT
iajs-3750	142	1	regul	regul	NOUN
iajs-3750	142	2	pept	pept	PROPN
iajs-3750	142	3	.	.	PUNCT
iajs-3750	142	4	2009	2009	NUM
iajs-3750	142	5	;	;	PUNCT
iajs-3750	142	6	152(1	152(1	NUM
iajs-3750	142	7	-	-	SYM
iajs-3750	142	8	3):61–66	3):61–66	NUM
iajs-3750	142	9	.	.	PUNCT
iajs-3750	143	1	https://doi.org/10.1016/j.regpep.2008.08.003	https://doi.org/10.1016/j.regpep.2008.08.003	PROPN
iajs-3750	143	2	.	.	PROPN
iajs-3750	143	3	7	7	X
iajs-3750	143	4	.	.	NOUN
iajs-3750	143	5	villarreal	villarreal	PROPN
iajs-3750	143	6	d	d	PROPN
iajs-3750	143	7	,	,	PUNCT
iajs-3750	143	8	pradhan	pradhan	PROPN
iajs-3750	143	9	g	g	PROPN
iajs-3750	143	10	,	,	PUNCT
iajs-3750	143	11	zhou	zhou	PROPN
iajs-3750	143	12	y	y	PROPN
iajs-3750	143	13	,	,	PUNCT
iajs-3750	143	14	xue	xue	PROPN
iajs-3750	143	15	b	b	PROPN
iajs-3750	143	16	,	,	PUNCT
iajs-3750	143	17	sun	sun	PROPN
iajs-3750	143	18	y.	y.	PROPN
iajs-3750	143	19	diverse	diverse	ADJ
iajs-3750	143	20	and	and	CCONJ
iajs-3750	143	21	complementary	complementary	ADJ
iajs-3750	143	22	effects	effect	NOUN
iajs-3750	143	23	of	of	ADP
iajs-3750	143	24	ghrelin	ghrelin	NOUN
iajs-3750	143	25	and	and	CCONJ
iajs-3750	143	26	obestatin	obestatin	NOUN
iajs-3750	143	27	.	.	PUNCT
iajs-3750	143	28	biomolecules	biomolecule	NOUN
iajs-3750	143	29	.	.	PUNCT
iajs-3750	143	30	2022	2022	NUM
iajs-3750	143	31	;	;	PUNCT
iajs-3750	143	32	12(4):517	12(4):517	NUM
iajs-3750	143	33	.	.	PUNCT
iajs-3750	144	1	https://doi.org/10.3390/biom12040517	https://doi.org/10.3390/biom12040517	PROPN
iajs-3750	144	2	.	.	PUNCT
iajs-3750	145	1	8	8	X
iajs-3750	145	2	.	.	PUNCT
iajs-3750	146	1	tahir	tahir	PROPN
iajs-3750	146	2	nt	nt	PROPN
iajs-3750	146	3	,	,	PUNCT
iajs-3750	146	4	jedda	jedda	PROPN
iajs-3750	146	5	waa	waa	PROPN
iajs-3750	146	6	,	,	PUNCT
iajs-3750	146	7	alfatlawi	alfatlawi	PROPN
iajs-3750	146	8	wr	wr	PROPN
iajs-3750	146	9	.	.	PUNCT
iajs-3750	146	10	ghrelin	ghrelin	NOUN
iajs-3750	146	11	and	and	CCONJ
iajs-3750	146	12	obestatin	obestatin	NOUN
iajs-3750	146	13	levels	level	NOUN
iajs-3750	146	14	as	as	ADP
iajs-3750	146	15	a	a	DET
iajs-3750	146	16	novel	novel	ADJ
iajs-3750	146	17	marker	marker	NOUN
iajs-3750	146	18	in	in	ADP
iajs-3750	146	19	iraqi	iraqi	ADJ
iajs-3750	146	20	obese	obese	ADJ
iajs-3750	146	21	children	child	NOUN
iajs-3750	146	22	.	.	PUNCT
iajs-3750	147	1	baghdad	baghdad	PROPN
iajs-3750	147	2	sci	sci	PROPN
iajs-3750	147	3	j.	j.	PROPN
iajs-3750	147	4	2023;20(5):1654	2023;20(5):1654	PROPN
iajs-3750	147	5	-	-	SYM
iajs-3750	147	6	1661	1661	NUM
iajs-3750	147	7	.	.	PUNCT
iajs-3750	148	1	https://dx.doi.org/10.21123/bsj.2023.7103	https://dx.doi.org/10.21123/bsj.2023.7103	X
iajs-3750	148	2	.	.	NOUN
iajs-3750	148	3	9	9	NUM
iajs-3750	148	4	.	.	X
iajs-3750	148	5	mallikarjuna	mallikarjuna	PROPN
iajs-3750	148	6	bg	bg	PROPN
iajs-3750	148	7	,	,	PUNCT
iajs-3750	148	8	manjappara	manjappara	PROPN
iajs-3750	148	9	uv	uv	PROPN
iajs-3750	148	10	.	.	PUNCT
iajs-3750	148	11	obestatin	obestatin	PROPN
iajs-3750	148	12	and	and	CCONJ
iajs-3750	148	13	rosiglitazone	rosiglitazone	NOUN
iajs-3750	148	14	differentially	differentially	ADV
iajs-3750	148	15	modulate	modulate	VERB
iajs-3750	148	16	lipid	lipid	ADJ
iajs-3750	148	17	metabolism	metabolism	NOUN
iajs-3750	148	18	through	through	ADP
iajs-3750	148	19	peroxisome	peroxisome	NOUN
iajs-3750	148	20	proliferator	proliferator	NOUN
iajs-3750	148	21	-	-	PUNCT
iajs-3750	148	22	activated	activate	VERB
iajs-3750	148	23	receptor	receptor	NOUN
iajs-3750	148	24	-	-	PUNCT
iajs-3750	148	25	γ	γ	NOUN
iajs-3750	148	26	(	(	PUNCT
iajs-3750	148	27	pparγ	pparγ	NOUN
iajs-3750	148	28	)	)	PUNCT
iajs-3750	148	29	in	in	ADP
iajs-3750	148	30	pre	pre	ADJ
iajs-3750	148	31	-	-	ADJ
iajs-3750	148	32	adipose	adipose	ADJ
iajs-3750	148	33	and	and	CCONJ
iajs-3750	148	34	mature	mature	ADJ
iajs-3750	148	35	3t3	3t3	NUM
iajs-3750	148	36	-	-	PUNCT
iajs-3750	148	37	l1	l1	NOUN
iajs-3750	148	38	cells	cell	NOUN
iajs-3750	148	39	.	.	PUNCT
iajs-3750	149	1	cell	cell	NOUN
iajs-3750	149	2	biochem	biochem	PROPN
iajs-3750	149	3	biophys	biophy	NOUN
iajs-3750	149	4	.	.	PUNCT
iajs-3750	150	1	2021	2021	NUM
iajs-3750	150	2	;	;	PUNCT
iajs-3750	150	3	79(1):73–85	79(1):73–85	NUM
iajs-3750	150	4	.	.	X
iajs-3750	151	1	https://doi.org/10.1007/s12013020-00958-7	https://doi.org/10.1007/s12013020-00958-7	NOUN
iajs-3750	151	2	.	.	PUNCT
iajs-3750	152	1	10	10	NUM
iajs-3750	152	2	.	.	X
iajs-3750	153	1	szentpeteri	szentpeteri	PROPN
iajs-3750	153	2	a	a	PRON
iajs-3750	153	3	,	,	PUNCT
iajs-3750	153	4	lorincz	lorincz	PROPN
iajs-3750	153	5	h	h	NOUN
iajs-3750	153	6	,	,	PUNCT
iajs-3750	153	7	somodi	somodi	PROPN
iajs-3750	153	8	s	s	PROPN
iajs-3750	153	9	,	,	PUNCT
iajs-3750	153	10	varga	varga	PROPN
iajs-3750	153	11	ve	ve	PROPN
iajs-3750	153	12	,	,	PUNCT
iajs-3750	153	13	seres	sere	VERB
iajs-3750	153	14	i	i	PRON
iajs-3750	153	15	,	,	PUNCT
iajs-3750	153	16	paragh	paragh	PROPN
iajs-3750	153	17	g	g	PROPN
iajs-3750	153	18	,	,	PUNCT
iajs-3750	153	19	harangi	harangi	PROPN
iajs-3750	153	20	m.	m.	NOUN
iajs-3750	153	21	human	human	ADJ
iajs-3750	153	22	obestatin	obestatin	NOUN
iajs-3750	153	23	level	level	NOUN
iajs-3750	153	24	and	and	CCONJ
iajs-3750	153	25	its	its	PRON
iajs-3750	153	26	correlations	correlation	NOUN
iajs-3750	153	27	with	with	ADP
iajs-3750	153	28	metabolic	metabolic	NOUN
iajs-3750	153	29	syndrome	syndrome	NOUN
iajs-3750	153	30	components	component	NOUN
iajs-3750	153	31	in	in	ADP
iajs-3750	153	32	non	non	ADJ
iajs-3750	153	33	-	-	ADJ
iajs-3750	153	34	diabetic	diabetic	ADJ
iajs-3750	153	35	obese	obese	ADJ
iajs-3750	153	36	patients	patient	NOUN
iajs-3750	153	37	.	.	PUNCT
iajs-3750	154	1	atherosclerosis	atherosclerosis	NOUN
iajs-3750	154	2	.	.	PUNCT
iajs-3750	155	1	2017	2017	NUM
iajs-3750	155	2	;	;	PUNCT
iajs-3750	155	3	263	263	NUM
iajs-3750	155	4	:	:	PUNCT
iajs-3750	155	5	e250	e250	PROPN
iajs-3750	155	6	.	.	PUNCT
iajs-3750	156	1	https://doi.org/10.1016/j.atherosclerosis.2017.06.811	https://doi.org/10.1016/j.atherosclerosis.2017.06.811	PROPN
iajs-3750	156	2	.	.	PROPN
iajs-3750	156	3	11	11	NUM
iajs-3750	156	4	.	.	PUNCT
iajs-3750	157	1	cowan	cowan	PROPN
iajs-3750	157	2	e	e	PROPN
iajs-3750	157	3	,	,	PUNCT
iajs-3750	157	4	burch	burch	PROPN
iajs-3750	157	5	kj	kj	PROPN
iajs-3750	157	6	,	,	PUNCT
iajs-3750	157	7	green	green	PROPN
iajs-3750	157	8	bd	bd	PROPN
iajs-3750	157	9	,	,	PUNCT
iajs-3750	157	10	grieve	grieve	VERB
iajs-3750	157	11	dj	dj	NOUN
iajs-3750	157	12	.	.	PUNCT
iajs-3750	157	13	obestatin	obestatin	PROPN
iajs-3750	157	14	as	as	ADP
iajs-3750	157	15	a	a	DET
iajs-3750	157	16	key	key	ADJ
iajs-3750	157	17	regulator	regulator	NOUN
iajs-3750	157	18	of	of	ADP
iajs-3750	157	19	metabolism	metabolism	NOUN
iajs-3750	157	20	and	and	CCONJ
iajs-3750	157	21	cardiovascular	cardiovascular	ADJ
iajs-3750	157	22	function	function	NOUN
iajs-3750	157	23	with	with	ADP
iajs-3750	157	24	emerging	emerge	VERB
iajs-3750	157	25	therapeutic	therapeutic	ADJ
iajs-3750	157	26	potential	potential	NOUN
iajs-3750	157	27	for	for	ADP
iajs-3750	157	28	diabetes	diabetes	NOUN
iajs-3750	157	29	.	.	PUNCT
iajs-3750	158	1	br	br	PROPN
iajs-3750	158	2	j	j	PROPN
iajs-3750	158	3	pharmacol	pharmacol	PROPN
iajs-3750	158	4	.	.	PROPN
iajs-3750	159	1	2016	2016	NUM
iajs-3750	159	2	;	;	PUNCT
iajs-3750	160	1	173(14):2165–2181	173(14):2165–2181	NUM
iajs-3750	160	2	.	.	PUNCT
iajs-3750	161	1	https://doi.org/10.1111/bph.13502	https://doi.org/10.1111/bph.13502	INTJ
iajs-3750	161	2	.	.	PUNCT
iajs-3750	162	1	12	12	NUM
iajs-3750	162	2	.	.	PUNCT
iajs-3750	163	1	green	green	PROPN
iajs-3750	163	2	bd	bd	PROPN
iajs-3750	163	3	,	,	PUNCT
iajs-3750	163	4	grieve	grieve	VERB
iajs-3750	163	5	dj	dj	NOUN
iajs-3750	163	6	.	.	PUNCT
iajs-3750	164	1	biochemical	biochemical	ADJ
iajs-3750	164	2	properties	property	NOUN
iajs-3750	164	3	and	and	CCONJ
iajs-3750	164	4	biological	biological	ADJ
iajs-3750	164	5	actions	action	NOUN
iajs-3750	164	6	of	of	ADP
iajs-3750	164	7	obestatin	obestatin	NOUN
iajs-3750	164	8	and	and	CCONJ
iajs-3750	164	9	its	its	PRON
iajs-3750	164	10	relevance	relevance	NOUN
iajs-3750	164	11	in	in	ADP
iajs-3750	164	12	type	type	NOUN
iajs-3750	164	13	2	2	NUM
iajs-3750	164	14	diabetes	diabetes	NOUN
iajs-3750	164	15	.	.	PUNCT
iajs-3750	165	1	peptides	peptide	NOUN
iajs-3750	165	2	.	.	PUNCT
iajs-3750	166	1	2018	2018	NUM
iajs-3750	166	2	;	;	PUNCT
iajs-3750	166	3	100:249–259	100:249–259	NUM
iajs-3750	166	4	.	.	PUNCT
iajs-3750	167	1	https://doi.org/10.1016/j.peptides.2017.12.006	https://doi.org/10.1016/j.peptides.2017.12.006	NOUN
iajs-3750	167	2	.	.	PUNCT
iajs-3750	168	1	13	13	NUM
iajs-3750	168	2	.	.	PUNCT
iajs-3750	168	3	bora	bora	PROPN
iajs-3750	168	4	rr	rr	PROPN
iajs-3750	168	5	,	,	PUNCT
iajs-3750	168	6	prasad	prasad	PROPN
iajs-3750	168	7	r	r	PROPN
iajs-3750	168	8	,	,	PUNCT
iajs-3750	168	9	khatib	khatib	PROPN
iajs-3750	168	10	mn	mn	PROPN
iajs-3750	168	11	.	.	PUNCT
iajs-3750	169	1	cardio	cardio	NOUN
iajs-3750	169	2	-	-	PUNCT
iajs-3750	169	3	protective	protective	ADJ
iajs-3750	169	4	role	role	NOUN
iajs-3750	169	5	of	of	ADP
iajs-3750	169	6	a	a	DET
iajs-3750	169	7	gut	gut	NOUN
iajs-3750	169	8	hormone	hormone	NOUN
iajs-3750	169	9	obestatin	obestatin	NOUN
iajs-3750	169	10	:	:	PUNCT
iajs-3750	169	11	a	a	DET
iajs-3750	169	12	narrative	narrative	NOUN
iajs-3750	169	13	review	review	NOUN
iajs-3750	169	14	.	.	PUNCT
iajs-3750	170	1	cureus	cureus	NOUN
iajs-3750	170	2	.	.	PUNCT
iajs-3750	171	1	2023	2023	NUM
iajs-3750	171	2	;	;	PUNCT
iajs-3750	171	3	15(4):e37972	15(4):e37972	X
iajs-3750	171	4	.	.	PROPN
iajs-3750	171	5	https://doi.org/10.7759/cureus.37972	https://doi.org/10.7759/cureus.37972	PROPN
iajs-3750	171	6	.	.	PUNCT
iajs-3750	172	1	14	14	NUM
iajs-3750	172	2	.	.	PUNCT
iajs-3750	173	1	lin	lin	PROPN
iajs-3750	173	2	eyh	eyh	PROPN
iajs-3750	173	3	,	,	PUNCT
iajs-3750	173	4	xi	xi	ADP
iajs-3750	173	5	w	w	PROPN
iajs-3750	173	6	,	,	PUNCT
iajs-3750	173	7	aggarwal	aggarwal	PROPN
iajs-3750	173	8	n	n	CCONJ
iajs-3750	173	9	,	,	PUNCT
iajs-3750	173	10	shinohara	shinohara	PROPN
iajs-3750	173	11	ml	ml	NOUN
iajs-3750	173	12	.	.	PUNCT
iajs-3750	174	1	osteopontin	osteopontin	NOUN
iajs-3750	174	2	(	(	PUNCT
iajs-3750	174	3	opn)/spp1	opn)/spp1	NUM
iajs-3750	174	4	:	:	PUNCT
iajs-3750	174	5	from	from	ADP
iajs-3750	174	6	its	its	PRON
iajs-3750	174	7	biochemistry	biochemistry	NOUN
iajs-3750	174	8	to	to	ADP
iajs-3750	174	9	biological	biological	ADJ
iajs-3750	174	10	functions	function	NOUN
iajs-3750	174	11	in	in	ADP
iajs-3750	174	12	the	the	DET
iajs-3750	174	13	innate	innate	ADJ
iajs-3750	174	14	immune	immune	ADJ
iajs-3750	174	15	system	system	NOUN
iajs-3750	174	16	and	and	CCONJ
iajs-3750	174	17	the	the	DET
iajs-3750	174	18	central	central	ADJ
iajs-3750	174	19	nervous	nervous	ADJ
iajs-3750	174	20	system	system	NOUN
iajs-3750	174	21	(	(	PUNCT
iajs-3750	174	22	cns	cns	NOUN
iajs-3750	174	23	)	)	PUNCT
iajs-3750	174	24	.	.	PUNCT
iajs-3750	175	1	int	int	NOUN
iajs-3750	175	2	immunol	immunol	NOUN
iajs-3750	175	3	.	.	PUNCT
iajs-3750	176	1	2023	2023	NUM
iajs-3750	176	2	;	;	PUNCT
iajs-3750	176	3	35(4):171–180	35(4):171–180	PROPN
iajs-3750	176	4	.	.	PUNCT
iajs-3750	176	5	https://doi.org/10.1093/intimm/dxac060	https://doi.org/10.1093/intimm/dxac060	PROPN
iajs-3750	176	6	.	.	PUNCT
iajs-3750	177	1	https://doi.org/10.3390/ijerph18010275	https://doi.org/10.3390/ijerph18010275	PROPN
iajs-3750	177	2	https://doi.org/10.30526/34.3.2675	https://doi.org/10.30526/34.3.2675	X
iajs-3750	178	1	https://doi.org/10.3390/nu11071652	https://doi.org/10.3390/nu11071652	PRON
iajs-3750	178	2	https://doi.org/10.15537/smj.2022.43.11.20220558	https://doi.org/10.15537/smj.2022.43.11.20220558	VERB
iajs-3750	178	3	https://doi.org/10.1111/ahe.12801	https://doi.org/10.1111/ahe.12801	NOUN
iajs-3750	178	4	https://doi.org/10.1016/j.regpep.2008.08.003	https://doi.org/10.1016/j.regpep.2008.08.003	ADJ
iajs-3750	178	5	https://doi.org/10.3390/biom12040517	https://doi.org/10.3390/biom12040517	PROPN
iajs-3750	178	6	https://dx.doi.org/10.21123/bsj.2023.7103	https://dx.doi.org/10.21123/bsj.2023.7103	NUM
iajs-3750	178	7	file:///c:/users	file:///c:/user	NOUN
iajs-3750	178	8	/	/	SYM
iajs-3750	178	9	alrawasi	alrawasi	NOUN
iajs-3750	178	10	/	/	SYM
iajs-3750	178	11	downloads/.%20https:/doi.org/10.1007	downloads/.%20https:/doi.org/10.1007	ADJ
iajs-3750	178	12	/	/	SYM
iajs-3750	178	13	s12013	s12013	VERB
iajs-3750	178	14	-	-	PUNCT
iajs-3750	178	15	020	020	NUM
iajs-3750	178	16	-	-	PUNCT
iajs-3750	178	17	00958	00958	NUM
iajs-3750	178	18	-	-	SYM
iajs-3750	178	19	7	7	NUM
iajs-3750	178	20	file:///c:/users	file:///c:/user	NOUN
iajs-3750	178	21	/	/	SYM
iajs-3750	178	22	alrawasi	alrawasi	NOUN
iajs-3750	178	23	/	/	SYM
iajs-3750	178	24	downloads/.%20https:/doi.org/10.1007	downloads/.%20https:/doi.org/10.1007	ADJ
iajs-3750	178	25	/	/	SYM
iajs-3750	178	26	s12013	s12013	VERB
iajs-3750	178	27	-	-	PUNCT
iajs-3750	178	28	020	020	NUM
iajs-3750	178	29	-	-	PUNCT
iajs-3750	178	30	00958	00958	NUM
iajs-3750	178	31	-	-	SYM
iajs-3750	178	32	7	7	NUM
iajs-3750	178	33	https://doi.org/10.1016/j.atherosclerosis.2017.06.811	https://doi.org/10.1016/j.atherosclerosis.2017.06.811	PRON
iajs-3750	179	1	https://doi.org/10.1111/bph.13502	https://doi.org/10.1111/bph.13502	PROPN
iajs-3750	179	2	https://doi.org/10.1016/j.peptides.2017.12.006	https://doi.org/10.1016/j.peptides.2017.12.006	NUM
iajs-3750	179	3	https://doi.org/10.7759/cureus.37972	https://doi.org/10.7759/cureus.37972	ADJ
iajs-3750	179	4	https://doi.org/10.1093/intimm/dxac060	https://doi.org/10.1093/intimm/dxac060	NOUN
iajs-3750	179	5	ihjpas	ihjpa	VERB
iajs-3750	179	6	.	.	PUNCT
iajs-3750	180	1	2025	2025	NUM
iajs-3750	180	2	,	,	PUNCT
iajs-3750	180	3	38(3	38(3	NUM
iajs-3750	180	4	)	)	PUNCT
iajs-3750	180	5	263	263	NUM
iajs-3750	180	6	15	15	NUM
iajs-3750	180	7	.	.	PUNCT
iajs-3750	180	8	ascar	ascar	VERB
iajs-3750	180	9	if	if	SCONJ
iajs-3750	180	10	.	.	PUNCT
iajs-3750	181	1	biochemical	biochemical	ADJ
iajs-3750	181	2	study	study	NOUN
iajs-3750	181	3	on	on	ADP
iajs-3750	181	4	a	a	DET
iajs-3750	181	5	group	group	NOUN
iajs-3750	181	6	of	of	ADP
iajs-3750	181	7	iraqi	iraqi	ADJ
iajs-3750	181	8	patients	patient	NOUN
iajs-3750	181	9	with	with	ADP
iajs-3750	181	10	thyroid	thyroid	NOUN
iajs-3750	181	11	cancer	cancer	NOUN
iajs-3750	181	12	in	in	ADP
iajs-3750	181	13	relation	relation	NOUN
iajs-3750	181	14	to	to	ADP
iajs-3750	181	15	osteopontin	osteopontin	NOUN
iajs-3750	181	16	[	[	X
iajs-3750	181	17	dissertation	dissertation	NOUN
iajs-3750	181	18	]	]	PUNCT
iajs-3750	181	19	.	.	PUNCT
iajs-3750	182	1	baghdad	baghdad	PROPN
iajs-3750	182	2	:	:	PUNCT
iajs-3750	182	3	university	university	NOUN
iajs-3750	182	4	of	of	ADP
iajs-3750	182	5	baghdad	baghdad	PROPN
iajs-3750	182	6	,	,	PUNCT
iajs-3750	182	7	college	college	NOUN
iajs-3750	182	8	of	of	ADP
iajs-3750	182	9	sciences	science	NOUN
iajs-3750	182	10	for	for	ADP
iajs-3750	182	11	women	woman	NOUN
iajs-3750	182	12	;	;	PUNCT
iajs-3750	182	13	2019	2019	NUM
iajs-3750	182	14	.	.	PUNCT
iajs-3750	183	1	16	16	NUM
iajs-3750	183	2	.	.	PUNCT
iajs-3750	184	1	kitamura	kitamura	PROPN
iajs-3750	184	2	k.	k.	PROPN
iajs-3750	184	3	osteopontin	osteopontin	PROPN
iajs-3750	184	4	.	.	PUNCT
iajs-3750	185	1	in	in	ADP
iajs-3750	185	2	:	:	PUNCT
iajs-3750	185	3	takei	takei	PROPN
iajs-3750	185	4	y	y	PROPN
iajs-3750	185	5	,	,	PUNCT
iajs-3750	185	6	ando	ando	PROPN
iajs-3750	185	7	h	h	PROPN
iajs-3750	185	8	,	,	PUNCT
iajs-3750	185	9	tsutsui	tsutsui	PROPN
iajs-3750	185	10	k	k	PROPN
iajs-3750	185	11	,	,	PUNCT
iajs-3750	185	12	editors	editor	NOUN
iajs-3750	185	13	.	.	PUNCT
iajs-3750	186	1	handbook	handbook	NOUN
iajs-3750	186	2	of	of	ADP
iajs-3750	186	3	hormones	hormone	NOUN
iajs-3750	186	4	.	.	PUNCT
iajs-3750	187	1	amsterdam	amsterdam	PROPN
iajs-3750	187	2	:	:	PUNCT
iajs-3750	187	3	elsevier	elsevier	NOUN
iajs-3750	187	4	;	;	PUNCT
iajs-3750	187	5	2021	2021	NUM
iajs-3750	187	6	;	;	PUNCT
iajs-3750	187	7	p.	p.	NOUN
iajs-3750	187	8	597–599	597–599	NUM
iajs-3750	187	9	.	.	PUNCT
iajs-3750	188	1	https://doi.org/10.1016/b978-0-12-820649-2.00152-2	https://doi.org/10.1016/b978-0-12-820649-2.00152-2	X
iajs-3750	188	2	.	.	PROPN
iajs-3750	188	3	17	17	NUM
iajs-3750	188	4	.	.	PUNCT
iajs-3750	189	1	al	al	PROPN
iajs-3750	189	2	-	-	PUNCT
iajs-3750	189	3	husaini	husaini	PROPN
iajs-3750	189	4	fk	fk	PROPN
iajs-3750	189	5	,	,	PUNCT
iajs-3750	189	6	hywar	hywar	PROPN
iajs-3750	189	7	fa	fa	PROPN
iajs-3750	189	8	,	,	PUNCT
iajs-3750	189	9	elias	elias	PROPN
iajs-3750	189	10	ng	ng	PROPN
iajs-3750	189	11	,	,	PUNCT
iajs-3750	189	12	falih	falih	PROPN
iajs-3750	189	13	iq	iq	PROPN
iajs-3750	189	14	.	.	PUNCT
iajs-3750	189	15	evaluation	evaluation	NOUN
iajs-3750	189	16	of	of	ADP
iajs-3750	189	17	chemerin	chemerin	NOUN
iajs-3750	189	18	in	in	ADP
iajs-3750	189	19	diabetic	diabetic	ADJ
iajs-3750	189	20	type	type	NOUN
iajs-3750	189	21	2	2	NUM
iajs-3750	189	22	patients	patient	NOUN
iajs-3750	189	23	with	with	ADP
iajs-3750	189	24	metabolic	metabolic	NOUN
iajs-3750	189	25	syndrome	syndrome	NOUN
iajs-3750	189	26	in	in	ADP
iajs-3750	189	27	both	both	DET
iajs-3750	189	28	genders	gender	NOUN
iajs-3750	189	29	.	.	PUNCT
iajs-3750	190	1	iran	iran	PROPN
iajs-3750	190	2	j	j	PROPN
iajs-3750	190	3	war	war	PROPN
iajs-3750	190	4	public	public	ADJ
iajs-3750	190	5	health	health	NOUN
iajs-3750	190	6	.	.	PUNCT
iajs-3750	190	7	2022	2022	NUM
iajs-3750	190	8	;	;	PUNCT
iajs-3750	190	9	14(4	14(4	NUM
iajs-3750	190	10	):	):	PUNCT
iajs-3750	190	11	409–414	409–414	NUM
iajs-3750	190	12	.	.	PUNCT
iajs-3750	191	1	https://doi.org/10.29252/ijwph.14.4.409	https://doi.org/10.29252/ijwph.14.4.409	NOUN
iajs-3750	191	2	.	.	NOUN
iajs-3750	191	3	18	18	NUM
iajs-3750	191	4	.	.	PUNCT
iajs-3750	191	5	parker	parker	PROPN
iajs-3750	191	6	j.	j.	PROPN
iajs-3750	191	7	glucose	glucose	PROPN
iajs-3750	191	8	metabolism	metabolism	NOUN
iajs-3750	191	9	,	,	PUNCT
iajs-3750	191	10	energy	energy	NOUN
iajs-3750	191	11	production	production	NOUN
iajs-3750	191	12	and	and	CCONJ
iajs-3750	191	13	regulation	regulation	NOUN
iajs-3750	191	14	of	of	ADP
iajs-3750	191	15	cellular	cellular	ADJ
iajs-3750	191	16	and	and	CCONJ
iajs-3750	191	17	whole	whole	ADJ
iajs-3750	191	18	-	-	PUNCT
iajs-3750	191	19	body	body	NOUN
iajs-3750	191	20	metabolism	metabolism	NOUN
iajs-3750	191	21	.	.	PUNCT
iajs-3750	192	1	j	j	PROPN
iajs-3750	192	2	australas	australas	PROPN
iajs-3750	192	3	coll	coll	PROPN
iajs-3750	192	4	nutr	nutr	PROPN
iajs-3750	192	5	environ	environ	PROPN
iajs-3750	192	6	med	med	PROPN
iajs-3750	192	7	.	.	PUNCT
iajs-3750	193	1	2020	2020	NUM
iajs-3750	193	2	;	;	PUNCT
iajs-3750	194	1	39(1):29–33	39(1):29–33	NUM
iajs-3750	194	2	.	.	X
iajs-3750	194	3	https://doi.org/10.3316/informit.154784110868319	https://doi.org/10.3316/informit.154784110868319	PROPN
iajs-3750	194	4	.	.	PUNCT
iajs-3750	195	1	19	19	NUM
iajs-3750	195	2	.	.	PUNCT
iajs-3750	195	3	kunzova	kunzova	PROPN
iajs-3750	195	4	s	s	PROPN
iajs-3750	195	5	,	,	PUNCT
iajs-3750	195	6	maugeri	maugeri	ADJ
iajs-3750	195	7	a	a	PRON
iajs-3750	195	8	,	,	PUNCT
iajs-3750	195	9	medina	medina	PROPN
iajs-3750	195	10	-	-	PUNCT
iajs-3750	195	11	inojosa	inojosa	PROPN
iajs-3750	195	12	j	j	PROPN
iajs-3750	195	13	,	,	PUNCT
iajs-3750	195	14	lopez	lopez	PROPN
iajs-3750	195	15	-	-	PUNCT
iajs-3750	195	16	jimenez	jimenez	PROPN
iajs-3750	195	17	f	f	PROPN
iajs-3750	195	18	,	,	PUNCT
iajs-3750	195	19	vinciguerra	vinciguerra	NOUN
iajs-3750	195	20	m	m	PROPN
iajs-3750	195	21	,	,	PUNCT
iajs-3750	195	22	marques	marques	PROPN
iajs-3750	195	23	-	-	PUNCT
iajs-3750	195	24	vidal	vidal	ADJ
iajs-3750	195	25	p.	p.	NOUN
iajs-3750	195	26	determinants	determinant	NOUN
iajs-3750	195	27	of	of	ADP
iajs-3750	195	28	metabolic	metabolic	NOUN
iajs-3750	195	29	health	health	NOUN
iajs-3750	195	30	across	across	ADP
iajs-3750	195	31	body	body	NOUN
iajs-3750	195	32	mass	mass	NOUN
iajs-3750	195	33	index	index	NOUN
iajs-3750	195	34	categories	category	NOUN
iajs-3750	195	35	in	in	ADP
iajs-3750	195	36	central	central	ADJ
iajs-3750	195	37	europe	europe	PROPN
iajs-3750	195	38	:	:	PUNCT
iajs-3750	195	39	a	a	DET
iajs-3750	195	40	comparison	comparison	NOUN
iajs-3750	195	41	between	between	ADP
iajs-3750	195	42	swiss	swiss	ADJ
iajs-3750	195	43	and	and	CCONJ
iajs-3750	195	44	czech	czech	ADJ
iajs-3750	195	45	populations	population	NOUN
iajs-3750	195	46	.	.	PUNCT
iajs-3750	196	1	front	front	ADJ
iajs-3750	196	2	public	public	ADJ
iajs-3750	196	3	health	health	NOUN
iajs-3750	196	4	.	.	PUNCT
iajs-3750	197	1	2020	2020	NUM
iajs-3750	197	2	;	;	PUNCT
iajs-3750	197	3	8:108	8:108	NUM
iajs-3750	197	4	.	.	PUNCT
iajs-3750	198	1	https://doi.org/10.3389/fpubh.2020.00108	https://doi.org/10.3389/fpubh.2020.00108	PROPN
iajs-3750	198	2	.	.	PUNCT
iajs-3750	199	1	20	20	NUM
iajs-3750	199	2	.	.	PUNCT
iajs-3750	200	1	arnlov	arnlov	PROPN
iajs-3750	200	2	j	j	PROPN
iajs-3750	200	3	,	,	PUNCT
iajs-3750	200	4	ingelsson	ingelsson	NOUN
iajs-3750	200	5	e	e	NOUN
iajs-3750	200	6	,	,	PUNCT
iajs-3750	200	7	sundström	sundström	PROPN
iajs-3750	200	8	j	j	PROPN
iajs-3750	200	9	,	,	PUNCT
iajs-3750	200	10	lind	lind	PROPN
iajs-3750	200	11	l.	l.	PROPN
iajs-3750	200	12	impact	impact	PROPN
iajs-3750	200	13	of	of	ADP
iajs-3750	200	14	body	body	NOUN
iajs-3750	200	15	mass	mass	NOUN
iajs-3750	200	16	index	index	NOUN
iajs-3750	200	17	and	and	CCONJ
iajs-3750	200	18	the	the	DET
iajs-3750	200	19	metabolic	metabolic	NOUN
iajs-3750	200	20	syndrome	syndrome	NOUN
iajs-3750	200	21	on	on	ADP
iajs-3750	200	22	the	the	DET
iajs-3750	200	23	risk	risk	NOUN
iajs-3750	200	24	of	of	ADP
iajs-3750	200	25	cardiovascular	cardiovascular	ADJ
iajs-3750	200	26	disease	disease	NOUN
iajs-3750	200	27	and	and	CCONJ
iajs-3750	200	28	death	death	NOUN
iajs-3750	200	29	in	in	ADP
iajs-3750	200	30	middle	middle	ADJ
iajs-3750	200	31	-	-	PUNCT
iajs-3750	200	32	aged	aged	ADJ
iajs-3750	200	33	men	man	NOUN
iajs-3750	200	34	.	.	PUNCT
iajs-3750	201	1	circulation	circulation	NOUN
iajs-3750	201	2	.	.	PUNCT
iajs-3750	202	1	2010	2010	NUM
iajs-3750	202	2	;	;	PUNCT
iajs-3750	203	1	121(2):230–236	121(2):230–236	NUM
iajs-3750	203	2	.	.	PUNCT
iajs-3750	203	3	https://doi.org/10.1161/circulationaha.109.887521	https://doi.org/10.1161/circulationaha.109.887521	PROPN
iajs-3750	203	4	.	.	PROPN
iajs-3750	204	1	21	21	NUM
iajs-3750	204	2	.	.	PUNCT
iajs-3750	205	1	amini	amini	PROPN
iajs-3750	205	2	m	m	PROPN
iajs-3750	205	3	,	,	PUNCT
iajs-3750	205	4	zayeri	zayeri	PROPN
iajs-3750	205	5	f	f	PROPN
iajs-3750	205	6	,	,	PUNCT
iajs-3750	205	7	salehi	salehi	PROPN
iajs-3750	205	8	m.	m.	NOUN
iajs-3750	205	9	trend	trend	NOUN
iajs-3750	205	10	analysis	analysis	NOUN
iajs-3750	205	11	of	of	ADP
iajs-3750	205	12	cardiovascular	cardiovascular	ADJ
iajs-3750	205	13	disease	disease	NOUN
iajs-3750	205	14	mortality	mortality	NOUN
iajs-3750	205	15	,	,	PUNCT
iajs-3750	205	16	incidence	incidence	NOUN
iajs-3750	205	17	,	,	PUNCT
iajs-3750	205	18	and	and	CCONJ
iajs-3750	205	19	mortality	mortality	NOUN
iajs-3750	205	20	-	-	PUNCT
iajs-3750	205	21	to	to	ADP
iajs-3750	205	22	-	-	PUNCT
iajs-3750	205	23	incidence	incidence	NOUN
iajs-3750	205	24	ratio	ratio	NOUN
iajs-3750	205	25	:	:	PUNCT
iajs-3750	205	26	results	result	NOUN
iajs-3750	205	27	from	from	ADP
iajs-3750	205	28	global	global	ADJ
iajs-3750	205	29	burden	burden	NOUN
iajs-3750	205	30	of	of	ADP
iajs-3750	205	31	disease	disease	NOUN
iajs-3750	205	32	study	study	NOUN
iajs-3750	205	33	2017	2017	NUM
iajs-3750	205	34	.	.	PUNCT
iajs-3750	206	1	bmc	bmc	VERB
iajs-3750	206	2	public	public	ADJ
iajs-3750	206	3	health	health	NOUN
iajs-3750	206	4	.	.	PUNCT
iajs-3750	206	5	2021	2021	NUM
iajs-3750	206	6	;	;	PUNCT
iajs-3750	207	1	21(401):1–12	21(401):1–12	PROPN
iajs-3750	207	2	.	.	PUNCT
iajs-3750	208	1	https://doi.org/10.1186/s12889-021-10429-0	https://doi.org/10.1186/s12889-021-10429-0	NUM
iajs-3750	208	2	.	.	PUNCT
iajs-3750	209	1	22	22	NUM
iajs-3750	209	2	.	.	PUNCT
iajs-3750	210	1	alowfi	alowfi	PROPN
iajs-3750	210	2	a	a	X
iajs-3750	210	3	,	,	PUNCT
iajs-3750	210	4	binladen	binladen	PROPN
iajs-3750	210	5	s	s	PROPN
iajs-3750	210	6	,	,	PUNCT
iajs-3750	210	7	irqsous	irqsous	ADJ
iajs-3750	210	8	s	s	PROPN
iajs-3750	210	9	,	,	PUNCT
iajs-3750	210	10	khashoggi	khashoggi	X
iajs-3750	210	11	a	a	PROPN
iajs-3750	210	12	,	,	PUNCT
iajs-3750	210	13	khan	khan	PROPN
iajs-3750	210	14	ma	ma	PROPN
iajs-3750	210	15	,	,	PUNCT
iajs-3750	210	16	calacattawi	calacattawi	PROPN
iajs-3750	210	17	r.	r.	PROPN
iajs-3750	210	18	metabolic	metabolic	PROPN
iajs-3750	210	19	syndrome	syndrome	PROPN
iajs-3750	210	20	:	:	PUNCT
iajs-3750	210	21	prevalence	prevalence	NOUN
iajs-3750	210	22	and	and	CCONJ
iajs-3750	210	23	risk	risk	NOUN
iajs-3750	210	24	factors	factor	NOUN
iajs-3750	210	25	among	among	ADP
iajs-3750	210	26	adolescent	adolescent	ADJ
iajs-3750	210	27	female	female	ADJ
iajs-3750	210	28	intermediate	intermediate	ADJ
iajs-3750	210	29	and	and	CCONJ
iajs-3750	210	30	secondary	secondary	ADJ
iajs-3750	210	31	students	student	NOUN
iajs-3750	210	32	in	in	ADP
iajs-3750	210	33	saudi	saudi	PROPN
iajs-3750	210	34	arabia	arabia	PROPN
iajs-3750	210	35	.	.	PUNCT
iajs-3750	211	1	int	int	PROPN
iajs-3750	212	1	j	j	PROPN
iajs-3750	212	2	environ	environ	PROPN
iajs-3750	212	3	res	re	VERB
iajs-3750	212	4	public	public	ADJ
iajs-3750	212	5	health	health	NOUN
iajs-3750	212	6	.	.	PUNCT
iajs-3750	212	7	2021	2021	NUM
iajs-3750	212	8	;	;	PUNCT
iajs-3750	212	9	18(4):2142	18(4):2142	NUM
iajs-3750	212	10	.	.	PUNCT
iajs-3750	213	1	https://doi.org/10.3390/ijerph18042142	https://doi.org/10.3390/ijerph18042142	PROPN
iajs-3750	213	2	.	.	PUNCT
iajs-3750	214	1	23	23	NUM
iajs-3750	214	2	.	.	PUNCT
iajs-3750	215	1	natesan	natesan	PROPN
iajs-3750	215	2	v	v	PROPN
iajs-3750	215	3	,	,	PUNCT
iajs-3750	215	4	kim	kim	PROPN
iajs-3750	215	5	sj	sj	PROPN
iajs-3750	215	6	.	.	PROPN
iajs-3750	215	7	lipid	lipid	PROPN
iajs-3750	215	8	metabolism	metabolism	NOUN
iajs-3750	215	9	,	,	PUNCT
iajs-3750	215	10	disorders	disorder	NOUN
iajs-3750	215	11	and	and	CCONJ
iajs-3750	215	12	therapeutic	therapeutic	ADJ
iajs-3750	215	13	drugs	drug	NOUN
iajs-3750	215	14	–	–	PUNCT
iajs-3750	215	15	review	review	NOUN
iajs-3750	215	16	.	.	PUNCT
iajs-3750	216	1	biomol	biomol	VERB
iajs-3750	216	2	ther	ther	ADV
iajs-3750	216	3	.	.	PUNCT
iajs-3750	217	1	2021	2021	NUM
iajs-3750	217	2	;	;	PUNCT
iajs-3750	218	1	29(6):596	29(6):596	NUM
iajs-3750	218	2	.	.	PUNCT
iajs-3750	219	1	https://doi.org/10.4062/biomolther.2021.122	https://doi.org/10.4062/biomolther.2021.122	NOUN
iajs-3750	219	2	.	.	PUNCT
iajs-3750	220	1	24	24	NUM
iajs-3750	220	2	.	.	PUNCT
iajs-3750	220	3	vasse	vasse	PROPN
iajs-3750	220	4	j	j	PROPN
iajs-3750	220	5	,	,	PUNCT
iajs-3750	220	6	lassartesse	lassartesse	VERB
iajs-3750	220	7	a	a	PRON
iajs-3750	220	8	,	,	PUNCT
iajs-3750	220	9	marmontel	marmontel	PROPN
iajs-3750	220	10	o	o	NOUN
iajs-3750	220	11	,	,	PUNCT
iajs-3750	220	12	charrière	charrière	NOUN
iajs-3750	220	13	s	s	PROPN
iajs-3750	220	14	,	,	PUNCT
iajs-3750	220	15	bouveyron	bouveyron	ADP
iajs-3750	220	16	c	c	NOUN
iajs-3750	220	17	,	,	PUNCT
iajs-3750	220	18	marrié	marrié	PROPN
iajs-3750	220	19	n.	n.	NOUN
iajs-3750	220	20	assessment	assessment	NOUN
iajs-3750	220	21	of	of	ADP
iajs-3750	220	22	three	three	NUM
iajs-3750	220	23	equations	equation	NOUN
iajs-3750	220	24	to	to	PART
iajs-3750	220	25	calculate	calculate	VERB
iajs-3750	220	26	plasma	plasma	NOUN
iajs-3750	220	27	ldl	ldl	NOUN
iajs-3750	220	28	cholesterol	cholesterol	NOUN
iajs-3750	220	29	concentration	concentration	NOUN
iajs-3750	220	30	in	in	ADP
iajs-3750	220	31	fasting	fast	VERB
iajs-3750	220	32	and	and	CCONJ
iajs-3750	220	33	non	non	ADJ
iajs-3750	220	34	-	-	ADJ
iajs-3750	220	35	fasting	fasting	ADJ
iajs-3750	220	36	hypertriglyceridemic	hypertriglyceridemic	ADJ
iajs-3750	220	37	patients	patient	NOUN
iajs-3750	220	38	.	.	PUNCT
iajs-3750	221	1	clin	clin	PROPN
iajs-3750	221	2	chem	chem	NOUN
iajs-3750	221	3	lab	lab	NOUN
iajs-3750	221	4	med	me	VERB
iajs-3750	221	5	.	.	PUNCT
iajs-3750	221	6	2023	2023	NUM
iajs-3750	221	7	;	;	PUNCT
iajs-3750	222	1	62(2):270–279	62(2):270–279	NOUN
iajs-3750	222	2	.	.	PUNCT
iajs-3750	223	1	https://doi.org/10.1515/cclm-2023-0360	https://doi.org/10.1515/cclm-2023-0360	NOUN
iajs-3750	223	2	.	.	PUNCT
iajs-3750	224	1	25	25	NUM
iajs-3750	224	2	.	.	PUNCT
iajs-3750	225	1	tachebele	tachebele	PROPN
iajs-3750	225	2	b	b	PROPN
iajs-3750	225	3	,	,	PUNCT
iajs-3750	225	4	abebe	abebe	PROPN
iajs-3750	225	5	m	m	PROPN
iajs-3750	225	6	,	,	PUNCT
iajs-3750	225	7	addis	addis	PROPN
iajs-3750	225	8	z	z	PROPN
iajs-3750	225	9	,	,	PUNCT
iajs-3750	225	10	mesfin	mesfin	ADJ
iajs-3750	225	11	n.	n.	PROPN
iajs-3750	225	12	metabolic	metabolic	PROPN
iajs-3750	225	13	syndrome	syndrome	NOUN
iajs-3750	225	14	among	among	ADP
iajs-3750	225	15	hypertensive	hypertensive	ADJ
iajs-3750	225	16	patients	patient	NOUN
iajs-3750	225	17	at	at	ADP
iajs-3750	225	18	university	university	PROPN
iajs-3750	225	19	of	of	ADP
iajs-3750	225	20	gondar	gondar	PROPN
iajs-3750	225	21	hospital	hospital	NOUN
iajs-3750	225	22	,	,	PUNCT
iajs-3750	225	23	north	north	NOUN
iajs-3750	225	24	west	west	PROPN
iajs-3750	225	25	ethiopia	ethiopia	PROPN
iajs-3750	225	26	:	:	PUNCT
iajs-3750	225	27	a	a	DET
iajs-3750	225	28	cross	cross	ADJ
iajs-3750	225	29	sectional	sectional	ADJ
iajs-3750	225	30	study	study	NOUN
iajs-3750	225	31	.	.	PUNCT
iajs-3750	226	1	bmc	bmc	PROPN
iajs-3750	226	2	cardiovasc	cardiovasc	PROPN
iajs-3750	226	3	disord	disord	PROPN
iajs-3750	226	4	.	.	PUNCT
iajs-3750	227	1	2014	2014	NUM
iajs-3750	227	2	;	;	PUNCT
iajs-3750	228	1	14(177):1–9	14(177):1–9	NUM
iajs-3750	228	2	.	.	PUNCT
iajs-3750	229	1	http://www.biomedcentral.com/1471-2261/14/177	http://www.biomedcentral.com/1471-2261/14/177	PROPN
iajs-3750	229	2	.	.	PUNCT
iajs-3750	230	1	26	26	NUM
iajs-3750	230	2	.	.	PUNCT
iajs-3750	231	1	okafor	okafor	PROPN
iajs-3750	231	2	ci	ci	PROPN
iajs-3750	231	3	.	.	PUNCT
iajs-3750	232	1	the	the	DET
iajs-3750	232	2	metabolic	metabolic	NOUN
iajs-3750	232	3	syndrome	syndrome	NOUN
iajs-3750	232	4	in	in	ADP
iajs-3750	232	5	africa	africa	PROPN
iajs-3750	232	6	:	:	PUNCT
iajs-3750	232	7	current	current	ADJ
iajs-3750	232	8	trends	trend	NOUN
iajs-3750	232	9	.	.	PUNCT
iajs-3750	233	1	indian	indian	PROPN
iajs-3750	233	2	j	j	PROPN
iajs-3750	233	3	endocrinol	endocrinol	NOUN
iajs-3750	233	4	metab	metab	NOUN
iajs-3750	233	5	.	.	PUNCT
iajs-3750	234	1	2012	2012	NUM
iajs-3750	234	2	;	;	PUNCT
iajs-3750	234	3	16(1):56–66	16(1):56–66	NUM
iajs-3750	234	4	.	.	PUNCT
iajs-3750	235	1	https://doi.org/10.4103/2230-8210.91191	https://doi.org/10.4103/2230-8210.91191	PROPN
iajs-3750	235	2	.	.	PUNCT
iajs-3750	236	1	27	27	NUM
iajs-3750	236	2	.	.	PUNCT
iajs-3750	237	1	zhang	zhang	PROPN
iajs-3750	237	2	l	l	PROPN
iajs-3750	237	3	,	,	PUNCT
iajs-3750	237	4	ma	ma	PROPN
iajs-3750	237	5	x	x	PROPN
iajs-3750	237	6	,	,	PUNCT
iajs-3750	237	7	jiang	jiang	PROPN
iajs-3750	237	8	z	z	PROPN
iajs-3750	237	9	,	,	PUNCT
iajs-3750	237	10	zhang	zhang	PROPN
iajs-3750	237	11	k	k	PROPN
iajs-3750	237	12	,	,	PUNCT
iajs-3750	237	13	zhang	zhang	PROPN
iajs-3750	237	14	m	m	PROPN
iajs-3750	237	15	,	,	PUNCT
iajs-3750	237	16	li	li	PROPN
iajs-3750	237	17	y	y	PROPN
iajs-3750	237	18	,	,	PUNCT
iajs-3750	237	19	zhao	zhao	PROPN
iajs-3750	237	20	x	x	PROPN
iajs-3750	237	21	,	,	PUNCT
iajs-3750	237	22	xiong	xiong	PROPN
iajs-3750	237	23	h.	h.	PROPN
iajs-3750	237	24	liver	liver	NOUN
iajs-3750	237	25	enzymes	enzyme	NOUN
iajs-3750	237	26	and	and	CCONJ
iajs-3750	237	27	metabolic	metabolic	NOUN
iajs-3750	237	28	syndrome	syndrome	NOUN
iajs-3750	237	29	:	:	PUNCT
iajs-3750	237	30	a	a	DET
iajs-3750	237	31	large	large	ADJ
iajs-3750	237	32	-	-	PUNCT
iajs-3750	237	33	scale	scale	NOUN
iajs-3750	237	34	case	case	NOUN
iajs-3750	237	35	-	-	PUNCT
iajs-3750	237	36	control	control	NOUN
iajs-3750	237	37	study	study	NOUN
iajs-3750	237	38	.	.	PUNCT
iajs-3750	238	1	oncotarget	oncotarget	NOUN
iajs-3750	238	2	.	.	PUNCT
iajs-3750	239	1	2015	2015	NUM
iajs-3750	239	2	;	;	PUNCT
iajs-3750	239	3	6(29):26782	6(29):26782	NUM
iajs-3750	239	4	-	-	SYM
iajs-3750	239	5	26788	26788	NUM
iajs-3750	239	6	.	.	PUNCT
iajs-3750	240	1	https://doi.org/10.18632/oncotarget.5792	https://doi.org/10.18632/oncotarget.5792	X
iajs-3750	240	2	28	28	NUM
iajs-3750	240	3	.	.	PUNCT
iajs-3750	241	1	paredes	paredes	PROPN
iajs-3750	241	2	s	s	PROPN
iajs-3750	241	3	,	,	PUNCT
iajs-3750	241	4	fonseca	fonseca	PROPN
iajs-3750	241	5	l	l	PROPN
iajs-3750	241	6	,	,	PUNCT
iajs-3750	241	7	ribeiro	ribeiro	PROPN
iajs-3750	241	8	l	l	PROPN
iajs-3750	241	9	,	,	PUNCT
iajs-3750	241	10	ramos	ramos	PROPN
iajs-3750	241	11	h	h	PROPN
iajs-3750	241	12	,	,	PUNCT
iajs-3750	241	13	oliveira	oliveira	PROPN
iajs-3750	241	14	jc	jc	PROPN
iajs-3750	241	15	,	,	PUNCT
iajs-3750	241	16	palma	palma	PROPN
iajs-3750	241	17	i.	i.	PROPN
iajs-3750	241	18	novel	novel	PROPN
iajs-3750	241	19	and	and	CCONJ
iajs-3750	241	20	traditional	traditional	ADJ
iajs-3750	241	21	lipid	lipid	NOUN
iajs-3750	241	22	profiles	profile	NOUN
iajs-3750	241	23	in	in	ADP
iajs-3750	241	24	metabolic	metabolic	NOUN
iajs-3750	241	25	syndrome	syndrome	NOUN
iajs-3750	241	26	reveal	reveal	VERB
iajs-3750	241	27	a	a	DET
iajs-3750	241	28	high	high	ADJ
iajs-3750	241	29	atherogenicity	atherogenicity	NOUN
iajs-3750	241	30	.	.	PUNCT
iajs-3750	242	1	sci	sci	PROPN
iajs-3750	242	2	rep	rep	PROPN
iajs-3750	242	3	.	.	PROPN
iajs-3750	242	4	2019	2019	NUM
iajs-3750	242	5	;	;	PUNCT
iajs-3750	242	6	9:11792	9:11792	NUM
iajs-3750	242	7	.	.	PUNCT
iajs-3750	242	8	https://doi.org/10.1038/s41598-019-48120-5	https://doi.org/10.1038/s41598-019-48120-5	PROPN
iajs-3750	242	9	29	29	NUM
iajs-3750	242	10	.	.	PUNCT
iajs-3750	243	1	kosmas	kosmas	PROPN
iajs-3750	243	2	ce	ce	PROPN
iajs-3750	243	3	,	,	PUNCT
iajs-3750	243	4	rodriguez	rodriguez	PROPN
iajs-3750	243	5	polanco	polanco	PROPN
iajs-3750	243	6	s	s	PROPN
iajs-3750	243	7	,	,	PUNCT
iajs-3750	243	8	bousvarou	bousvarou	PROPN
iajs-3750	243	9	md	md	PROPN
iajs-3750	243	10	,	,	PUNCT
iajs-3750	243	11	papakonstantinou	papakonstantinou	PROPN
iajs-3750	243	12	ej	ej	PROPN
iajs-3750	243	13	,	,	PUNCT
iajs-3750	243	14	peña	peña	PROPN
iajs-3750	243	15	genao	genao	PROPN
iajs-3750	243	16	e	e	PROPN
iajs-3750	243	17	,	,	PUNCT
iajs-3750	243	18	guzman	guzman	PROPN
iajs-3750	243	19	e	e	PROPN
iajs-3750	243	20	,	,	PUNCT
iajs-3750	243	21	et	et	PROPN
iajs-3750	243	22	al	al	PROPN
iajs-3750	243	23	.	.	PUNCT
iajs-3750	244	1	the	the	DET
iajs-3750	244	2	triglyceride	triglyceride	ADJ
iajs-3750	244	3	/	/	SYM
iajs-3750	244	4	high	high	ADJ
iajs-3750	244	5	-	-	PUNCT
iajs-3750	244	6	density	density	NOUN
iajs-3750	244	7	lipoprotein	lipoprotein	ADJ
iajs-3750	244	8	cholesterol	cholesterol	NOUN
iajs-3750	244	9	(	(	PUNCT
iajs-3750	244	10	tg	tg	PROPN
iajs-3750	244	11	/	/	SYM
iajs-3750	244	12	hdl	hdl	PROPN
iajs-3750	244	13	-	-	PUNCT
iajs-3750	244	14	c	c	NOUN
iajs-3750	244	15	)	)	PUNCT
iajs-3750	244	16	ratio	ratio	NOUN
iajs-3750	244	17	as	as	ADP
iajs-3750	244	18	a	a	DET
iajs-3750	244	19	risk	risk	NOUN
iajs-3750	244	20	marker	marker	NOUN
iajs-3750	244	21	for	for	ADP
iajs-3750	244	22	metabolic	metabolic	NOUN
iajs-3750	244	23	syndrome	syndrome	NOUN
iajs-3750	244	24	and	and	CCONJ
iajs-3750	244	25	cardiovascular	cardiovascular	ADJ
iajs-3750	244	26	disease	disease	NOUN
iajs-3750	244	27	.	.	PUNCT
iajs-3750	245	1	diagnostics	diagnostic	NOUN
iajs-3750	245	2	.	.	PUNCT
iajs-3750	246	1	2023	2023	NUM
iajs-3750	246	2	;	;	PUNCT
iajs-3750	246	3	13(5):929	13(5):929	NOUN
iajs-3750	246	4	.	.	PUNCT
iajs-3750	247	1	https://doi.org/10.3390/diagnostics13050929	https://doi.org/10.3390/diagnostics13050929	NOUN
iajs-3750	247	2	30	30	NUM
iajs-3750	247	3	.	.	PUNCT
iajs-3750	248	1	szentpéteri	szentpéteri	VERB
iajs-3750	248	2	a	a	DET
iajs-3750	248	3	,	,	PUNCT
iajs-3750	248	4	lőrincz	lőrincz	ADJ
iajs-3750	248	5	h	h	NOUN
iajs-3750	248	6	,	,	PUNCT
iajs-3750	248	7	somodi	somodi	PROPN
iajs-3750	248	8	s	s	PROPN
iajs-3750	248	9	,	,	PUNCT
iajs-3750	248	10	varga	varga	PROPN
iajs-3750	248	11	ve	ve	PROPN
iajs-3750	248	12	,	,	PUNCT
iajs-3750	248	13	paragh	paragh	PROPN
iajs-3750	248	14	g	g	PROPN
iajs-3750	248	15	jr	jr	PROPN
iajs-3750	248	16	,	,	PUNCT
iajs-3750	248	17	seres	sere	VERB
iajs-3750	248	18	i	i	PRON
iajs-3750	248	19	,	,	PUNCT
iajs-3750	248	20	paragh	paragh	PROPN
iajs-3750	248	21	g	g	PROPN
iajs-3750	248	22	,	,	PUNCT
iajs-3750	248	23	harangi	harangi	PROPN
iajs-3750	248	24	m.	m.	NOUN
iajs-3750	248	25	serum	serum	PROPN
iajs-3750	248	26	obestatin	obestatin	NOUN
iajs-3750	248	27	level	level	NOUN
iajs-3750	248	28	strongly	strongly	ADV
iajs-3750	248	29	correlates	correlate	VERB
iajs-3750	248	30	with	with	ADP
iajs-3750	248	31	lipoprotein	lipoprotein	ADJ
iajs-3750	248	32	subfractions	subfraction	NOUN
iajs-3750	248	33	in	in	ADP
iajs-3750	248	34	non	non	ADJ
iajs-3750	248	35	-	-	ADJ
iajs-3750	248	36	diabetic	diabetic	ADJ
iajs-3750	248	37	obese	obese	ADJ
iajs-3750	248	38	patients	patient	NOUN
iajs-3750	248	39	.	.	PUNCT
iajs-3750	249	1	lipids	lipids	ADP
iajs-3750	249	2	health	health	NOUN
iajs-3750	249	3	dis	dis	PROPN
iajs-3750	249	4	.	.	PUNCT
iajs-3750	250	1	2018	2018	NUM
iajs-3750	250	2	;	;	PUNCT
iajs-3750	251	1	17(1):39	17(1):39	NUM
iajs-3750	251	2	.	.	PUNCT
iajs-3750	252	1	https://doi.org/10.1186/s12944-018-0691-y	https://doi.org/10.1186/s12944-018-0691-y	PROPN
iajs-3750	252	2	.	.	PROPN
iajs-3750	253	1	31	31	NUM
iajs-3750	253	2	.	.	PUNCT
iajs-3750	254	1	sarac	sarac	PROPN
iajs-3750	254	2	f	f	PROPN
iajs-3750	254	3	,	,	PUNCT
iajs-3750	254	4	basoglu	basoglu	PROPN
iajs-3750	254	5	o	o	NOUN
iajs-3750	254	6	,	,	PUNCT
iajs-3750	254	7	gunduz	gunduz	NOUN
iajs-3750	254	8	c	c	NOUN
iajs-3750	254	9	,	,	PUNCT
iajs-3750	254	10	bayrak	bayrak	PROPN
iajs-3750	254	11	h	h	NOUN
iajs-3750	254	12	,	,	PUNCT
iajs-3750	254	13	avci	avci	PROPN
iajs-3750	254	14	cb	cb	PROPN
iajs-3750	254	15	,	,	PUNCT
iajs-3750	254	16	akcicek	akcicek	PROPN
iajs-3750	254	17	f.	f.	PROPN
iajs-3750	254	18	association	association	PROPN
iajs-3750	254	19	of	of	ADP
iajs-3750	254	20	osteopontin	osteopontin	PROPN
iajs-3750	254	21	and	and	CCONJ
iajs-3750	254	22	tumor	tumor	NOUN
iajs-3750	254	23	necrosis	necrosis	NOUN
iajs-3750	254	24	factor	factor	NOUN
iajs-3750	254	25	-	-	PUNCT
iajs-3750	254	26	α	α	NOUN
iajs-3750	254	27	levels	level	NOUN
iajs-3750	254	28	with	with	ADP
iajs-3750	254	29	insulin	insulin	NOUN
iajs-3750	254	30	resistance	resistance	NOUN
iajs-3750	254	31	in	in	ADP
iajs-3750	254	32	obese	obese	ADJ
iajs-3750	254	33	patients	patient	NOUN
iajs-3750	254	34	with	with	ADP
iajs-3750	254	35	obstructive	obstructive	ADJ
iajs-3750	254	36	sleep	sleep	NOUN
iajs-3750	254	37	apnea	apnea	NOUN
iajs-3750	254	38	syndrome	syndrome	NOUN
iajs-3750	254	39	.	.	PUNCT
iajs-3750	255	1	j	j	PROPN
iajs-3750	255	2	endocrinol	endocrinol	NOUN
iajs-3750	255	3	invest	inv	ADJ
iajs-3750	255	4	.	.	PUNCT
iajs-3750	256	1	2011	2011	NUM
iajs-3750	256	2	;	;	PUNCT
iajs-3750	257	1	34(7):528–533	34(7):528–533	X
iajs-3750	257	2	.	.	PUNCT
iajs-3750	258	1	https://doi.org/10.3275/7287	https://doi.org/10.3275/7287	X
iajs-3750	258	2	.	.	PUNCT
iajs-3750	259	1	https://doi.org/10.1016/b978-0-12-820649-2.00152-2	https://doi.org/10.1016/b978-0-12-820649-2.00152-2	NOUN
iajs-3750	259	2	https://doi.org/10.29252/ijwph.14.4.409	https://doi.org/10.29252/ijwph.14.4.409	PUNCT
iajs-3750	259	3	https://doi.org/10.3316/informit.154784110868319	https://doi.org/10.3316/informit.154784110868319	PRON
iajs-3750	260	1	https://doi.org/10.3389/fpubh.2020.00108	https://doi.org/10.3389/fpubh.2020.00108	PROPN
iajs-3750	260	2	https://doi.org/10.1161/circulationaha.109.887521	https://doi.org/10.1161/circulationaha.109.887521	VERB
iajs-3750	260	3	https://doi.org/10.1186/s12889-021-10429-0	https://doi.org/10.1186/s12889-021-10429-0	ADJ
iajs-3750	260	4	https://doi.org/10.3390/ijerph18042142	https://doi.org/10.3390/ijerph18042142	NOUN
iajs-3750	260	5	https://doi.org/10.4062/biomolther.2021.122	https://doi.org/10.4062/biomolther.2021.122	NOUN
iajs-3750	260	6	https://doi.org/10.1515/cclm-2023-0360	https://doi.org/10.1515/cclm-2023-0360	NOUN
iajs-3750	260	7	http://www.biomedcentral.com/1471-2261/14/177	http://www.biomedcentral.com/1471-2261/14/177	NOUN
iajs-3750	260	8	https://doi.org/10.4103/2230-8210.91191	https://doi.org/10.4103/2230-8210.91191	PROPN
iajs-3750	260	9	https://doi.org/10.18632/oncotarget.5792	https://doi.org/10.18632/oncotarget.5792	PROPN
iajs-3750	260	10	https://doi.org/10.1038/s41598-019-48120-5	https://doi.org/10.1038/s41598-019-48120-5	PROPN
iajs-3750	261	1	https://doi.org/10.3390/diagnostics13050929	https://doi.org/10.3390/diagnostics13050929	PROPN
iajs-3750	262	1	https://doi.org/10.1186/s12944-018-0691-y	https://doi.org/10.1186/s12944-018-0691-y	PROPN
iajs-3750	262	2	https://doi.org/10.3275/7287	https://doi.org/10.3275/7287	PROPN
iajs-3750	262	3	ihjpas	ihjpas	PROPN
iajs-3750	262	4	.	.	PUNCT
iajs-3750	263	1	2025	2025	NUM
iajs-3750	263	2	,	,	PUNCT
iajs-3750	263	3	38(3	38(3	NUM
iajs-3750	263	4	)	)	PUNCT
iajs-3750	263	5	264	264	NUM
iajs-3750	263	6	32	32	NUM
iajs-3750	263	7	.	.	PUNCT
iajs-3750	264	1	bartosińska	bartosińska	PROPN
iajs-3750	264	2	j	j	PROPN
iajs-3750	264	3	,	,	PUNCT
iajs-3750	264	4	przepiórka	przepiórka	PROPN
iajs-3750	264	5	-	-	PUNCT
iajs-3750	264	6	kosińska	kosińska	PROPN
iajs-3750	264	7	j	j	PROPN
iajs-3750	264	8	,	,	PUNCT
iajs-3750	264	9	sarecka	sarecka	PROPN
iajs-3750	264	10	-	-	PUNCT
iajs-3750	264	11	hujar	hujar	PROPN
iajs-3750	264	12	b	b	NOUN
iajs-3750	264	13	,	,	PUNCT
iajs-3750	264	14	raczkiewicz	raczkiewicz	ADJ
iajs-3750	264	15	d	d	PROPN
iajs-3750	264	16	,	,	PUNCT
iajs-3750	264	17	kowal	kowal	PROPN
iajs-3750	264	18	m	m	PROPN
iajs-3750	264	19	,	,	PUNCT
iajs-3750	264	20	chyl	chyl	PROPN
iajs-3750	264	21	-	-	PUNCT
iajs-3750	264	22	surdacka	surdacka	PROPN
iajs-3750	264	23	k	k	PROPN
iajs-3750	264	24	,	,	PUNCT
iajs-3750	264	25	bartosiński	bartosiński	PROPN
iajs-3750	264	26	j	j	PROPN
iajs-3750	264	27	,	,	PUNCT
iajs-3750	264	28	kosiński	kosiński	PROPN
iajs-3750	264	29	j	j	PROPN
iajs-3750	264	30	,	,	PUNCT
iajs-3750	264	31	krasowska	krasowska	PROPN
iajs-3750	264	32	d	d	PROPN
iajs-3750	264	33	,	,	PUNCT
iajs-3750	264	34	chodorowska	chodorowska	PROPN
iajs-3750	264	35	g.	g.	PROPN
iajs-3750	264	36	osteopontin	osteopontin	PROPN
iajs-3750	264	37	serum	serum	PROPN
iajs-3750	264	38	concentration	concentration	NOUN
iajs-3750	264	39	and	and	CCONJ
iajs-3750	264	40	metabolic	metabolic	NOUN
iajs-3750	264	41	syndrome	syndrome	NOUN
iajs-3750	264	42	in	in	ADP
iajs-3750	264	43	male	male	ADJ
iajs-3750	264	44	psoriatic	psoriatic	ADJ
iajs-3750	264	45	patients	patient	NOUN
iajs-3750	264	46	.	.	PUNCT
iajs-3750	265	1	j	j	PROPN
iajs-3750	265	2	clin	clin	PROPN
iajs-3750	265	3	med	med	PROPN
iajs-3750	265	4	.	.	PROPN
iajs-3750	265	5	2021	2021	NUM
iajs-3750	265	6	;	;	PUNCT
iajs-3750	265	7	10(4):755	10(4):755	NUM
iajs-3750	265	8	.	.	PUNCT
iajs-3750	266	1	https://doi.org/10.3390/jcm10040755	https://doi.org/10.3390/jcm10040755	PROPN
iajs-3750	266	2	.	.	PROPN
iajs-3750	267	1	33	33	NUM
iajs-3750	267	2	.	.	PUNCT
iajs-3750	268	1	ahmad	ahmad	PROPN
iajs-3750	268	2	r	r	PROPN
iajs-3750	268	3	,	,	PUNCT
iajs-3750	268	4	al	al	PROPN
iajs-3750	268	5	-	-	PUNCT
iajs-3750	268	6	mass	mass	PROPN
iajs-3750	268	7	a	a	PROPN
iajs-3750	268	8	,	,	PUNCT
iajs-3750	268	9	al	al	PROPN
iajs-3750	268	10	-	-	PUNCT
iajs-3750	268	11	ghawas	ghawas	PROPN
iajs-3750	268	12	d	d	PROPN
iajs-3750	268	13	,	,	PUNCT
iajs-3750	268	14	shareif	shareif	NOUN
iajs-3750	268	15	n	n	CCONJ
iajs-3750	268	16	,	,	PUNCT
iajs-3750	268	17	zghoul	zghoul	PROPN
iajs-3750	268	18	n	n	CCONJ
iajs-3750	268	19	,	,	PUNCT
iajs-3750	268	20	melhem	melhem	PROPN
iajs-3750	268	21	m	m	PROPN
iajs-3750	268	22	,	,	PUNCT
iajs-3750	268	23	hasan	hasan	PROPN
iajs-3750	268	24	a	a	PROPN
iajs-3750	268	25	,	,	PUNCT
iajs-3750	268	26	al	al	PROPN
iajs-3750	268	27	-	-	PUNCT
iajs-3750	268	28	ghimlas	ghimla	NOUN
iajs-3750	268	29	f	f	NOUN
iajs-3750	268	30	,	,	PUNCT
iajs-3750	268	31	dermime	dermime	NOUN
iajs-3750	268	32	s	s	PROPN
iajs-3750	268	33	,	,	PUNCT
iajs-3750	268	34	behbehani	behbehani	PROPN
iajs-3750	268	35	k.	k.	PROPN
iajs-3750	268	36	interaction	interaction	NOUN
iajs-3750	268	37	of	of	ADP
iajs-3750	268	38	osteopontin	osteopontin	NOUN
iajs-3750	268	39	with	with	ADP
iajs-3750	268	40	il-18	il-18	NOUN
iajs-3750	268	41	in	in	ADP
iajs-3750	268	42	obese	obese	ADJ
iajs-3750	268	43	individuals	individual	NOUN
iajs-3750	268	44	:	:	PUNCT
iajs-3750	268	45	implications	implication	NOUN
iajs-3750	268	46	for	for	ADP
iajs-3750	268	47	insulin	insulin	NOUN
iajs-3750	268	48	resistance	resistance	NOUN
iajs-3750	268	49	.	.	PUNCT
iajs-3750	269	1	plos	plos	PROPN
iajs-3750	269	2	one	one	NUM
iajs-3750	269	3	.	.	PUNCT
iajs-3750	269	4	2013	2013	NUM
iajs-3750	269	5	;	;	PUNCT
iajs-3750	269	6	8(5):e63944	8(5):e63944	NUM
iajs-3750	269	7	.	.	PUNCT
iajs-3750	270	1	https://doi.org/10.1371/journal.pone.0063944	https://doi.org/10.1371/journal.pone.0063944	AUX
iajs-3750	270	2	.	.	PUNCT
iajs-3750	271	1	34	34	NUM
iajs-3750	271	2	.	.	PUNCT
iajs-3750	272	1	nahm	nahm	PROPN
iajs-3750	272	2	fs	fs	PROPN
iajs-3750	272	3	.	.	PROPN
iajs-3750	273	1	receiver	receiver	ADJ
iajs-3750	273	2	operating	operate	VERB
iajs-3750	273	3	characteristic	characteristic	ADJ
iajs-3750	273	4	curve	curve	NOUN
iajs-3750	273	5	:	:	PUNCT
iajs-3750	273	6	overview	overview	NOUN
iajs-3750	273	7	and	and	CCONJ
iajs-3750	273	8	practical	practical	ADJ
iajs-3750	273	9	use	use	NOUN
iajs-3750	273	10	for	for	ADP
iajs-3750	273	11	clinicians	clinician	NOUN
iajs-3750	273	12	.	.	PUNCT
iajs-3750	274	1	korean	korean	PROPN
iajs-3750	274	2	j	j	PROPN
iajs-3750	274	3	anesthesiol	anesthesiol	NOUN
iajs-3750	274	4	.	.	PUNCT
iajs-3750	275	1	2022	2022	NUM
iajs-3750	275	2	;	;	PUNCT
iajs-3750	276	1	75(1):25–36	75(1):25–36	NUM
iajs-3750	276	2	.	.	PUNCT
iajs-3750	277	1	https://doi.org/10.4097/kja.21209	https://doi.org/10.4097/kja.21209	NOUN
iajs-3750	277	2	.	.	PUNCT
iajs-3750	278	1	https://doi.org/10.3390/jcm10040755	https://doi.org/10.3390/jcm10040755	PROPN
iajs-3750	278	2	https://doi.org/10.1371/journal.pone.0063944	https://doi.org/10.1371/journal.pone.0063944	AUX
iajs-3750	278	3	https://doi.org/10.4097/kja.21209	https://doi.org/10.4097/kja.21209	VERB